UniProtAccession	GeneName	Mutation	WT	Position	MUT	AlignmentPosition	MutationType	Description	Source
Q13131	PRKAA1	V307G	V	307	G	822	activating	MUTAGEN V->G,Q: Activates the kinase activity.	UniProt
P00519	ABL1	A337T	A	337	T	324	increase	VARIANT A -> T (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499548)	UniProt
P00519	ABL1	Y226C	Y	226	C	13	increase	VARIANT Y -> C (in CHDSKM; increases kinase activity; no effect on protein levels; dbSNP:rs1060499547)	UniProt
Q07912	TNK2	L487F	L	487	F	-	activating	MUTAGEN L->F: Constantly active kinase.	UniProt
Q07912	TNK2	V365R	V	365	R	762	increase	MUTAGEN V->R: Increased autophosphorylation at Y-284.	UniProt
P36896	ACVR1B	T206V	T	206	V	27	activating	MUTAGEN T->V: Leads to constitutive activation.	UniProt
P31749	AKT1	E17K	E	17	K	-	increase	VARIANT E->K: No effect on membrane localization. Loss of membrane localization; when associated with Q-20.	UniProt
Q9Y243	AKT3	E17K	E	17	K	-	activating	VARIANT E -> K (in MPPH2 and melanoma; results in activation of AKT; dbSNP:rs397514606)	UniProt
Q9UM73	ALK	F1174L	F	1174	L	185	activating	VARIANT F -> L (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs863225281)	UniProt
Q9UM73	ALK	F1174V	F	1174	V	185	activating	VARIANT F -> V (in NBLST3; somatic mutation; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs281864719)	UniProt
Q9UM73	ALK	R1275Q	R	1275	Q	449	activating	VARIANT R -> Q (in NBLST3; constitutively activated; retained in the endoplasmic reticulum and Golgi compartments; dbSNP:rs113994087)	UniProt
O14965	AURKA	I57V	I	57	V	-	increase	VARIANT I -> V (increased kinase activity; dbSNP:rs1047972)	UniProt
O14965	AURKA	T288D	T	288	D	513	increase	MUTAGEN T->D: Mimics phosphorylation state and increases kinase activity.	UniProt
O14965	AURKA	V174M	V	174	M	145	activating	VARIANT V -> M (in a metastatic melanoma sample; somatic mutation; constitutively enhanced kinase activity)	UniProt
Q13873	BMPR2	R899P	R	899	P	-	activating	VARIANT R -> P (in PPH1; leads to constitutive activation of the MAPK14 pathway; dbSNP:rs137852752)	UniProt
P15056	BRAF	G464V	G	464	V	38	increase	VARIANT G -> V (in a colorectal cancer cell line; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913348)	UniProt
P15056	BRAF	G469A	G	469	A	43	increase	VARIANT G -> A (in NHL; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913355)	UniProt
P15056	BRAF	L597V	L	597	V	446	increase	VARIANT L -> V (in NS7; also in a lung adenocarcinoma sample; somatic mutation; elevated kinase activity; efficiently induces cell transformation; dbSNP:rs121913369)	UniProt
P15056	BRAF	R671K	R	671	K	640	increase	MUTAGEN R->K: Increased kinase activity and stability in response to EGF treatment.	UniProt
Q8IWQ3	BRSK2	T174E	T	174	E	513	activating	MUTAGEN T->E: Constitutively activated.	UniProt
Q8IWQ3	BRSK2	T443A	T	443	A	-	activating	MUTAGEN T->A: Constitutively activated. Promotes formation of actin stress fibers.	UniProt
Q9BWU1	CDK19	Y32H	Y	32	H	42	increase	VARIANT Y -> H (in DEE87; fails to rescue neurologic phenotypes in a Drosophila model system; increased protein kinase activity; dbSNP:rs1236246272)	UniProt
P24941	CDK2	T14A	T	14	A	41	increase	MUTAGEN T->A: 2-fold increase in activity.	UniProt
P24941	CDK2	Y15F	Y	15	F	42	increase	MUTAGEN Y->F: 2-fold increase in activity.	UniProt
P50750	CDK9	S175A	S	175	A	457	activating	MUTAGEN S->A: Constitutive kinase activity.	UniProt
P50750	CDK9	T186D	T	186	D	512	activating	MUTAGEN T->D: Mimics autophosphorylation; constitutive kinase activity, independently of calcium signaling.	UniProt
P07333	CSF1R	L301S	L	301	S	-	activating	MUTAGEN L->S: Constitutive kinase activity.	UniProt
Q08345	DDR1	N211A	N	211	A	-	activating	MUTAGEN N->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	UniProt
Q08345	DDR1	S213A	S	213	A	-	activating	MUTAGEN S->A: Phosphorylates regardless of collagen presence, collagen addition does not alter significantly the levels of constitutive phosphorylation.	UniProt
Q16832	DDR2	L610P	L	610	P	130	increase	VARIANT L -> P (in WRCN; increased autophosphorylation in patient fibroblasts)	UniProt
Q16832	DDR2	Y740C	Y	740	C	462	increase	VARIANT Y -> C (in WRCN; increased autophosphorylation in patient fibroblasts)	UniProt
Q9Y463	DYRK1B	H90P	H	90	P	10	increase	VARIANT H -> P (in AOMS3; expression of glucose-6-phosphatase is significantly higher than wild-type; dbSNP:rs587777380)	UniProt
O43781	DYRK3	S350E	S	350	E	438	increase	MUTAGEN S->E,D: Phosphomimetic mutant; increased stability of the protein.	UniProt
P19525	EIF2AK2	G130R	G	130	R	-	increase	VARIANT G -> R (in DYT33; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	UniProt
P19525	EIF2AK2	N32T	N	32	T	-	increase	VARIANT N -> T (in DYT33; unknown pathological significance; gain-of-function variant resulting in increased levels of phosphorylated EIF2AK2 and EIF2A in patient cells compared to controls)	UniProt
P00533	EGFR	E709G	E	709	G	28	activating	VARIANT E -> G (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs397517085)	UniProt
P00533	EGFR	G719S	G	719	S	38	activating	VARIANT G -> S (found in a lung cancer sample; somatic mutation; strongly increased kinase activity; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs28929495)	UniProt
P00533	EGFR	L858R	L	858	R	446	activating	VARIANT L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity; more sensitive to gefitinib than wild-type; dbSNP:rs121434568)	UniProt
P06213	INSR	Y1011A	Y	1011	A	17	increase	MUTAGEN Y->A: Increases kinase activity.	UniProt
P00533	EGFR	L861Q	L	861	Q	453	activating	VARIANT L -> Q (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913444)	UniProt
P00533	EGFR	S768I	S	768	I	182	activating	VARIANT S -> I (found in a lung cancer sample; constitutively activated kinase with higher levels of basal autophosphorylation; more sensitive to gefitinib than wild-type; dbSNP:rs121913465)	UniProt
P00533	EGFR	T790M	T	790	M	267	increase	VARIANT T -> M (found in a lung cancer sample; increased kinase activity; dbSNP:rs121434569)	UniProt
P00533	EGFR	V689M	V	689	M	8	activating	MUTAGEN V->M: Constitutively activated kinase.	UniProt
P29317	EPHA2	R721Q	R	721	Q	354	activating	VARIANT R -> Q (in CTRCT6; retained in the cytoplasm and constitutively active it alters EPHA2 signaling; dbSNP:rs116506614)	UniProt
P21860	ERBB3	A1337T	A	1337	T	-	increase	VARIANT A -> T (in FERLK; risk factor for erythroleukemia; results in increased ERBB-mediated signaling; results in a block of erythroid differentiation and increased cell proliferation; dbSNP:rs755855285)	UniProt
Q15303	ERBB4	I947R	I	947	R	753	activating	MUTAGEN I->R: Constitutively autophosphorylated.	UniProt
Q15303	ERBB4	Q646C	Q	646	C	-	activating	MUTAGEN Q->C: Constitutively activated kinase.	UniProt
P07332	FES	L145P	L	145	P	-	activating	MUTAGEN L->P: Constitutively activated kinase that can act as oncogene. Promotes myeloid cell survival and proliferation.	UniProt
P21802	FGFR2	C278F	C	278	F	-	activating	VARIANT C -> F (in CS, JWS and PS; forms disulfide-linked dimers with constitutive kinase activity, is retained in an intracellular compartment and not detected at the cell surface; dbSNP:rs776587763)	UniProt
P21802	FGFR2	E565A	E	565	A	268	activating	MUTAGEN E->A: Constitutive kinase activity.	UniProt
P21802	FGFR2	E565G	E	565	G	268	activating	VARIANT E -> G (in PS; constitutive kinase activity; dbSNP:rs121918506)	UniProt
P21802	FGFR2	K526E	K	526	E	142	activating	VARIANT K -> E (in FSPC; constitutive kinase activity; dbSNP:rs121918507)	UniProt
P21802	FGFR2	K641R	K	641	R	440	activating	VARIANT K -> R (in PS; constitutive kinase activity; dbSNP:rs1057519047)	UniProt
P21802	FGFR2	K659N	K	659	N	510	activating	VARIANT K -> N (in craniosynostosis; constitutive kinase activity; dbSNP:rs1589722765)	UniProt
P21802	FGFR2	N549H	N	549	H	204	activating	VARIANT N -> H (in CS; constitutive kinase activity; dbSNP:rs1057519045)	UniProt
P21802	FGFR2	N549T	N	549	T	204	activating	MUTAGEN N->T: Constitutive kinase activity.	UniProt
P22607	FGFR3	G380R	G	380	R	-	activating	VARIANT G -> R (in keratinocytic non-epidermolytic nevus and ACH; very common mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs28931614)	UniProt
P22607	FGFR3	K650D	K	650	D	510	activating	MUTAGEN K->D: Constitutively activated kinase.	UniProt
P22607	FGFR3	K650E	K	650	E	510	activating	VARIANT K -> E (in KERSEB, TD2, TGCT and BLC; bladder transitional cell carcinoma; somatic mutation; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs78311289)	UniProt
P22607	FGFR3	K650L	K	650	L	510	activating	MUTAGEN K->L: Constitutively activated kinase.	UniProt
P22607	FGFR3	R248C	R	248	C	-	activating	VARIANT R -> C (in KERSEB, BLC, keratinocytic non-epidermolytic nevus and TD1; severe and lethal; also found as somatic mutation in one patient with multiple myeloma; constitutive dimerization and kinase activation; dbSNP:rs121913482)	UniProt
P22607	FGFR3	Y373C	Y	373	C	-	activating	VARIANT Y -> C (in KERSEB and TD1; disulfide-linked dimer with constitutive kinase activation; dbSNP:rs121913485)	UniProt
P09769	FGR	Y523F	Y	523	F	809	increase	MUTAGEN Y->F: Strongly increased catalytic activity. Functions as oncogene.	UniProt
P36888	FLT3	D835E	D	835	E	453	activating	VARIANT D -> E (in acute lymphoblastic leukemia patients and acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913487)	UniProt
P36888	FLT3	D835H	D	835	H	453	activating	VARIANT D -> H (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	UniProt
P36888	FLT3	D835N	D	835	N	453	activating	VARIANT D -> N (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	UniProt
P36888	FLT3	D835V	D	835	V	453	activating	VARIANT D -> V (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121909646)	UniProt
P36888	FLT3	D835Y	D	835	Y	453	activating	VARIANT D -> Y (in acute lymphoblastic leukemia patients and in acute myelogenous leukemia patients; somatic mutation; constitutively activated; dbSNP:rs121913488)	UniProt
P49841	GSK3B	S9A	S	9	A	-	activating	MUTAGEN S->A: Loss of phosphorylation; abolished inhibition of activity, leading to constitutively active.	UniProt
P25092	GUCY2C	S840I	S	840	I	-	increase	VARIANT S -> I (in DIAR6; activating mutation; exposure of the mutant receptor to its ligands results in markedly increased production of cyclic guanosine monophosphate; dbSNP:rs587776871)	UniProt
Q96GX5	MASTL	K72M	K	72	M	143	activating	MUTAGEN K->M: Hyperactive form.	UniProt
P08631	HCK	Y522F	Y	522	F	809	activating	MUTAGEN Y->F: Constitutively activated kinase, leading to cellular transformation.	UniProt
O15111	CHUK	S176E	S	176	E	461	activating	MUTAGEN S->E: Full activation.	UniProt
O14920	IKBKB	K171E	K	171	E	449	increase	MUTAGEN K->E: Increased activation of NF-kappa-B signaling.	UniProt
O14920	IKBKB	V203I	V	203	I	581	increase	VARIANT V -> I (in IMD15A; gain-of-function mutation resulting in increased activation of NF-kappa-B signaling pathway; dbSNP:rs1563340753)	UniProt
P22455	FGFR4	V550M	V	550	M	267	resistance	-	COSMIC
P23458	JAK1	A634D	A	634	D	-	activating	VARIANT A -> D (in AIIDE; constitutive gain of function resulting in increased receptor signaling pathway via JAK-STAT; no effect on protein abundance)	UniProt
P23458	JAK1	V658F	V	658	F	-	activating	MUTAGEN V->F: Constitutively active. Increased receptor signaling pathway via JAK-STAT.	UniProt
P52333	JAK3	C759R	C	759	R	-	activating	VARIANT C -> R (in T(-)B(+)NK(-) SCID; constitutive phosphorylation)	UniProt
P17612	PRKACA	L206R	L	206	R	532	activating	VARIANT L -> R (in PPNAD4; somatic mutation; the mutation results in cAMP-independent basal protein kinase activity and constitutive activation of protein kinase A; dbSNP:rs386352352)	UniProt
Q9UQM7	CAMK2A	P212Q	P	212	Q	617	increase	VARIANT P -> Q (in MRD53; increased basal autophosphorylation)	UniProt
Q13555	CAMK2G	R292P	R	292	P	814	activating	VARIANT R -> P (in MRD59; gain-of-function variant affecting regulation of neurite formation and arborization; results in constitutive autophosphorylation; dbSNP:rs397514627)	UniProt
Q13976	PRKG1	R177Q	R	177	Q	-	activating	VARIANT R -> Q (in AAT8; impairs cGMP binding; the mutant protein is constitutively active; dbSNP:rs397515330)	UniProt
P10721	KIT	D816F	D	816	F	453	activating	VARIANT D -> F (in MASTC; sporadic case; somatic mutation; requires 2 nucleotide substitutions; constitutively activated and is much more rapidly autophosphorylated than wild type)	UniProt
P10721	KIT	D816H	D	816	H	453	activating	VARIANT D -> H (in a testicular tumor; seminoma; somatic mutation; constitutively activated; dbSNP:rs121913506)	UniProt
P10721	KIT	D816I	D	816	I	453	activating	VARIANT D -> I (in MASTC; somatic mutation; constitutively activated; requires 2 nucleotide substitutions; dbSNP:rs1057519709)	UniProt
P10721	KIT	D816Y	D	816	Y	453	activating	VARIANT D -> Y (in MASTSYS and MASTC; also found in acute myeloid leukemia and a germ cell tumor of the testis; somatic mutation; constitutively activated; dbSNP:rs121913506)	UniProt
P10721	KIT	N822I	N	822	I	462	activating	VARIANT N -> I (in MASTC; constitutively activated; dbSNP:rs993022333)	UniProt
Q15139	PRKD1	Y463E	Y	463	E	-	activating	MUTAGEN Y->E: Constitutive activation and constitutive phosphorylation of S-738 and S-742.	UniProt
Q04759	PRKCQ	A148E	A	148	E	-	activating	MUTAGEN A->E: Constitutively active form.	UniProt
O75676	RPS6KA4	F709A	F	709	A	-	increase	MUTAGEN F->A: Strongly elevates basal activity.	UniProt
P43405	SYK	A353T	A	353	T	10	activating	VARIANT A -> T (in IMD82; constitutively active protein tyrosine kinase activity)	UniProt
P43405	SYK	M450I	M	450	I	269	activating	VARIANT M -> I (in IMD82; constitutively active protein tyrosine kinase activity)	UniProt
P43405	SYK	P342T	P	342	T	-	activating	VARIANT P -> T (in IMD82; constitutively active protein tyrosine kinase activity)	UniProt
P43405	SYK	S550F	S	550	F	578	activating	VARIANT S -> F (in IMD82; constitutively active protein tyrosine kinase activity)	UniProt
P43405	SYK	S550Y	S	550	Y	578	activating	VARIANT S -> Y (in IMD82; constitutively active protein tyrosine kinase activity)	UniProt
P53667	LIMK1	T508E	T	508	E	513	increase	MUTAGEN T->E: Phosphomimetic mutant; enhances kinase activity.	UniProt
P53671	LIMK2	T505E	T	505	E	513	increase	MUTAGEN T->E: Phosphomimetic mutant; enhances kinase activity.	UniProt
Q5S007	LRRK2	H2391D	H	2391	D	-	increase	MUTAGEN H->D: Increases kinase activity.	UniProt
Q5S007	LRRK2	I2020T	I	2020	T	446	increase	VARIANT I -> T (in PARK8; significant increase in autophosphorylation of about 40% in comparison to wild-type protein in vitro; shows a progressive reduction in neurite length and branching; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs35870237)	UniProt
Q5S007	LRRK2	R1441G	R	1441	G	-	increase	VARIANT R->G: Decreased membrane association when associated with D-727, D-728, or D-729. Inhibits autophosphorylation and RAB10 phosphorylation when associated with N-1348 or A-2017.	UniProt
Q5S007	LRRK2	R1728H	R	1728	H	-	increase	VARIANT R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs145364431)	UniProt
Q5S007	LRRK2	T2031S	T	2031	S	513	increase	VARIANT T -> S (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; dbSNP:rs78029637)	UniProt
P29376	LTK	E763K	E	763	K	768	increase	VARIANT E -> K (may possibly contribute to susceptibility to systemic lupus erythematosus; increases autophosphorylation and interaction with PI3-kinase subunit p85; dbSNP:rs76282169)	UniProt
P29376	LTK	G750E	G	750	E	753	increase	MUTAGEN G->E: Increases autophosphorylation and interaction with PI3-kinase subunit p85 (demonstrated with chimeric EGFR-LTK).	UniProt
P07948	LYN	Y508F	Y	508	F	810	increase	MUTAGEN Y->F: Abolishes autoinhibition and thereby increases kinase activity.	UniProt
Q13233	MAP3K1	L189P	L	189	P	-	increase	VARIANT L -> P (in SRXY6; increases phosphorylation of the downstream target MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	UniProt
Q13233	MAP3K1	L189R	L	189	R	-	increase	VARIANT L -> R (in SRXY6; increases phosphorylation of the downstream targets MAPK14 and MAPK3/MAPK1 compared to wild-type and enhances binding of RHOA to the mutant MAP3K1 complex; dbSNP:rs387906788)	UniProt
Q99683	MAP3K5	S1033A	S	1033	A	-	increase	MUTAGEN S->A: Enhanced induction of apoptosis and increased kinase activity.	UniProt
O43318	MAP3K7	P512L	P	512	L	-	increase	VARIANT P -> L (in FMD2; does not affect interaction with TAB2; does not affect homodimerization; increases autophosphorylation; increases MAPK signaling; increases NF-kappa-B signaling; dbSNP:rs886039230)	UniProt
Q92918	MAP4K1	T355A	T	355	A	-	activating	MUTAGEN T->A: Retains kinase activity. Not degraded by the Cul7-RING ubiquitin-protein ligase complex containing FBXW8.	UniProt
P49137	MAPKAPK2	K353R	K	353	R	822	increase	MUTAGEN K->R: Induces decreased sumoylation and increase in protein kinase activity.	UniProt
P49137	MAPKAPK2	S272D	S	272	D	639	increase	MUTAGEN S->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	UniProt
O15530	PDPK1	A277V	A	277	V	601	increase	MUTAGEN A->V: 3-fold increase in kinase activity.	UniProt
P49137	MAPKAPK2	T222D	T	222	D	513	increase	MUTAGEN T->D: Mimicks phosphorylation state, leading to slight increase of basal kinase activity.	UniProt
P49137	MAPKAPK2	T334D	T	334	D	803	increase	MUTAGEN T->D,E: Mimicks phosphorylation state, leading to elevated basal kinase activity.	UniProt
Q16644	MAPKAPK3	K73M	K	73	M	128	loss	MUTAGEN K->M: Higher affinity toward PCH2.	UniProt
Q8IW41	MAPKAPK5	L337G	L	337	G	-	activating	MUTAGEN L->G: Induces constitutive protein kinase activity.	UniProt
Q8IW41	MAPKAPK5	S212D	S	212	D	564	increase	MUTAGEN S->D: Mimicks phosphorylation state and displays a slightly higher protein kinase activity.	UniProt
Q8IW41	MAPKAPK5	T182D	T	182	D	513	activating	MUTAGEN T->D: Mimicks phosphorylation state and induces constitutive protein kinase activity.	UniProt
Q9P0L2	MARK1	T215E	T	215	E	513	activating	MUTAGEN T->E: Constitutively active.	UniProt
Q96L34	MARK4	T214E	T	214	E	513	increase	MUTAGEN T->E: Mimicks phosphorylation state, leading to increased activity. Decreases mTORC1 activity.	UniProt
P08581	MET	H1094L	H	1094	L	53	activating	VARIANT H -> L (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	UniProt
P08581	MET	H1094Y	H	1094	Y	53	activating	VARIANT H -> Y (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines; dbSNP:rs121913244)	UniProt
P08581	MET	H1106D	H	1106	D	118	activating	VARIANT H -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	UniProt
P08581	MET	V1092I	V	1092	I	46	activating	VARIANT V -> I (in RCCP; constitutive autophosphorylation; dbSNP:rs786202724)	UniProt
P08581	MET	Y1230D	Y	1230	D	457	activating	VARIANT Y -> D (in RCCP; constitutive autophosphorylation; causes malignant transformation in cell lines)	UniProt
P53778	MAPK12	D179A	D	179	A	457	activating	MUTAGEN D->A: Emulation of the active state.	UniProt
Q9BUB5	MKNK1	T385D	T	385	D	805	activating	MUTAGEN T->D: Constitutively active.	UniProt
Q9HBH9	MKNK2	T379D	T	379	D	805	activating	MUTAGEN T->D: Constitutively active.	UniProt
Q02750	MAP2K1	K57N	K	57	N	20	increase	VARIANT K -> N (in MEL; somatic mutation; results in increased MAPK signal transduction; dbSNP:rs869025608)	UniProt
Q02750	MAP2K1	M219V	M	219	V	461	increase	MUTAGEN M->V: Increases interaction with KSR1 and BRAF.	UniProt
Q02750	MAP2K1	N221Y	N	221	Y	512	increase	MUTAGEN N->Y: Increases interaction with KSR1 and BRAF.	UniProt
P36507	MAP2K2	P128Q	P	128	Q	196	increase	VARIANT P -> Q (in CFC4; results in increased kinase activity; dbSNP:rs267607230)	UniProt
P46734	MAP2K3	S218E	S	218	E	460	activating	MUTAGEN S->E: Constitutive activation.	UniProt
P46734	MAP2K3	T222E	T	222	E	512	activating	MUTAGEN T->E: Constitutive activation.	UniProt
P52564	MAP2K6	S207E	S	207	E	460	activating	MUTAGEN S->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.	UniProt
P52564	MAP2K6	T211E	T	211	E	512	activating	MUTAGEN T->E: Constitutive activation according to PubMed:8622669, but not to PubMed:8621675.	UniProt
Q5VT25	CDC42BPA	D478A	D	478	A	-	loss	MUTAGEN D->A: Prevents cleavage by CASP3, impairs the increase of its kinase activity and impairs extrusion apical actin ring assembly.	UniProt
P42345	MTOR	A1459D	A	1459	D	-	increase	VARIANT A -> D (in FCORD2; somatic mutation; increased TOR signaling)	UniProt
P42345	MTOR	C1483R	C	1483	R	-	increase	VARIANT C -> R (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1057519914)	UniProt
P42345	MTOR	E1799K	E	1799	K	-	increase	VARIANT E -> K (in SKS; results in increased mTOR signaling; dbSNP:rs863225264)	UniProt
P42345	MTOR	L1460P	L	1460	P	-	increase	VARIANT L -> P (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs1057519779)	UniProt
P42345	MTOR	L2427P	L	2427	P	-	increase	VARIANT L -> P (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113)	UniProt
P42345	MTOR	L2427Q	L	2427	Q	-	increase	VARIANT L -> Q (in FCORD2; somatic mutation; increased TOR signaling; increased kinase activity; dbSNP:rs1085307113)	UniProt
P42345	MTOR	S2215F	S	2215	F	-	increase	VARIANT S -> F (in FCORD2; somatic mutation; increased TOR signaling; dbSNP:rs587777894)	UniProt
P42345	MTOR	S2215Y	S	2215	Y	-	increase	VARIANT S -> Y (in FCORD2; also found in a colorectal adenocarcinoma sample; somatic mutation; increased TOR signaling; dbSNP:rs587777894)	UniProt
P42345	MTOR	T2173A	T	2173	A	-	increase	MUTAGEN T->A: Increased mTOR kinase activity.	UniProt
P51955	NEK2	S171D	S	171	D	462	increase	MUTAGEN S->D: Kinase activity increased by two fold.	UniProt
P51955	NEK2	T170E	T	170	E	461	increase	MUTAGEN T->E: Kinase activity increased by two fold.	UniProt
P51955	NEK2	T175E	T	175	E	513	increase	MUTAGEN T->E: Kinase activity increased by two fold.	UniProt
Q9HC98	NEK6	Y108A	Y	108	A	206	increase	MUTAGEN Y->A: Increase in catalytic activity.	UniProt
Q8TDX7	NEK7	Y97A	Y	97	A	206	increase	MUTAGEN Y->A: 5-fold increase in catalytic activity.	UniProt
Q8TDX7	NEK7	Y97F	Y	97	F	206	increase	MUTAGEN Y->F,L: Moderate increase in catalytic activity.	UniProt
Q8TD19	NEK9	I167T	I	167	T	366	increase	VARIANT I -> T (in NC; increased autophosphorylation at T-210; dbSNP:rs879253775)	UniProt
Q8TD19	NEK9	I573T	I	573	T	-	increase	VARIANT I -> T (in NC; increased autophosphorylation at T-210; dbSNP:rs1555352529)	UniProt
Q13153	PAK1	L107F	L	107	F	-	activating	MUTAGEN L->F: Abolishes autoinhibition, leading to constitutive kinase activity.	UniProt
Q13153	PAK1	T423E	T	423	E	513	activating	MUTAGEN T->E: Constitutive kinase activity.	UniProt
O96013	PAK4	S445N	S	445	N	395	activating	MUTAGEN S->N: Approximately 30-fold increased autophosphorylation (constitutively active mutant).	UniProt
O96013	PAK4	S474E	S	474	E	513	increase	MUTAGEN S->E: Approximately 3-fold increased autophosphorylation.	UniProt
O15530	PDPK1	T513E	T	513	E	-	increase	MUTAGEN T->E: Enhanced kinase activity towards PKB.	UniProt
P16234	PDGFRA	D842V	D	842	V	453	activating	VARIANT D -> V (in a GIST sample; imatinib resistant, constitutively activated kinase; dbSNP:rs121908585)	UniProt
P16234	PDGFRA	D842Y	D	842	Y	453	activating	VARIANT D -> Y (in a GIST sample; imatinib sensitive, constitutively activated kinase; dbSNP:rs121913265)	UniProt
P16234	PDGFRA	H650Q	H	650	Q	182	activating	VARIANT H -> Q (in a hypereosinophilic syndrome sample; constitutively activated kinase)	UniProt
P16234	PDGFRA	N659K	N	659	K	204	activating	VARIANT N -> K (in GIST sample; constitutively activated kinase; dbSNP:rs1057519700)	UniProt
P16234	PDGFRA	N659S	N	659	S	204	activating	VARIANT N -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	UniProt
P16234	PDGFRA	R748G	R	748	G	-	activating	VARIANT R -> G (in a hypereosinophilic syndrome sample; constitutively activated kinase)	UniProt
P16234	PDGFRA	V561D	V	561	D	-	activating	VARIANT V -> D (in a GIST sample; constitutively activated kinase; dbSNP:rs121908586)	UniProt
P16234	PDGFRA	Y555C	Y	555	C	-	activating	VARIANT Y -> C (in GISTPS; increased platelet-derived growth factor alpha-receptor activity; constitutively activated kinase; dbSNP:rs121908589)	UniProt
P16234	PDGFRA	Y849S	Y	849	S	463	activating	VARIANT Y -> S (in a hypereosinophilic syndrome sample; constitutively activated kinase)	UniProt
P09619	PDGFRB	V665A	V	665	A	203	activating	VARIANT V -> A (in PENTT; gain of function in protein tyrosine kinase activity; shows ligand-independent constitutive signaling; dbSNP:rs1554108211)	UniProt
P11309	PIM1	H68Y	H	68	Y	129	increase	MUTAGEN H->Y: Increased kinase activity.	UniProt
P53350	PLK1	S137D	S	137	D	275	increase	MUTAGEN S->D: Increases activity. Results in a block in G1/S.	UniProt
P53350	PLK1	T210D	T	210	D	513	increase	MUTAGEN T->D: Increases activity and restores recovery after 	UniProt
O00444	PLK4	T170D	T	170	D	513	activating	MUTAGEN T->D: Activating mutant.	UniProt
Q13882	PTK6	W184A	W	184	A	23	loss	MUTAGEN W->A: Abrogates interaction between PTK6-domain kinase and PTK6-linker. Abrogates autophosphorylation and phosphorylation of KHDRBS1.	UniProt
P04049	RAF1	A237T	A	237	T	-	increase	VARIANT A -> T (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777588)	UniProt
P04049	RAF1	H626R	H	626	R	816	increase	VARIANT H -> R (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1553609795)	UniProt
P04049	RAF1	L613V	L	613	V	803	increase	VARIANT L -> V (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs80338797)	UniProt
P04049	RAF1	P261A	P	261	A	-	increase	VARIANT P -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	UniProt
P04049	RAF1	P261L	P	261	L	-	increase	VARIANT P -> L (in NS5; shows greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516828)	UniProt
P04049	RAF1	P261S	P	261	S	-	increase	VARIANT P -> S (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs121434594)	UniProt
P04049	RAF1	P332A	P	332	A	11	increase	VARIANT P -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs1057403865)	UniProt
P04049	RAF1	R563K	R	563	K	640	increase	MUTAGEN R->K: Loss of methylation. Increased stability and catalytic activity in response to EGF treatment.	UniProt
P04049	RAF1	S257L	S	257	L	-	increase	VARIANT S -> L (in NS5 and LPRD2; shows in vitro greater kinase activity and enhanced ERK activation than wild-type; dbSNP:rs80338796)	UniProt
P04049	RAF1	S259A	S	259	A	-	increase	VARIANT S -> A (in an ovarian serous carcinoma sample; somatic mutation; increased ERK activation; dbSNP:rs3730271)	UniProt
P04049	RAF1	T310A	T	310	A	-	increase	VARIANT T -> A (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs778155315)	UniProt
P04049	RAF1	T641M	T	641	M	-	increase	VARIANT T -> M (in CMD1NN; shows a mild increase in kinase activity; dbSNP:rs587777587)	UniProt
P04049	RAF1	V263A	V	263	A	-	increase	VARIANT V -> A (in NS5; shows in vitro greater kinase activity and enhanced MAPK1 activation than wild-type; dbSNP:rs397516830)	UniProt
P07949	RET	G894S	G	894	S	445	activating	VARIANT G -> S (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	UniProt
P07949	RET	V376A	V	376	A	-	activating	VARIANT V -> A (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; expressed only the immature intracellular form)	UniProt
P07949	RET	V778I	V	778	I	178	activating	VARIANT V -> I (in a patient with renal agenesis; unknown pathological significance; constitutively phosphorylated; dbSNP:rs75686697)	UniProt
Q13546	RIPK1	D324H	D	324	H	-	increase	VARIANT D -> H (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	UniProt
Q13546	RIPK1	D324V	D	324	V	-	increase	VARIANT D -> V (in AIEFL; prevents cleavage by CASP8; increased kinase activity; increased inflammatory response)	UniProt
Q01974	ROR2	D482G	D	482	G	40	increase	MUTAGEN D->G: Slight increase in kinase activity.	UniProt
O00141	SGK1	S422D	S	422	D	-	increase	MUTAGEN S->D: 10-fold activation.	UniProt
Q9HBY8	SGK2	S356D	S	356	D	-	increase	MUTAGEN S->D: Increased activation.	UniProt
Q96BR1	SGK3	S486D	S	486	D	-	increase	MUTAGEN S->D: Increased activation.	UniProt
Q9H0K1	SIK2	T175E	T	175	E	513	activating	MUTAGEN T->E: Constitutively active.	UniProt
P12931	SRC	E527K	E	527	K	806	increase	VARIANT E -> K (in THC6; increased protein tyrosine kinase activity; increased autophosphorylation at Y-419; causes defective megakaryopoiesis associated with increased overall tyrosine phosphorylation in megakaryocytes; dbSNP:rs879255268)	UniProt
Q15831	STK11	K48R	K	48	R	26	increase	MUTAGEN K->R: Enhanced phosphorylation at Thr-336 and Ser-428, enhanced cytoplasmic localization and increased kinase activity.	UniProt
P42345	MTOR	F2108L	F	2108	L	-	resistance	-	COSMIC
P49842	STK19	D89N	D	89	N	-	increase	VARIANT D -> N (recurrent gain-of-function variant found in metastatic melanoma; promotes NRAS signaling; somatic mutation; dbSNP:rs267600971)	UniProt
P36897	TGFBR1	T204D	T	204	D	27	activating	MUTAGEN T->D: Constitutive activation.	UniProt
Q02763	TEK	A925S	A	925	S	306	increase	VARIANT A -> S (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	UniProt
Q02763	TEK	K1100N	K	1100	N	805	increase	VARIANT K -> N (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation)	UniProt
Q02763	TEK	L914F	L	914	F	287	increase	VARIANT L -> F (found in patients with solitary and multiple sporadic venous malformations; increased ligand-independent autophosphorylation; novel location at endoplasmic reticulum and Golgi apparatus; partially retained at endoplasmic reticulum and Golgi apparatus; dbSNP:rs1825682849)	UniProt
Q02763	TEK	R849W	R	849	W	109	increase	VARIANT R -> W (in VMCM; increased ligand-independent autophosphorylation and kinase activation; no effect on location at membrane; dbSNP:rs80338908)	UniProt
Q02763	TEK	R915C	R	915	C	288	increase	VARIANT R -> C (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation; dbSNP:rs1825682922)	UniProt
Q02763	TEK	R915H	R	915	H	288	increase	VARIANT R -> H (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs387906745)	UniProt
Q02763	TEK	R918C	R	918	C	291	increase	VARIANT R -> C (in VMCM; strongly increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs1825683100)	UniProt
Q02763	TEK	S917I	S	917	I	290	increase	VARIANT S -> I (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	UniProt
Q02763	TEK	V919L	V	919	L	292	increase	VARIANT V -> L (in VMCM; increased ligand-independent autophosphorylation and kinase activation)	UniProt
Q02763	TEK	Y897C	Y	897	C	259	increase	VARIANT Y -> C (in VMCM; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	UniProt
Q02763	TEK	Y897H	Y	897	H	259	increase	VARIANT Y -> H (found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation)	UniProt
Q02763	TEK	Y897S	Y	897	S	259	increase	VARIANT Y -> S (in VMCM; also found in a patient with solitary sporadic venous malformations; increased ligand-independent autophosphorylation and kinase activation; dbSNP:rs80338909)	UniProt
Q86UE8	TLK2	S617A	S	617	A	448	increase	MUTAGEN S->A: Increase in autophosphorylation.	UniProt
O75962	TRIO	P1461L	P	1461	L	-	increase	VARIANT P -> L (in MRD63; slightly increased occipitofrontal circumference; slightly increased RAC1-mediated signaling; slightly increased neurite outgrowth)	UniProt
O75962	TRIO	R1078G	R	1078	G	-	increase	VARIANT R -> G (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	UniProt
O75962	TRIO	R1078Q	R	1078	Q	-	increase	VARIANT R -> Q (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth)	UniProt
O75962	TRIO	R1078W	R	1078	W	-	increase	VARIANT R -> W (in MRD63; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs1554065887)	UniProt
Q9BXA7	TSSK1B	T174E	T	174	E	513	activating	MUTAGEN T->E: Constitutively active.	UniProt
P17948	FLT1	N1050D	N	1050	D	460	increase	MUTAGEN N->D: Strongly increases kinase activity. Increases activity in promoting proliferation of endothelial cells.	UniProt
P35968	KDR	C1045A	C	1045	A	442	increase	MUTAGEN C->A: Significantly higher kinase activity.	UniProt
P43403	ZAP70	A141E	A	141	E	-	increase	MUTAGEN A->E: Increased constitutive kinase activity.	UniProt
P43403	ZAP70	D327P	D	327	P	15	increase	MUTAGEN D->P: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	UniProt
P43403	ZAP70	K362E	K	362	E	100	increase	MUTAGEN K->E: Increases constitutive kinase activity on LAT phosphorylation, strongly increases subcellular localization of CD69 at the cell surface and decreases autoinhibition conformation.	UniProt
P43403	ZAP70	L133A	L	133	A	-	increase	MUTAGEN L->A: Increased constitutive kinase activity.	UniProt
P43403	ZAP70	P147A	P	147	A	-	increase	MUTAGEN P->A: Increased kinase activity after activation by LCK.	UniProt
P43403	ZAP70	Q145A	Q	145	A	-	increase	MUTAGEN Q->A: Increased kinase activity after activation by LCK.	UniProt
P43403	ZAP70	S144A	S	144	A	-	increase	MUTAGEN S->A: Increased kinase activity after activation by LCK.	UniProt
P43403	ZAP70	V314A	V	314	A	2	increase	MUTAGEN V->A: Increased constitutive kinase activity.	UniProt
P43403	ZAP70	W131A	W	131	A	-	increase	MUTAGEN W->A: Increased constitutive kinase activity.	UniProt
P43403	ZAP70	Y292F	Y	292	F	-	increase	MUTAGEN Y->F: Induces constitutive TCR stimulation-independent NFAT induction.	UniProt
P43403	ZAP70	Y492F	Y	492	F	463	increase	MUTAGEN Y->F: Increases kinase activity.	UniProt
P43403	ZAP70	Y597A	Y	597	A	805	increase	MUTAGEN Y->A: Increased kinase activity after activation by LCK.	UniProt
P43403	ZAP70	Y598A	Y	598	A	806	increase	MUTAGEN Y->A: Increased kinase activity after activation by LCK.	UniProt
Q07912	TNK2	K158R	K	158	R	128	loss	MUTAGEN K->R: Loss of autophosphorylation at Y-284.	UniProt
Q8NER5	ACVR1C	K222R	K	222	R	128	loss	MUTAGEN K->R: Loss of response to NODAL and SMAD2 phosphorylation.	UniProt
P37023	ACVRL1	C41G	C	41	G	-	loss	VARIANT C -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	C41Y	C	41	Y	-	loss	VARIANT C -> Y (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs1184716348)	UniProt
P37023	ACVRL1	C46G	C	46	G	-	loss	VARIANT C -> G (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	R47P	R	47	P	-	loss	VARIANT R -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs774389618)	UniProt
P37023	ACVRL1	H66Y	H	66	Y	-	loss	VARIANT H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1480110873)	UniProt
P37023	ACVRL1	C77F	C	77	F	-	loss	VARIANT C -> F (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1330837892)	UniProt
P37023	ACVRL1	G211D	G	211	D	40	loss	VARIANT G -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs28936687)	UniProt
P37023	ACVRL1	G211S	G	211	S	40	loss	VARIANT G -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	A306P	A	306	P	356	loss	VARIANT A -> P (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1940807179)	UniProt
P37023	ACVRL1	L313V	L	313	V	366	loss	VARIANT L -> V (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	H314Y	H	314	Y	368	loss	VARIANT H -> Y (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1565594311)	UniProt
P37023	ACVRL1	P378S	P	378	S	534	loss	VARIANT P -> S (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs959973779)	UniProt
P37023	ACVRL1	E379D	E	379	D	535	loss	VARIANT E -> D (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	E379K	E	379	K	535	loss	VARIANT E -> K (in HHT2; loss of receptor activity in response to BMP9; retained in the endoplasmic reticulum; dbSNP:rs1131691686)	UniProt
P37023	ACVRL1	V404G	V	404	G	590	loss	VARIANT V -> G (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum)	UniProt
P37023	ACVRL1	R411W	R	411	W	603	loss	VARIANT R -> W (in HHT2; loss of receptor activity in response to BMP9; predominantly retained in the endoplasmic reticulum; dbSNP:rs121909287)	UniProt
P31749	AKT1	K14Q	K	14	Q	-	decrease	MUTAGEN K->Q: Substantial reduction of phosphorylation at T-308 and S-473, loss of AKT activation, and loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	UniProt
P31749	AKT1	K179M	K	179	M	128	loss	MUTAGEN K->M: Abolished serine/threonine-protein kinase activity.	UniProt
P31749	AKT1	T305Y	T	305	Y	510	loss	MUTAGEN T->Y: Abolishes phosphorylation at Thr-308.	UniProt
P31749	AKT1	T312Y	T	312	Y	522	loss	MUTAGEN T->Y: Abolishes phosphorylation at Thr-308.	UniProt
Q9Y243	AKT3	S472A	S	472	A	-	decrease	MUTAGEN S->A: 67% decrease of activity after pervanadate treatment.	UniProt
Q96QP1	ALPK1	K1067M	K	1067	M	-	loss	MUTAGEN K->M: Abolishes the serine/threonine-protein kinase and ability to initiate the innate immune response.	UniProt
P20594	NPR2	W115G	W	115	G	-	decrease	VARIANT W -> G (in AMD1; markedly deficient activity; dbSNP:rs28931582)	UniProt
P20594	NPR2	T297M	T	297	M	-	decrease	VARIANT T -> M (in AMD1; markedly deficient activity; dbSNP:rs1313765432)	UniProt
P20594	NPR2	G413E	G	413	E	-	decrease	VARIANT G -> E (in AMD1; markedly deficient activity)	UniProt
P25098	GRK2	K220R	K	220	R	128	loss	Loss of activity.	UniProt
P25098	GRK2	D3A	D	3	A	-	decrease	MUTAGEN D->A: 85% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	UniProt
P25098	GRK2	D3N	D	3	N	-	decrease	MUTAGEN D->N: 60% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	UniProt
P25098	GRK2	L4K	L	4	K	-	decrease	MUTAGEN L->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	UniProt
P25098	GRK2	E5A	E	5	A	-	decrease	MUTAGEN E->A: 50% reduction in phosphorylation of G-protein coupled receptor rhodopsin.	UniProt
Q13315	ATM	L1465P	L	1465	P	-	decrease	VARIANT L -> P (in AT; decreased phosphorylation of target proteins; dbSNP:rs730881391)	UniProt
Q13315	ATM	L2068S	L	2068	S	-	decrease	VARIANT L -> S (in AT; decreased protein abundance; loss of 	UniProt
Q13315	ATM	Y2080D	Y	2080	D	-	loss	VARIANT Y -> D (in AT; loss of DNA damage induced protein autophosphorylation; dbSNP:rs1064795467)	UniProt
Q13315	ATM	F2827C	F	2827	C	-	decrease	VARIANT F -> C (in AT; mild; decreased phosphorylation of target proteins; dbSNP:rs121434216)	UniProt
Q13315	ATM	K1807E	K	1807	E	-	decrease	MUTAGEN K->E: Decreased phosphorylation of target proteins.	UniProt
Q13315	ATM	V1941L	V	1941	L	-	decrease	MUTAGEN V->L: Decreased phosphorylation of target proteins.	UniProt
Q13315	ATM	Y2019C	Y	2019	C	-	loss	MUTAGEN Y->C: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	E2039K	E	2039	K	-	decrease	MUTAGEN E->K: Decreased phosphorylation of target proteins.	UniProt
Q13315	ATM	L2338P	L	2338	P	-	loss	MUTAGEN L->P: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	S2394L	S	2394	L	-	loss	MUTAGEN S->L: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	L2452P	L	2452	P	-	loss	MUTAGEN L->P: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	P2699L	P	2699	L	-	loss	MUTAGEN P->L: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	D2708N	D	2708	N	-	decrease	MUTAGEN D->N: Decreased phosphorylation of target proteins.	UniProt
Q13315	ATM	Q2730P	Q	2730	P	-	loss	MUTAGEN Q->P: Loss of phosphorylation of target proteins.	UniProt
Q13315	ATM	D2870A	D	2870	A	-	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q13315	ATM	N2875K	N	2875	K	-	loss	MUTAGEN N->K: Loss of kinase activity.	UniProt
Q13315	ATM	K3016R	K	3016	R	-	loss	MUTAGEN K->R: Loss of DNA damage-inducible acetylation. Retains constitutive kinase activity, but blocks DNA damage-induced kinase activation. Disrupts dimer and abolishes S-1981 autophosphorylation.	UniProt
Q13315	ATM	R3047Q	R	3047	Q	-	loss	MUTAGEN R->Q: Abolished interaction with PEX5 and translocation to peroxisomes in response to reactive oxygen species (ROS).	UniProt
Q13535	ATR	K2327R	K	2327	R	-	loss	MUTAGEN K->R: Abolishes kinase activity.	UniProt
Q13535	ATR	D2475A	D	2475	A	-	loss	MUTAGEN D->A: Abolishes kinase activity; increases sensitivity to IR and impairs translocation to nuclear foci upon DNA damage.	UniProt
Q13535	ATR	D2494E	D	2494	E	-	loss	MUTAGEN D->E: Abolishes kinase activity; reduces cell viability, augments sensitivity to IR and UV.	UniProt
O14965	AURKA	K162R	K	162	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
O14965	AURKA	D274N	D	274	N	443	loss	MUTAGEN D->N: Abolishes cilia disassembly and kinase activity.	UniProt
O14965	AURKA	T288A	T	288	A	513	decrease	MUTAGEN T->A: Reduces cilia disassembly and kinase activity.	UniProt
Q96GD4	AURKB	K106R	K	106	R	128	loss	MUTAGEN K->R: Leads to loss of kinase activity and severely impairs mitotic progression.	UniProt
Q9UQB9	AURKC	K72R	K	72	R	128	decrease	MUTAGEN K->R: Impairs kinase activity.	UniProt
Q9UQB9	AURKC	D166Y	D	166	Y	390	decrease	MUTAGEN D->Y: Impairs kinase activity, and keeps AURKC with the chromosomes until the end of mitosis.	UniProt
Q9UQB9	AURKC	T198A	T	198	A	513	decrease	MUTAGEN T->A: Impairs kinase activity.	UniProt
Q9UIG0	BAZ1B	C338A	C	338	A	-	loss	MUTAGEN C->A: Loss of tyrosine-protein kinase activity.	UniProt
O14874	BCKDK	R174G	R	174	G	-	decrease	VARIANT R -> G (in BCKDKD; partial loss of kinase activity)	UniProt
O14874	BCKDK	L389P	L	389	P	-	loss	VARIANT L -> P (in BCKDKD; complete loss of kinase activity)	UniProt
Q13873	BMPR2	D485G	D	485	G	766	loss	VARIANT D -> G (in PPH1; complete loss of function; dbSNP:rs137852745)	UniProt
P51813	BMX	Y566F	Y	566	F	511	loss	MUTAGEN Y->F: Abolishes almost completely the SRC-induced phosphorylation of BMX.	UniProt
P15056	BRAF	K483S	K	483	S	128	decrease	MUTAGEN K->S: Reduces kinase activity with MAP2K1.	UniProt
O60885	BRD4	S503A	S	503	A	-	decrease	MUTAGEN S->A: Impaired phosphorylation by CK2 and binding to acetylated histones.	UniProt
Q8TDC3	BRSK1	K59A	K	59	A	118	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q8TDC3	BRSK1	G327A	G	327	A	-	loss	MUTAGEN G->A: Abolishes activation of kinase activity.	UniProt
Q8IWQ3	BRSK2	K48M	K	48	M	128	loss	MUTAGEN K->M: Loss of catalytic activity. Causes disintegration of actin stress fibers.	UniProt
Q8IWQ3	BRSK2	T260A	T	260	A	776	decrease	MUTAGEN T->A: Decreased phosphorylation. Nearly abolishes stimulation of insulin secretion.	UniProt
Q8IWQ3	BRSK2	G310A	G	310	A	-	decrease	MUTAGEN G->A: Decreased activation of kinase activity.	UniProt
Q06187	BTK	R307G	R	307	G	-	loss	VARIANT R -> G (in XLA; loss of activity; dbSNP:rs128621195)	UniProt
Q06187	BTK	K430E	K	430	E	128	loss	VARIANT K -> E (in XLA; loss of phosphorylation of GTF2I; dbSNP:rs128620184)	UniProt
Q06187	BTK	Y223F	Y	223	F	-	loss	MUTAGEN Y->F: Loss of phosphorylation of GTF2I.	UniProt
Q06187	BTK	R307K	R	307	K	-	loss	MUTAGEN R->K: Loss of phosphorylation of GTF2I.	UniProt
Q06187	BTK	Y551F	Y	551	F	511	loss	MUTAGEN Y->F: Loss of phosphorylation of GTF2I.	UniProt
O43683	BUB1	K821A	K	821	A	136	loss	MUTAGEN K->A: Loss of activity.	UniProt
Q9NYV4	CDK12	D877N	D	877	N	443	loss	MUTAGEN D->N: Abolishes kinase activity.	UniProt
O94921	CDK14	K164R	K	164	R	128	loss	MUTAGEN K->R: Abolishes protein kinase activity.	UniProt
Q00536	CDK16	S12A	S	12	A	-	loss	MUTAGEN S->A: Abolishes phosphorylation by BRSK2. Abolishes effect on insulin secretion.	UniProt
Q00536	CDK16	K194A	K	194	A	128	loss	MUTAGEN K->A: Loss of kinase activity. Abolishes effect on insulin secretion.	UniProt
Q00536	CDK16	K194R	K	194	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q9BWU1	CDK19	G28R	G	28	R	38	decrease	VARIANT G -> R (in DEE87; decreased protein kinase activity)	UniProt
Q8IZL9	CDK20	T161A	T	161	A	512	decrease	MUTAGEN T->A: Impairs CDK2 T-160 phosphorylation and activity.	UniProt
P24941	CDK2	K9F	K	9	F	36	decrease	MUTAGEN K->F: Reduced phosphorylation by CAK.	UniProt
P24941	CDK2	T160A	T	160	A	512	loss	MUTAGEN T->A: Abolishes activity.	UniProt
P24941	CDK2	L166R	L	166	R	526	decrease	MUTAGEN L->R: Reduced phosphorylation by CAK and reduced kinase activity.	UniProt
P50613	CDK7	K41A	K	41	A	128	loss	MUTAGEN K->A: Total loss of activity.	UniProt
P50613	CDK7	T170A	T	170	A	512	loss	MUTAGEN T->A: Total loss of activity. Total loss of transcriptional activity of the reconstituted TFIIH complex.	UniProt
P49336	CDK8	V27L	V	27	L	37	decrease	VARIANT V -> L (in IDDHBA; decreased protein kinase activity)	UniProt
P49336	CDK8	R29G	R	29	G	39	decrease	VARIANT R -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218885)	UniProt
P49336	CDK8	G30S	G	30	S	40	decrease	VARIANT G -> S (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593218890)	UniProt
P49336	CDK8	S62L	S	62	L	171	decrease	VARIANT S -> L (in IDDHBA; decreased protein kinase activity; dbSNP:rs1565977796)	UniProt
P49336	CDK8	R178Q	R	178	Q	449	decrease	VARIANT R -> Q (in IDDHBA; decreased protein kinase activity; dbSNP:rs1418353379)	UniProt
P49336	CDK8	V193G	V	193	G	517	decrease	VARIANT V -> G (in IDDHBA; decreased protein kinase activity; dbSNP:rs1875421510)	UniProt
P49336	CDK8	I223M	I	223	M	590	decrease	VARIANT I -> M (in IDDHBA; decreased protein kinase activity; dbSNP:rs1593310364)	UniProt
P50750	CDK9	K44R	K	44	R	118	decrease	MUTAGEN K->R: Impaired kinase and transcriptional elongation activities, but normal cyclin T1 and HEXIM1 binding.	UniProt
P50750	CDK9	K48Q	K	48	Q	128	decrease	MUTAGEN K->Q: Mimics acetylation; leading to impaired protein kinase activity.	UniProt
P50750	CDK9	K48R	K	48	R	128	activating	MUTAGEN K->R: Decreased acetylation; leading to enhanced protein kinase activity.	UniProt
P50750	CDK9	S175D	S	175	D	457	loss	MUTAGEN S->D: Mimics phosphorylation, constitutive loss of kinase activity.	UniProt
Q9Y5P4	CERT1	S132A	S	132	A	-	loss	MUTAGEN S->A: Abolishes the phosphorylation. Strongly reduces the interaction with phosphatidylinositol 4-phosphate. Increases the ceramide transfer activity.	UniProt
O14757	CHEK1	K38R	K	38	R	128	loss	MUTAGEN K->R: Abolishes kinase activity.	UniProt
O14757	CHEK1	D130A	D	130	A	390	loss	MUTAGEN D->A: Abolishes kinase activity.	UniProt
O96017	CHEK2	H371Y	H	371	Y	446	decrease	VARIANT H -> Y (confers a moderate risk of breast cancer; partially reduces kinase activity; dbSNP:rs531398630)	UniProt
O96017	CHEK2	T68A	T	68	A	-	loss	MUTAGEN T->A: Loss of activation and phosphorylation.	UniProt
O96017	CHEK2	S73A	S	73	A	-	decrease	MUTAGEN S->A: Impaired activation, phosphorylation by ATM and G2/M transition checkpoint.	UniProt
O96017	CHEK2	D347A	D	347	A	390	loss	MUTAGEN D->A: Loss of kinase activity and of the ability to phosphorylate CDC25A.	UniProt
O96017	CHEK2	D368N	D	368	N	443	loss	MUTAGEN D->N: Loss of autophosphorylation activity.	UniProt
O96017	CHEK2	T383A	T	383	A	513	loss	MUTAGEN T->A: Loss of phosphorylation in response to ionizing radiation.	UniProt
O96017	CHEK2	T387A	T	387	A	522	loss	MUTAGEN T->A: Loss of phosphorylation in response to ionizing radiation.	UniProt
Q9UPZ9	CILK1	R272Q	R	272	Q	774	decrease	VARIANT R -> Q (in ECO; significantly impairs kinase activity; decreased localization at the ciliary tips; impaired ciliogenesis; results in abnormally elongated cilia; impairs mitosis, cell-cycle exit and radial neuroblast migration, while promoting apoptosis, when tested in a heterologous system; loss of nuclear localization; dbSNP:rs118203918)	UniProt
Q9HAZ1	CLK4	K189R	K	189	R	128	loss	MUTAGEN K->R: Loss of function.	UniProt
P07333	CSF1R	P132L	P	132	L	-	decrease	VARIANT P -> L (in BANDDOS; impairs phosphorylation of JNK kinases upon stimulation with CSF1; dbSNP:rs1351319114)	UniProt
P07333	CSF1R	E633K	E	633	K	175	decrease	VARIANT E -> K (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860269)	UniProt
P07333	CSF1R	G765D	G	765	D	359	decrease	VARIANT G -> D (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs690016566)	UniProt
P07333	CSF1R	M766T	M	766	T	360	decrease	VARIANT M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860270)	UniProt
P07333	CSF1R	I775N	I	775	N	387	decrease	VARIANT I -> N (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860273)	UniProt
P07333	CSF1R	A781E	A	781	E	393	decrease	VARIANT A -> E (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs587777247)	UniProt
P07333	CSF1R	R782H	R	782	H	394	decrease	VARIANT R -> H (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860281)	UniProt
P07333	CSF1R	I794T	I	794	T	441	decrease	VARIANT I -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860274)	UniProt
P07333	CSF1R	P824S	P	824	S	534	decrease	VARIANT P -> S (in HDLS1; impairs autophosphorylation upon stimulation with CSF1)	UniProt
P07333	CSF1R	M875T	M	875	T	671	decrease	VARIANT M -> T (in HDLS1; impairs autophosphorylation upon stimulation with CSF1; dbSNP:rs281860279)	UniProt
P07333	CSF1R	Y809F	Y	809	F	463	decrease	MUTAGEN Y->F: Reduced kinase activity. Reduced interaction with SRC, FYN and YES1.	UniProt
P07333	CSF1R	Y969F	Y	969	F	-	loss	MUTAGEN Y->F: Abolishes down-regulation of activated CSF1R.	UniProt
P41240	CSK	Y184F	Y	184	F	18	loss	MUTAGEN Y->F: Abolishes phosphorylation.	UniProt
P41240	CSK	Y304F	Y	304	F	365	decrease	MUTAGEN Y->F: Decreases activity by two-thirds and alters conformation.	UniProt
P41240	CSK	S364A	S	364	A	578	decrease	MUTAGEN S->A: Strong decrease of phosphorylation by PRKACA (catalytic subunit of PKA).	UniProt
O14578	CIT	G106V	G	106	V	40	decrease	VARIANT G -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037892)	UniProt
O14578	CIT	K126Q	K	126	Q	128	decrease	VARIANT K -> Q (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037893)	UniProt
O14578	CIT	D230V	D	230	V	399	decrease	VARIANT D -> V (in MCPH17; impairs kinase activity; exhibits abnormal mitotic cytokinesis; exhibits multipolar spindles; increases the neurons apoptotic process; dbSNP:rs886037894)	UniProt
P53355	DAPK1	K42A	K	42	A	128	loss	MUTAGEN K->A: Loss of activity, apoptotic function and of autophosphorylation.	UniProt
P53355	DAPK1	S289A	S	289	A	808	activating	MUTAGEN S->A: Loss of phosphorylation and significant increase in proapoptotic activity.	UniProt
P53355	DAPK1	S308D	S	308	D	-	decrease	MUTAGEN S->D: Reduced Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Decreases apoptotic activity.	UniProt
Q9UIK4	DAPK2	K52A	K	52	A	128	loss	MUTAGEN K->A: Loss of activity, apoptotic function and of autophosphorylation.	UniProt
Q9UIK4	DAPK2	S318A	S	318	A	-	activating	MUTAGEN S->A: Loss of Ca(2+)-calmodulin independent phosphorylation, increase in apoptotic activity.	UniProt
O43293	DAPK3	T112M	T	112	M	323	decrease	VARIANT T -> M (in a colorectal adenocarcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	UniProt
O43293	DAPK3	D161N	D	161	N	443	decrease	VARIANT D -> N (in an ovarian mucinous carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation and cell survival)	UniProt
O43293	DAPK3	P216S	P	216	S	617	decrease	VARIANT P -> S (in a lung neuroendocrine carcinoma sample; somatic mutation; greatly reduces kinase activity, increases cell proliferation, cell adhesion and cell survival)	UniProt
O43293	DAPK3	K42A	K	42	A	128	loss	MUTAGEN K->A: Loss of kinase activity at low concentrations of ATP.	UniProt
O43293	DAPK3	D161A	D	161	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
O43293	DAPK3	T180A	T	180	A	522	decrease	MUTAGEN T->A: Greatly reduced kinase activity.	UniProt
O43293	DAPK3	T225A	T	225	A	637	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
O43293	DAPK3	T265A	T	265	A	776	loss	MUTAGEN T->A: Loss of phosphorylation by ROCK1, catalytically inactive.	UniProt
O43293	DAPK3	T299A	T	299	A	818	loss	MUTAGEN T->A: Loss of phosphorylation by ROCK1.	UniProt
Q16832	DDR2	K608A	K	608	A	128	loss	MUTAGEN K->A: Abolishes kinase activity.	UniProt
Q09013	DMPK	K100A	K	100	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q13627	DYRK1A	K188R	K	188	R	128	loss	MUTAGEN K->R: Abolished protein kinase activity.	UniProt
Q13627	DYRK1A	Y321F	Y	321	F	517	decrease	MUTAGEN Y->F: Mildly reduces kinase activity. Does not abolish autophosphorylation on tyrosine residues.	UniProt
Q9Y463	DYRK1B	D239A	D	239	A	390	loss	MUTAGEN D->A: Abolishes kinase activity.	UniProt
Q92630	DYRK2	K251R	K	251	R	128	loss	MUTAGEN K->R: Abolishes protein serine/threonine kinase activity.	UniProt
Q9NR20	DYRK4	K133R	K	133	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q9NR20	DYRK4	Y264F	Y	264	F	517	loss	MUTAGEN Y->F: Abolishes kinase activity.	UniProt
P19525	EIF2AK2	A67E	A	67	E	-	loss	MUTAGEN A->E: Significant loss of activity; loss of dsRNA binding and dimerization.	UniProt
P19525	EIF2AK2	T258A	T	258	A	22	decrease	MUTAGEN T->A: Moderate loss of activity.	UniProt
P19525	EIF2AK2	K296R	K	296	R	128	loss	MUTAGEN K->R: Loss of activity.	UniProt
P19525	EIF2AK2	T446A	T	446	A	512	decrease	MUTAGEN T->A: Significant loss of activity and impairs autophosphorylation of T-451.	UniProt
P19525	EIF2AK2	T451A	T	451	A	522	loss	MUTAGEN T->A: Loss of activity.	UniProt
Q9P2K8	EIF2AK4	K614A	K	614	A	110	loss	Loss of activity.	UniProt
O00418	EEF2K	S78A	S	78	A	-	decrease	MUTAGEN S->A: Decreased kinase activity.	UniProt
O00418	EEF2K	T348A	T	348	A	-	decrease	MUTAGEN T->A: Decreased kinase activity.	UniProt
O00418	EEF2K	S366A	S	366	A	-	decrease	MUTAGEN S->A: Decreased kinase activity.	UniProt
P00533	EGFR	G428D	G	428	D	-	loss	VARIANT G -> D (in NISBD2; loss of function; the mutant does not localize to the cell membrane; has diffuse cytoplasmic localization; dbSNP:rs606231253)	UniProt
P00533	EGFR	R429E	R	429	E	-	loss	MUTAGEN R->E: Abolishes autophosphorylation and activation of downstream kinases.	UniProt
P00533	EGFR	L688A	L	688	A	7	decrease	MUTAGEN L->A: Strongly reduced phosphorylation.	UniProt
P00533	EGFR	V689A	V	689	A	8	decrease	MUTAGEN V->A: Reduced autophosphorylation.	UniProt
P00533	EGFR	E690A	E	690	A	9	decrease	MUTAGEN E->A: Reduced phosphorylation.	UniProt
P00533	EGFR	L692A	L	692	A	11	decrease	MUTAGEN L->A,P: Strongly reduced phosphorylation.	UniProt
P00533	EGFR	T693D	T	693	D	12	decrease	MUTAGEN T->D: Strongly reduced phosphorylation.	UniProt
P00533	EGFR	P694A	P	694	A	13	decrease	MUTAGEN P->A: Strongly reduced phosphorylation.	UniProt
P00533	EGFR	P699A	P	699	A	18	decrease	MUTAGEN P->A: Reduced phosphorylation.	UniProt
P00533	EGFR	N700A	N	700	A	19	loss	MUTAGEN N->A: Abolishes phosphorylation.	UniProt
P00533	EGFR	L704A	L	704	A	23	loss	MUTAGEN L->A: Abolishes phosphorylation.	UniProt
P00533	EGFR	R705A	R	705	A	24	loss	MUTAGEN R->A: Abolishes phosphorylation.	UniProt
P00533	EGFR	I706A	I	706	A	25	loss	MUTAGEN I->A: Abolishes phosphorylation.	UniProt
P00533	EGFR	K745A	K	745	A	128	loss	MUTAGEN K->A,M: Abolishes kinase activity.	UniProt
P00533	EGFR	D974A	D	974	A	804	decrease	MUTAGEN D->A: Strongly reduced phosphorylation.	UniProt
P00533	EGFR	R977A	R	977	A	807	decrease	MUTAGEN R->A: Reduced phosphorylation.	UniProt
P29317	EPHA2	K646M	K	646	M	128	loss	MUTAGEN K->M: Loss of kinase activity.	UniProt
P29320	EPHA3	V133E	V	133	E	-	loss	MUTAGEN V->E: Loss of EFNA5-binding ability and function.	UniProt
P29320	EPHA3	F152L	F	152	L	-	loss	MUTAGEN F->L: Loss of EFNA5-binding ability and function.	UniProt
P54762	EPHB1	K651R	K	651	R	128	loss	MUTAGEN K->R: Kinase-dead mutant. Unable to autophosphorylate, to interact with SH2 domain-containing interactors, to activate the MAPK/ERK and JUN signaling cascades. Not ubiquitinated by CBL.	UniProt
P54753	EPHB3	K665R	K	665	R	128	loss	MUTAGEN K->R: Kinase-dead. Loss of autophosphorylation.	UniProt
P54760	EPHB4	K650N	K	650	N	131	decrease	VARIANT K -> N (in CMAVM2; highly decreased tyrosine phosphorylation; highly decreased interaction with RASA1; dbSNP:rs1584658113)	UniProt
P54760	EPHB4	E664K	E	664	K	175	loss	VARIANT E -> K (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1562969219)	UniProt
P54760	EPHB4	R739Q	R	739	Q	389	loss	VARIANT R -> Q (in LMPHM7; loss of kinase activity; dbSNP:rs1057519263)	UniProt
P54760	EPHB4	I782S	I	782	S	527	loss	VARIANT I -> S (in LMPHM7; loss of kinase activity; dbSNP:rs1057519264)	UniProt
P54760	EPHB4	R838W	R	838	W	670	loss	VARIANT R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs764827256)	UniProt
P54760	EPHB4	C845R	C	845	R	682	loss	VARIANT C -> R (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs1584653054)	UniProt
P54760	EPHB4	R864W	R	864	W	774	loss	VARIANT R -> W (in CMAVM2; the mutant protein is not detected by Western blot; loss of localization to cell membrane; dbSNP:rs769965440)	UniProt
P04626	ERBB2	A710V	A	710	V	19	loss	VARIANT A -> V (in VSCN2; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	UniProt
P21860	ERBB3	T787P	T	787	P	267	loss	VARIANT T -> P (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	UniProt
P21860	ERBB3	V899M	V	899	M	589	loss	VARIANT V -> M (in VSCN1; almost complete loss of ERBB2 and ERBB3 phosphorylation in the presence or in the absence of NRG1 stimulation, suggesting alteration of downstream signaling; does not affect the subcellular localization at the cell membrane)	UniProt
P21860	ERBB3	K742M	K	742	M	128	decrease	MUTAGEN K->M: Strongly reduced autophosphorylation.	UniProt
P21860	ERBB3	Y868E	Y	868	E	511	decrease	MUTAGEN Y->E: Strongly reduced tyrosine phosphorylation.	UniProt
Q15303	ERBB4	R927Q	R	927	Q	648	decrease	VARIANT R -> Q (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514262)	UniProt
Q15303	ERBB4	R1275W	R	1275	W	-	decrease	VARIANT R -> W (in ALS19; reduces autophosphorylation upon NRG1 stimulation; dbSNP:rs397514263)	UniProt
Q15303	ERBB4	L710N	L	710	N	21	decrease	MUTAGEN L->N: Strongly reduced autophosphorylation.	UniProt
Q15303	ERBB4	K751R	K	751	R	128	loss	MUTAGEN K->R: Abolishes kinase activity. Abolishes phosphorylation, proteolytic processing and nuclear localization.	UniProt
Q15303	ERBB4	M766R	M	766	R	173	decrease	MUTAGEN M->R: Strongly reduced autophosphorylation.	UniProt
Q15303	ERBB4	D843N	D	843	N	390	loss	MUTAGEN D->N: Loss of kinase activity.	UniProt
Q15303	ERBB4	D861Y	D	861	Y	443	loss	MUTAGEN D->Y: Loss of kinase activity.	UniProt
Q15303	ERBB4	L864R	L	864	R	446	decrease	MUTAGEN L->R: Strongly reduced autophosphorylation.	UniProt
O75460	ERN1	K599A	K	599	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation and of endoribonuclease activity. Inhibition of growth arrest.	UniProt
Q76MJ5	ERN2	K548A	K	548	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation, of induction of apoptosis and of 28S rRNA cleavage, attenuation of repression of protein synthesis.	UniProt
Q14289	PTK2B	K457A	K	457	A	128	loss	MUTAGEN K->A: Abolishes kinase activity.	UniProt
Q14289	PTK2B	Y881F	Y	881	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation site. Strongly reduced interaction with GRB2.	UniProt
P16591	FER	R483Q	R	483	Q	-	loss	MUTAGEN R->Q: Abolishes kinase activity. Abolishes location at microtubules.	UniProt
P16591	FER	K591R	K	591	R	128	loss	MUTAGEN K->R: Abolishes kinase activity.	UniProt
P07332	FES	L334P	L	334	P	-	loss	MUTAGEN L->P: Abolishes autophosphorylation.	UniProt
P07332	FES	G463V	G	463	V	-	loss	MUTAGEN G->V: Abolishes kinase activity.	UniProt
P07332	FES	K590E	K	590	E	128	loss	MUTAGEN K->E: Abolishes kinase activity. Fails to inhibit proliferation of melanoma cells.	UniProt
P07332	FES	M704V	M	704	V	446	decrease	MUTAGEN M->V: Reduced autophosphorylation and strongly reduced kinase activity.	UniProt
P07332	FES	Y713F	Y	713	F	462	decrease	MUTAGEN Y->F: Reduces kinase activity by over 90%.	UniProt
P07332	FES	V743M	V	743	M	584	decrease	MUTAGEN V->M: Strongly reduced autophosphorylation and kinase activity.	UniProt
P07332	FES	S759F	S	759	F	615	decrease	MUTAGEN S->F: Reduced autophosphorylation and strongly reduced kinase activity.	UniProt
P11362	FGFR1	K618N	K	618	N	373	decrease	VARIANT K -> N (in HH2; some patients also carry GNRHR mutations; impairs tyrosine kinase activity)	UniProt
P11362	FGFR1	K514A	K	514	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
P11362	FGFR1	D623A	D	623	A	390	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
P21802	FGFR2	M391R	M	391	R	-	decrease	VARIANT M -> R (in BBDS1; the mutation selectively reduces plasma-membrane levels of the protein and markedly diminishes the receptor's responsiveness to extracellular FGF; dbSNP:rs387906677)	UniProt
P21802	FGFR2	A628T	A	628	T	392	decrease	VARIANT A -> T (in LADD1; strongly reduced kinase activity; dbSNP:rs121918509)	UniProt
P21802	FGFR2	Y769F	Y	769	F	808	decrease	MUTAGEN Y->F: Increases fibroblast proliferation. Decreases phosphorylation of PLCG1 and FRS2. Decreases activation of 	UniProt
P22607	FGFR3	K508A	K	508	A	128	loss	MUTAGEN K->A: Loss of kinase activity. Abolishes ubiquitination.	UniProt
P22607	FGFR3	Y724F	Y	724	F	757	decrease	MUTAGEN Y->F: Strongly reduced kinase activity. Strongly reduced mitogen activity.	UniProt
P22455	FGFR4	K503R	K	503	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
P36888	FLT3	K644A	K	644	A	128	loss	MUTAGEN K->A: Abolishes kinase activity.	UniProt
P42685	FRK	K262R	K	262	R	128	loss	MUTAGEN K->R: Loss of ability to phosphorylate PTEN.	UniProt
Q15835	GRK1	K219A	K	219	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation and RHO phosphorylation.	UniProt
P49841	GSK3B	L128A	L	128	A	262	loss	MUTAGEN L->A: Abolishes activity toward AXIN1.	UniProt
Q02846	GUCY2D	F565S	F	565	S	14	loss	VARIANT F -> S (in LCA1; loss of activity; dbSNP:rs61749755)	UniProt
Q8TF76	HASPIN	K282M	K	282	M	-	decrease	Loss of catalytic activity. Reduced nuclear;size in larval salivary glands.	UniProt
Q8TF76	HASPIN	E492A	E	492	A	39	decrease	MUTAGEN E->A: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	UniProt
Q8TF76	HASPIN	K511A	K	511	A	128	decrease	MUTAGEN K->A: Strongly reduced enzyme activity.	UniProt
Q8TF76	HASPIN	H651A	H	651	A	392	decrease	MUTAGEN H->A: Strongly reduced enzyme activity, markedly reduced affinity for histone H3.	UniProt
Q8TF76	HASPIN	D707L	D	707	L	-	decrease	MUTAGEN D->L: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	UniProt
Q8TF76	HASPIN	D709N	D	709	N	-	decrease	MUTAGEN D->N: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	UniProt
Q8TF76	HASPIN	G713F	G	713	F	-	decrease	MUTAGEN G->F: Markedly reduced affinity for histone H3 and reduced histone H3 phosphorylation.	UniProt
Q8TF76	HASPIN	D716L	D	716	L	-	decrease	MUTAGEN D->L: Markedly reduced histone H3 phosphorylation.	UniProt
P08631	HCK	K290E	K	290	E	128	loss	MUTAGEN K->E: Loss of kinase activity.	UniProt
P08631	HCK	E305A	E	305	A	175	loss	MUTAGEN E->A: Loss of kinase activity.	UniProt
P08631	HCK	D381E	D	381	E	390	loss	MUTAGEN D->E: Loss of kinase activity.	UniProt
P08631	HCK	Y411A	Y	411	A	511	decrease	MUTAGEN Y->A: Reduced catalytic activity and higher affinity for target peptides.	UniProt
Q86Z02	HIPK1	K219A	K	219	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q86Z02	HIPK1	D315N	D	315	N	390	loss	MUTAGEN D->N: Loss of kinase activity and impaired MAP3K5-JNK inactivation.	UniProt
Q9H422	HIPK3	K226R	K	226	R	128	loss	MUTAGEN K->R: Loss of kinase activity and impaired activation of SF1.	UniProt
P08069	IGF1R	R138Q	R	138	Q	-	decrease	VARIANT R -> Q (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912426)	UniProt
P08069	IGF1R	K145N	K	145	N	-	decrease	VARIANT K -> N (in IGF1RES; has decreased IGF1R function; dbSNP:rs121912427)	UniProt
P08069	IGF1R	N359Y	N	359	Y	-	decrease	VARIANT N -> Y (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	UniProt
P08069	IGF1R	Y865C	Y	865	C	-	decrease	VARIANT Y -> C (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	UniProt
P08069	IGF1R	R1256S	R	1256	S	774	decrease	VARIANT R -> S (in IGF1RES; significant decrease in IGF1-induced DNA synthesis and AKT1 phosphorylation in patient fibroblasts)	UniProt
O15111	CHUK	T23A	T	23	A	39	decrease	MUTAGEN T->A: Loss of phosphorylation and decrease of kinase activity.	UniProt
O15111	CHUK	K44A	K	44	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
O15111	CHUK	K44M	K	44	M	128	loss	MUTAGEN K->M: Loss of autophosphorylation.	UniProt
O15111	CHUK	S176A	S	176	A	461	loss	MUTAGEN S->A: Loss of phosphorylation and of activity.	UniProt
O14920	IKBKB	D166A	D	166	A	443	loss	MUTAGEN D->A: Loss of protein kinase activity.	UniProt
O14920	IKBKB	S177A	S	177	A	461	decrease	MUTAGEN S->A: Decrease of activity.	UniProt
O14920	IKBKB	S181A	S	181	A	513	decrease	MUTAGEN S->A: Decrease of activity.	UniProt
Q14164	IKBKE	K38A	K	38	A	128	loss	MUTAGEN K->A: Loss of kinase activity and loss of nuclear import.	UniProt
Q14164	IKBKE	E168A	E	168	A	461	decrease	MUTAGEN E->A: Slight decrease of kinase activity.	UniProt
Q14164	IKBKE	S172A	S	172	A	513	loss	MUTAGEN S->A: Loss of autophosphorylation and of kinase activity.	UniProt
Q14164	IKBKE	S172E	S	172	E	513	decrease	MUTAGEN S->E: Decrease in kinase activity.	UniProt
P06213	INSR	E1206D	E	1206	D	535	decrease	VARIANT E -> D (in IRAN type A; accelerates degradation of the protein and impairs kinase activity)	UniProt
P06213	INSR	W1220L	W	1220	L	585	decrease	VARIANT W -> L (in IRAN type A; accelerates degradation of the protein and impairs kinase activity; dbSNP:rs52800171)	UniProt
P06213	INSR	K1057M	K	1057	M	128	loss	MUTAGEN K->M,R: Abolishes the kinase activity.	UniProt
P06213	INSR	D1159N	D	1159	N	390	loss	MUTAGEN D->N: Loss of kinase activity.	UniProt
P06213	INSR	R1163Q	R	1163	Q	394	loss	MUTAGEN R->Q: Loss of kinase activity.	UniProt
P51617	IRAK1	T209A	T	209	A	26	loss	MUTAGEN T->A: Completely abolishes auto-phosphorylation in the kinase domain.	UniProt
P51617	IRAK1	K239S	K	239	S	128	loss	MUTAGEN K->S: Loss of kinase activity.	UniProt
P51617	IRAK1	D340N	D	340	N	390	loss	MUTAGEN D->N: Loss of kinase activity.	UniProt
P51617	IRAK1	T387A	T	387	A	522	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
Q9NWZ3	IRAK4	K213A	K	213	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
P23458	JAK1	K908A	K	908	A	128	loss	MUTAGEN K->A: Loss of protein tyrosine kinase activity.	UniProt
P52333	JAK3	Y785F	Y	785	F	-	decrease	MUTAGEN Y->F: Strong decrease of JAK3 phosphorylation.	UniProt
P52333	JAK3	K855A	K	855	A	128	loss	MUTAGEN K->A: More than 90% loss of STAT5a activation.	UniProt
P52333	JAK3	Y904F	Y	904	F	269	decrease	MUTAGEN Y->F: About 40% loss of STAT5a activation.	UniProt
P52333	JAK3	Y939F	Y	939	F	365	loss	MUTAGEN Y->F: About 80% loss of STAT5a activation.	UniProt
O60229	KALRN	K2713A	K	2713	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation.	UniProt
P22612	PRKACG	I74M	I	74	M	129	decrease	VARIANT I -> M (in BDPLT19; patient platelets show impaired activation; dbSNP:rs724159972)	UniProt
P48730	CSNK1D	T44A	T	44	A	137	decrease	VARIANT T -> A (in FASPS2; strongly reduces kinase activity; dbSNP:rs104894561)	UniProt
P48730	CSNK1D	H46R	H	46	R	141	decrease	VARIANT H -> R (in FASPS2; strongly reduces kinase activity; dbSNP:rs397514693)	UniProt
P48730	CSNK1D	K38M	K	38	M	128	decrease	MUTAGEN K->M: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	UniProt
P48730	CSNK1D	T176I	T	176	I	522	decrease	MUTAGEN T->I: Impaired kinase activity and abnormal subcellular localization with exclusive accumulation to the nucleus.	UniProt
P49674	CSNK1E	K38R	K	38	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q9HCP0	CSNK1G1	N169A	N	169	A	395	loss	MUTAGEN N->A: Loss of kinase activity.	UniProt
Q14012	CAMK1	T177A	T	177	A	513	loss	MUTAGEN T->A: Loss of activation by CaMKK1.	UniProt
Q6P2M8	PNCK	T179A	T	179	A	532	loss	Loss of activation by cmkC.	UniProt
Q8IU85	CAMK1D	T180A	T	180	A	513	loss	MUTAGEN T->A: Loss of ionomycin-induced activation.	UniProt
Q16566	CAMK4	S12A	S	12	A	-	loss	MUTAGEN S->A: Loss of activity.	UniProt
Q16566	CAMK4	S13A	S	13	A	-	loss	MUTAGEN S->A: Loss of activity.	UniProt
Q16566	CAMK4	K75E	K	75	E	128	loss	MUTAGEN K->E: Loss of activity; dominant negative form.	UniProt
Q16566	CAMK4	T200A	T	200	A	513	loss	MUTAGEN T->A: Loss of activation by CaMKK1 or CaMKK2.	UniProt
P10721	KIT	E839K	E	839	K	535	loss	VARIANT E -> K (in MASTC; sporadic case; somatic mutation; dominant negative mutation; loss of autophosphorylation; dbSNP:rs121913509)	UniProt
P10721	KIT	R381A	R	381	A	-	decrease	MUTAGEN R->A: Reduces autophosphorylation in response to KITLG/SCF.	UniProt
P21802	FGFR2	K659M	K	659	M	510	resistance	-	COSMIC
P10721	KIT	E386A	E	386	A	-	decrease	MUTAGEN E->A: Reduces autophosphorylation in response to KITLG/SCF.	UniProt
Q15139	PRKD1	Y502E	Y	502	E	-	loss	MUTAGEN Y->E: Loss of activation.	UniProt
Q15139	PRKD1	K612W	K	612	W	128	loss	MUTAGEN K->W: Loss of kinase activity.	UniProt
Q9BZL6	PRKD2	D695A	D	695	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q9BZL6	PRKD2	Y717F	Y	717	F	531	loss	MUTAGEN Y->F: Abolishes phosphorylation. Decreases substrate affinity and increases catalytic efficiency. Increases Ser-706 or/and Ser-710 phosphorylation. Increases NF-kappa-B activation in response to oxidative stress.	UniProt
Q05655	PRKCD	S299A	S	299	A	-	loss	MUTAGEN S->A: Loss of phosphorylation.	UniProt
Q02156	PRKCE	K437W	K	437	W	128	loss	MUTAGEN K->W: Abolishes activity and S-729 phosphorylation.	UniProt
Q02156	PRKCE	T566A	T	566	A	513	loss	MUTAGEN T->A: Abolishes phosphorylation by PDK1, and S-729 phosphorylation.	UniProt
P41743	PRKCI	K274W	K	274	W	87	loss	MUTAGEN K->W: Abolishes activity.	UniProt
Q04759	PRKCQ	K409A	K	409	A	128	loss	MUTAGEN K->A,E: Loss of kinase activity.	UniProt
Q04759	PRKCQ	T538A	T	538	A	513	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
Q04759	PRKCQ	S676A	S	676	A	-	decrease	MUTAGEN S->A: Reduction in kinase activity.	UniProt
Q04759	PRKCQ	S695A	S	695	A	-	decrease	MUTAGEN S->A: Reduction in kinase activity.	UniProt
P51812	RPS6KA3	R383W	R	383	W	-	decrease	VARIANT R -> W (in XLID19; kinase activity is decreased but not abolished; dbSNP:rs122454129)	UniProt
O75582	RPS6KA5	D195A	D	195	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
O75582	RPS6KA5	S360A	S	360	A	-	decrease	MUTAGEN S->A: Decreases kinase activity by 60% in response to PMA and UV-C.	UniProt
O75582	RPS6KA5	S376A	S	376	A	-	loss	MUTAGEN S->A: Loss of kinase activity, and decreases the phosphorylation of S-360 and T-581.	UniProt
O75582	RPS6KA5	D565A	D	565	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
O75582	RPS6KA5	T581A	T	581	A	513	loss	MUTAGEN T->A: Loss of kinase activity, and blocks phosphorylation of S-212; S-376 and S-381 in response to 	UniProt
O75582	RPS6KA5	T700A	T	700	A	808	decrease	MUTAGEN T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.	UniProt
Q9UK32	RPS6KA6	S389A	S	389	A	-	decrease	MUTAGEN S->A: Strongly decreases activity.	UniProt
P23443	RPS6KB1	K167N	K	167	N	259	decrease	MUTAGEN K->N: Greatly reduces activity. Greatly reduces phosphorylation at T-412 and moderately reduces phosphorylation at T-252.	UniProt
P23443	RPS6KB1	S394A	S	394	A	-	loss	MUTAGEN S->A: Loss of activity. Loss of phosphorylation at T-412.	UniProt
Q8IVT5	KSR1	E72K	E	72	K	-	decrease	MUTAGEN E->K: Loss of interaction with BRAF and MAP2K1 and severe decrease in MAP2K1 phosphorylation levels.	UniProt
Q6VAB6	KSR2	D786A	D	786	A	-	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
O95835	LATS1	S464A	S	464	A	-	loss	MUTAGEN S->A: Abolishes phosphorylation by NUAK1 and NUAK2.	UniProt
O95835	LATS1	K734A	K	734	A	128	loss	MUTAGEN K->A: Loss of kinase activity, autophosphorylation, increased ploidy, prolonged duration of mitosis and lack of p53 expression.	UniProt
Q9NRM7	LATS2	K697A	K	697	A	128	loss	MUTAGEN K->A: Loss of kinase activity, autophosphorylation and tumor suppressor activity.	UniProt
Q9NRM7	LATS2	S872A	S	872	A	513	loss	MUTAGEN S->A: Loss of tumor suppressor activity.	UniProt
P53667	LIMK1	T508A	T	508	A	513	loss	MUTAGEN T->A: Abolishes activation by ROCK1.	UniProt
P53667	LIMK1	T508V	T	508	V	513	decrease	MUTAGEN T->V: Reduces kinase activity.	UniProt
P53671	LIMK2	T505V	T	505	V	513	loss	MUTAGEN T->V: Abolishes cofilin phosphorylation and enhancement of stress fiber formation.	UniProt
Q38SD2	LRRK1	K1270W	K	1270	W	128	loss	MUTAGEN K->W: Loss of autophosphorylation.	UniProt
Q5S007	LRRK2	L760D	L	760	D	-	decrease	MUTAGEN L->D: Decreased kinase activity and loss of RAB29-mediated activation.	UniProt
Q5S007	LRRK2	L761D	L	761	D	-	decrease	MUTAGEN L->D: Decreased kinase activity and loss of RAB29-mediated activation.	UniProt
Q5S007	LRRK2	L762D	L	762	D	-	decrease	MUTAGEN L->D: Decreased kinase activity and loss of RAB29-mediated activation.	UniProt
Q5S007	LRRK2	D1994A	D	1994	A	390	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
P29376	LTK	K544M	K	544	M	128	loss	MUTAGEN K->M: Loss of interaction with PLCG1, PI3-kinase subunit p85, Ras GTPase-activating protein and RAF1.	UniProt
P29376	LTK	Y862F	Y	862	F	-	decrease	MUTAGEN Y->F: Impairs phosphorylation of CBLC (demonstrated with chimeric EGFR-LTK).	UniProt
P07948	LYN	K275L	K	275	L	128	loss	MUTAGEN K->L,R: Loss of kinase activity.	UniProt
P07948	LYN	Y397F	Y	397	F	511	decrease	MUTAGEN Y->F: Strongly reduced kinase activity.	UniProt
Q16584	MAP3K11	K144A	K	144	A	128	decrease	MUTAGEN K->A: Greatly reduced autophosphorylation activity.	UniProt
Q16584	MAP3K11	K144R	K	144	R	128	loss	MUTAGEN K->R: Loss of kinase activity. Prevents activation of SAPK and MAPK14.	UniProt
Q16584	MAP3K11	E164A	E	164	A	175	decrease	MUTAGEN E->A: Greatly reduced autophosphorylation activity.	UniProt
Q16584	MAP3K11	T277A	T	277	A	460	decrease	MUTAGEN T->A: Severely reduced autophosphorylation activity. Prevents phosphorylation of SAPK and MAPK14.	UniProt
Q16584	MAP3K11	S281A	S	281	A	513	decrease	MUTAGEN S->A: Reduced autophosphorylation activity. Reduced activation of SAPK and MAPK14.	UniProt
Q9NYL2	MAP3K20	K45M	K	45	M	128	loss	MUTAGEN K->M: Loss of kinase activity. Does not affect ability to activate EIF2AK4/GCN2 in response to mild ribosome collision.	UniProt
Q9NYL2	MAP3K20	T161A	T	161	A	460	loss	MUTAGEN T->A: Loss of autophosphorylation activity.	UniProt
Q9NYL2	MAP3K20	T162A	T	162	A	461	decrease	MUTAGEN T->A: Slight loss of autophosphorylation activity.	UniProt
Q9NYL2	MAP3K20	S165A	S	165	A	513	loss	MUTAGEN S->A: Loss of autophosphorylation activity.	UniProt
Q9Y6R4	MAP3K4	K1372R	K	1372	R	128	loss	MUTAGEN K->R: Loss of activity.	UniProt
Q99683	MAP3K5	K709M	K	709	M	128	loss	MUTAGEN K->M: Loss of kinase activity. Inhibits activation of JNK and apoptosis mediated by TNFRSF6 and DAXX. Does not affect interaction with TRIM48.	UniProt
Q99683	MAP3K5	K709R	K	709	R	128	loss	MUTAGEN K->R: Loss of kinase activity. Abolishes DAXX-mediated apoptosis. Loss of RC3H2-mediated ubiquitination.	UniProt
O43318	MAP3K7	K63W	K	63	W	128	loss	MUTAGEN K->W: Loss of kinase activity. Loss of autophosphorylation.	UniProt
P80192	MAP3K9	K171A	K	171	A	128	loss	MUTAGEN K->A: Loss of kinase activity and threonine phosphorylation.	UniProt
P80192	MAP3K9	T304A	T	304	A	460	decrease	MUTAGEN T->A: Reduces threonine phosphorylation. Impairs JNK activation.	UniProt
P80192	MAP3K9	S308A	S	308	A	513	decrease	MUTAGEN S->A: Impairs JNK activation.	UniProt
P80192	MAP3K9	T312A	T	312	A	522	loss	MUTAGEN T->A: Loss of threonine phosphorylation. Strongly impairs JNK activation.	UniProt
Q8IVH8	MAP4K3	K48E	K	48	E	131	loss	Loss of kinase activity and ability to;activate JNK family.	UniProt
Q9Y4K4	MAP4K5	K49R	K	49	R	128	loss	MUTAGEN K->R: Loss of kinase activity and ability to activate JNK family.	UniProt
P20794	MAK	G13S	G	13	S	40	loss	VARIANT G -> S (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906647)	UniProt
P20794	MAK	N130H	N	130	H	395	loss	VARIANT N -> H (in RP62; results in a complete loss of kinase activity compared to wild-type; dbSNP:rs387906646)	UniProt
P20794	MAK	K33R	K	33	R	128	loss	MUTAGEN K->R: Abolishes autophosphorylation.	UniProt
P20794	MAK	T157A	T	157	A	512	loss	MUTAGEN T->A: Abolishes autophosphorylation and impairs kinase activity.	UniProt
P49137	MAPKAPK2	K93R	K	93	R	128	loss	MUTAGEN K->R: Kinase defective mutant, abolishes activity.	UniProt
P49137	MAPKAPK2	D207A	D	207	A	443	loss	MUTAGEN D->A: Kinase defective mutant, abolishes activity.	UniProt
P49137	MAPKAPK2	T222A	T	222	A	513	decrease	MUTAGEN T->A: Strong decrease in kinase activity.	UniProt
P49137	MAPKAPK2	S272A	S	272	A	639	decrease	MUTAGEN S->A: Strong decrease in kinase activity.	UniProt
P49137	MAPKAPK2	T334A	T	334	A	803	decrease	MUTAGEN T->A: Slight decrease in kinase activity.	UniProt
Q8IW41	MAPKAPK5	K51M	K	51	M	128	loss	MUTAGEN K->M: Kinase defective mutant, abolishes activity.	UniProt
Q7KZI7	MARK2	S219A	S	219	A	535	loss	Loss of kinase activity.	UniProt
Q14680	MELK	D150A	D	150	A	443	loss	MUTAGEN D->A: Abolishes enzymatic activity.	UniProt
Q14680	MELK	T167A	T	167	A	513	loss	MUTAGEN T->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	UniProt
Q14680	MELK	S171A	S	171	A	522	loss	MUTAGEN S->A: Abolishes activation of serine/threonine-protein kinase activity and has only weak activity.	UniProt
P45983	MAPK8	K55D	K	55	D	128	loss	MUTAGEN K->D: Abolished protein kinase activity.	UniProt
P53778	MAPK12	Y185F	Y	185	F	517	loss	MUTAGEN Y->F: Loss of activity.	UniProt
O15264	MAPK13	T180A	T	180	A	512	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
O15264	MAPK13	Y182A	Y	182	A	517	loss	MUTAGEN Y->A: Loss of kinase activity.	UniProt
Q16539	MAPK14	A34V	A	34	V	41	decrease	MUTAGEN A->V: Lowered kinase activity.	UniProt
Q16539	MAPK14	K53R	K	53	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q16539	MAPK14	K54R	K	54	R	129	decrease	MUTAGEN K->R: Impairs MAP2K6/MKK6-dependent autophosphorylation.	UniProt
Q16539	MAPK14	Y69H	Y	69	H	173	decrease	MUTAGEN Y->H: Lowered kinase activity.	UniProt
Q16539	MAPK14	D168A	D	168	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q16539	MAPK14	D177A	D	177	A	459	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q16539	MAPK14	T180E	T	180	E	512	loss	MUTAGEN T->E: Loss of kinase activity.	UniProt
Q16539	MAPK14	Y182F	Y	182	F	517	loss	MUTAGEN Y->F: Loss of kinase activity.	UniProt
Q16539	MAPK14	A320T	A	320	T	806	decrease	MUTAGEN A->T: Lowered kinase activity.	UniProt
Q16539	MAPK14	W337R	W	337	R	823	loss	MUTAGEN W->R: Loss of kinase activity.	UniProt
Q8TD08	MAPK15	K42R	K	42	R	128	loss	MUTAGEN K->R: Loss of autophosphorylation and activity. Does not increase dopamine transporter activity. Impairs kinase activity. Does not rescue cilium assembly in MAPK15-depleted cells.	UniProt
Q8TD08	MAPK15	R59Q	R	59	Q	174	loss	MUTAGEN R->Q: Does not increase dopamine transporter activity. Impairs kinase activity.	UniProt
Q8TD08	MAPK15	Y177A	Y	177	A	517	loss	MUTAGEN Y->A: Loss of autophosphorylation and activity. Heavily phosphorylated at Thr-175.	UniProt
Q9HBH9	MKNK2	D228G	D	228	G	445	decrease	MUTAGEN D->G: Reduced phosphorylation.	UniProt
Q02750	MAP2K1	K97A	K	97	A	128	loss	MUTAGEN K->A: Loss of catalytic activity. Strongly reduces phosphorylation upon UV irradiation.	UniProt
Q5VT25	CDC42BPA	K106A	K	106	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q5VT25	CDC42BPA	S234A	S	234	A	511	loss	MUTAGEN S->A: Loss of autophosphorylation and kinase activity.	UniProt
Q5VT25	CDC42BPA	T240A	T	240	A	522	loss	MUTAGEN T->A: Loss of autophosphorylation and kinase activity.	UniProt
Q5VT25	CDC42BPA	T403A	T	403	A	-	loss	MUTAGEN T->A: Loss of autophosphorylation and kinase activity.	UniProt
P42345	MTOR	H2340A	H	2340	A	-	loss	MUTAGEN H->A: Barely detectable kinase activity.	UniProt
O15146	MUSK	I575T	I	575	T	29	decrease	VARIANT I -> T (in FADS1; reduces agrin-dependent AChR aggregation and tyrosine kinase activity in developing neuromuscular junction; dbSNP:rs751889864)	UniProt
O15146	MUSK	M605I	M	605	I	118	decrease	VARIANT M -> I (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs766640370)	UniProt
Q96BR1	SGK3	K191M	K	191	M	128	loss	MUTAGEN K->M: Abolishes activity.	UniProt
O15146	MUSK	A727V	A	727	V	392	decrease	VARIANT A -> V (in CMS9; affects interaction with DOK7 and impairs MUSK phosphorylation; altered AChR clustering; dbSNP:rs397515450)	UniProt
O15146	MUSK	V790M	V	790	M	589	decrease	VARIANT V -> M (in CMS9; does not affect catalytic kinase activity; reduces protein expression and stability; dbSNP:rs199476083)	UniProt
O15146	MUSK	G584C	G	584	C	40	decrease	MUTAGEN G->C,D: Mild decrease in kinase activity.	UniProt
O15146	MUSK	K609R	K	609	R	128	loss	MUTAGEN K->R: Severe loss of kinase activity.	UniProt
Q15746	MYLK	A1491S	A	1491	S	126	decrease	VARIANT A -> S (in AAT7; decreases kinase activity; dbSNP:rs1576422965)	UniProt
Q15746	MYLK	A1754T	A	1754	T	-	decrease	VARIANT A -> T (in AAT7; 4-fold reduced affinity for calmodulin; decreased kinase activity compared to wild-type protein)	UniProt
Q15746	MYLK	K608A	K	608	A	-	loss	MUTAGEN K->A: Loss of acetylation and no kinase activity repression by NAA10/ARD1.	UniProt
Q6ZWH5	NEK10	K548R	K	548	R	128	decrease	MUTAGEN K->R: Catalytically inactive. Impaired mucociliary transport.	UniProt
P51955	NEK2	K37R	K	37	R	128	loss	MUTAGEN K->R: Loss of kinase activity and of ability to activate NEK11. Loss of phosphorylation of CCDC102B.	UniProt
P51955	NEK2	D141A	D	141	A	390	loss	MUTAGEN D->A: Loss of autophosphorylation.	UniProt
P51955	NEK2	T175A	T	175	A	513	decrease	MUTAGEN T->A: Kinase activity decreased by two fold.	UniProt
P51955	NEK2	T179A	T	179	A	522	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
P51955	NEK2	T179E	T	179	E	522	loss	MUTAGEN T->E: Loss of kinase activity.	UniProt
P51955	NEK2	S241A	S	241	A	752	loss	MUTAGEN S->A: Loss of kinase activity.	UniProt
P51955	NEK2	S241D	S	241	D	752	loss	MUTAGEN S->D: Loss of kinase activity.	UniProt
Q8TDX7	NEK7	N33D	N	33	D	29	decrease	MUTAGEN N->D: Significant decrease in catalytic activity.	UniProt
Q8TD19	NEK9	K81M	K	81	M	128	loss	MUTAGEN K->M: Loss of activity and autophosphorylation.	UniProt
Q8TD19	NEK9	T210A	T	210	A	513	decrease	MUTAGEN T->A: Significant reduction of autophosphorylation.	UniProt
Q8IY84	NIM1K	T229A	T	229	A	513	loss	MUTAGEN T->A: Loss of autophosphorylation and kinase activity.	UniProt
P04629	NTRK1	G577R	G	577	R	208	loss	VARIANT G -> R (in CIPA; loss of function; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs121964866)	UniProt
P04629	NTRK1	D596N	D	596	N	275	loss	VARIANT D -> N (in CIPA; abolishes autophosphorylation)	UniProt
P04629	NTRK1	R780P	R	780	P	797	loss	VARIANT R -> P (in CIPA; loss of function; dbSNP:rs35669708)	UniProt
P04629	NTRK1	K544N	K	544	N	128	loss	MUTAGEN K->N: Loss of kinase activity.	UniProt
Q16620	NTRK2	Y706C	Y	706	C	462	decrease	VARIANT Y -> C (in OBHD; expressed normally on the cell surface; results in markedly impaired ligand-induced phosphorylation as well as impaired downstream MAPK1 phosphorylation; dbSNP:rs121434633)	UniProt
Q16288	NTRK3	K572N	K	572	N	128	loss	MUTAGEN K->N: Loss of autophosphorylation and loss of NTRK3 signaling.	UniProt
O60285	NUAK1	K84A	K	84	A	128	loss	MUTAGEN K->A: Abolishes kinase activity and ability to induce senescence.	UniProt
O60285	NUAK1	T211A	T	211	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Abolishes ability to induce senescence.	UniProt
Q9H093	NUAK2	K81R	K	81	R	128	loss	MUTAGEN K->R: Loss of autophosphorylation, kinase activity and of anti-apoptotic activity.	UniProt
O95747	OXSR1	K46A	K	46	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation and kinase activity.	UniProt
O95747	OXSR1	K46M	K	46	M	128	loss	MUTAGEN K->M: Loss of RELT, RELL1 and RELL2 phosphorylation. Retention of some autophosphorylation activity may be due to complex formation with other endogenous kinases in the assay.	UniProt
Q13153	PAK1	D393A	D	393	A	394	loss	MUTAGEN D->A: Abolishes autophosphorylation at Thr-423.	UniProt
Q13153	PAK1	T423A	T	423	A	513	decrease	MUTAGEN T->A: Decreases CDC42-stimulated activity and autophosphorylation.	UniProt
Q13177	PAK2	K278R	K	278	R	128	loss	MUTAGEN K->R: Abolishes kinase activity and autophosphorylation.	UniProt
Q13177	PAK2	T402A	T	402	A	513	loss	MUTAGEN T->A: Abolishes kinase activity and greatly inhibits autophosphorylation of PAK-2p27 and PAK-2p34.	UniProt
Q96RG2	PASK	K1028R	K	1028	R	128	loss	MUTAGEN K->R: Loss of autophosphorylating activity.	UniProt
Q96RG2	PASK	R1058A	R	1058	A	182	decrease	MUTAGEN R->A: Induces lower protein kinase activity.	UniProt
Q96RG2	PASK	A1151K	A	1151	K	449	decrease	MUTAGEN A->K: Induces lower protein kinase activity and ability to autophosphorylate.	UniProt
Q96RG2	PASK	Y1152F	Y	1152	F	453	decrease	MUTAGEN Y->F: Induces lower protein kinase activity.	UniProt
Q96RG2	PASK	T1161A	T	1161	A	513	loss	MUTAGEN T->A: Loss of catalytic activity (PubMed:11459942). According to another report, does not affect the protein kinase activity (PubMed:20943661). Does not affect protein translation.	UniProt
Q96RG2	PASK	T1165A	T	1165	A	522	loss	MUTAGEN T->A: Loss of catalytic activity. Does not affect protein translation.	UniProt
Q16654	PDK4	Y157F	Y	157	F	-	loss	MUTAGEN Y->F: Loss of activity.	UniProt
Q16654	PDK4	R161A	R	161	A	-	loss	MUTAGEN R->A: Loss of activity.	UniProt
O15530	PDPK1	Y9F	Y	9	F	-	decrease	MUTAGEN Y->F: Slight reduction in pervanadate-stimulated tyrosine phosphorylation.	UniProt
O15530	PDPK1	T354A	T	354	A	818	increase	MUTAGEN T->A: Abolishes phosphorylation by MELK.	UniProt
P11309	PIM1	P81S	P	81	S	147	decrease	MUTAGEN P->S: Decreased kinase activity.	UniProt
P11309	PIM1	N82K	N	82	K	168	decrease	MUTAGEN N->K: Decreased kinase activity.	UniProt
P11309	PIM1	L193F	L	193	F	456	decrease	MUTAGEN L->F: Decreased kinase activity.	UniProt
O00141	SGK1	K127M	K	127	M	128	loss	MUTAGEN K->M: Abolishes enzymatic activity.	UniProt
Q9BXM7	PINK1	T313M	T	313	M	259	decrease	VARIANT T -> M (in PARK6; decreases PRKN and SNCAIP ubiquitination and degradation; slightly decreases Drp1 phosphorylation; dbSNP:rs74315359)	UniProt
Q9BXM7	PINK1	G386A	G	386	A	445	loss	VARIANT G -> A (in PARK6; abolishes kinase activity)	UniProt
Q16512	PKN1	K644E	K	644	E	128	loss	MUTAGEN K->E: Abolishes Serine/threonine-protein kinase activity.	UniProt
Q16512	PKN1	K644R	K	644	R	128	decrease	MUTAGEN K->R: Substantial reduction of autophosphorylation.	UniProt
Q16513	PKN2	T816A	T	816	A	513	decrease	MUTAGEN T->A: Reduces catalytic activity.	UniProt
Q16513	PKN2	T958A	T	958	A	-	loss	MUTAGEN T->A: Abolishes catalytic activity.	UniProt
Q16513	PKN2	F977W	F	977	W	-	decrease	MUTAGEN F->W,Y: Reduces catalytic activity by 50%.	UniProt
Q16513	PKN2	Y979A	Y	979	A	-	decrease	MUTAGEN Y->A: Reduces catalytic activity by 50%.	UniProt
Q16513	PKN2	Y979F	Y	979	F	-	decrease	MUTAGEN Y->F,L,W: Reduces catalytic activity by 25%.	UniProt
Q6P5Z2	PKN3	K588E	K	588	E	128	loss	MUTAGEN K->E: Abolishes autophosphorylation and catalytic activity.	UniProt
Q6P5Z2	PKN3	K588R	K	588	R	128	loss	MUTAGEN K->R: Abolishes catalytic activity.	UniProt
Q6P5Z2	PKN3	T718A	T	718	A	513	loss	MUTAGEN T->A: Abolishes phosphorylation.	UniProt
P53350	PLK1	D176N	D	176	N	390	loss	MUTAGEN D->N: Abolishes kinase activity.	UniProt
P53350	PLK1	T210A	T	210	A	513	loss	MUTAGEN T->A: Abolishes activity. Abolishes checkpoint recovery.	UniProt
Q9NYY3	PLK2	N210A	N	210	A	395	loss	MUTAGEN N->A: Loss of kinase activity.	UniProt
Q9H4B4	PLK3	K91R	K	91	R	128	loss	MUTAGEN K->R: Kinase defective mutant, abolishes activity.	UniProt
Q9H4B4	PLK3	D203A	D	203	A	443	loss	MUTAGEN D->A: Kinase defective mutant, abolishes activity.	UniProt
O00444	PLK4	K41M	K	41	M	128	loss	MUTAGEN K->M: Abolishes ability to phosphorylate CDC25C and CHEK2.	UniProt
Q99640	PKMYT1	N238A	N	238	A	395	loss	MUTAGEN N->A: Loss of kinase activity.	UniProt
Q99640	PKMYT1	D251A	D	251	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
P78527	PRKDC	A3574V	A	3574	V	-	loss	VARIANT A -> V (in IMD26; shows impaired function in response to irradiation and a less severe defect in V(D)J end-joining suggesting that the missense mutation retained some functional capacity; consistent with a loss of function mutation; dbSNP:rs587777686)	UniProt
P51817	PRKX	K78R	K	78	R	128	loss	MUTAGEN K->R: Loss of function.	UniProt
Q13882	PTK6	W44A	W	44	A	-	decrease	MUTAGEN W->A: Strong decrease in STAP2 phosphorylation. Markedly decreased interaction between SH3 domain the linker region.	UniProt
Q13882	PTK6	Y66A	Y	66	A	-	decrease	MUTAGEN Y->A: Decrease in STAP2 phosphorylation.	UniProt
Q13882	PTK6	R105L	R	105	L	-	decrease	MUTAGEN R->L: Decrease in STAP2 phosphorylation.	UniProt
Q13882	PTK6	K219M	K	219	M	128	loss	MUTAGEN K->M: Abolishes kinase activity and cell transformation, and phosphorylation of STAP2.	UniProt
Q13882	PTK6	K219R	K	219	R	128	loss	MUTAGEN K->R: Abolishes kinase activity.	UniProt
P04049	RAF1	D486N	D	486	N	443	loss	VARIANT D -> N (in NS5; has reduced or absent kinase activity; dbSNP:rs80338798)	UniProt
P04049	RAF1	T491I	T	491	I	449	loss	VARIANT T -> I (in NS5; has reduced or absent kinase activity; dbSNP:rs80338799)	UniProt
P04049	RAF1	L603P	L	603	P	789	decrease	VARIANT L -> P (in CMD1NN; shows impaired kinase activity and reduced MAPK3 activation with this mutation; dbSNP:rs587777586)	UniProt
P07949	RET	Y1062F	Y	1062	F	-	loss	MUTAGEN Y->F: Abolishes GFRAL-mediated MAPK1/MAPK2 phosphorylation.	UniProt
Q13546	RIPK1	S25D	S	25	D	39	loss	MUTAGEN S->D: Phophomimetic mutant. Significant loss of kinase activity.	UniProt
Q13546	RIPK1	K45A	K	45	A	128	loss	MUTAGEN K->A: Abolishes kinase activity.	UniProt
Q13546	RIPK1	S161A	S	161	A	449	decrease	MUTAGEN S->A: Decreases RIPK1 kinase activity.	UniProt
O43353	RIPK2	K47A	K	47	A	128	loss	MUTAGEN K->A: Abolishes kinase activity.	UniProt
O43353	RIPK2	D146N	D	146	N	390	loss	MUTAGEN D->N: Abolishes kinase activity.	UniProt
O43353	RIPK2	Y381A	Y	381	A	-	decrease	MUTAGEN Y->A: Prevents phosphorylation. Reduces serine and threonine phosphorylation of ARHGEF2.	UniProt
Q9Y572	RIPK3	K50D	K	50	D	128	loss	MUTAGEN K->D: Abolishes kinase activity.	UniProt
Q9Y572	RIPK3	D142N	D	142	N	390	loss	MUTAGEN D->N: Abolishes kinase activity and ability to mediate necroptosis.	UniProt
P57078	RIPK4	I121N	I	121	N	352	loss	VARIANT I -> N (in BPS; loss of function; dbSNP:rs387906923)	UniProt
P57078	RIPK4	T184I	T	184	I	522	loss	VARIANT T -> I (in BPS; loss of function)	UniProt
Q05823	RNASEL	R462Q	R	462	Q	347	decrease	VARIANT R -> Q (risk factor for prostate cancer; reduced enzymatic activity; dbSNP:rs486907)	UniProt
Q05823	RNASEL	K392R	K	392	R	128	loss	MUTAGEN K->R: Complete loss of enzymatic activity and enzyme dimerization. No change in binding to 2-5A and RNA.	UniProt
Q05823	RNASEL	D661A	D	661	A	-	loss	MUTAGEN D->A: Complete loss of enzymatic activity.	UniProt
Q05823	RNASEL	R667A	R	667	A	-	loss	MUTAGEN R->A: Complete loss of enzymatic activity. No change in 2-5A binding and enzyme dimerization.	UniProt
Q05823	RNASEL	H672A	H	672	A	-	loss	MUTAGEN H->A: Complete loss of enzymatic activity. No change in 2-5A binding activity and enzyme dimerization.	UniProt
P08922	ROS1	K1980M	K	1980	M	128	loss	MUTAGEN K->M: Loss of kinase activity.	UniProt
Q52WX2	SBK1	K61R	K	61	R	39	loss	Loss of activity.	UniProt
P0C263	SBK2	K73M	K	73	M	42	loss	Loss of activity.	UniProt
Q9H5K3	POMK	L137R	L	137	R	206	loss	VARIANT L -> R (in MDDGA12; loss of kinase activity; dbSNP:rs397509385)	UniProt
P57059	SIK1	K56M	K	56	M	128	loss	MUTAGEN K->M: Loss of kinase activity.	UniProt
P57059	SIK1	S135A	S	135	A	358	decrease	MUTAGEN S->A: Decreased kinase activity without affecting much autophosphorylation status.	UniProt
P57059	SIK1	T182A	T	182	A	513	decrease	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex. Reduced inhibition of CRTC3-mediated transcriptional activity.	UniProt
P57059	SIK1	S186A	S	186	A	522	loss	MUTAGEN S->A,D,C,G: Impaired autophosphorylation and kinase activity.	UniProt
P57059	SIK1	S209A	S	209	A	586	decrease	MUTAGEN S->A: Decreased kinase activity without affecting much autophosphorylation status.	UniProt
P57059	SIK1	S248A	S	248	A	752	decrease	MUTAGEN S->A: Decreased kinase activity without affecting much autophosphorylation status.	UniProt
P57059	SIK1	S575E	S	575	E	-	decrease	MUTAGEN S->E: Strongly reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	UniProt
Q9Y2K2	SIK3	T469A	T	469	A	-	loss	MUTAGEN T->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	UniProt
Q9Y2K2	SIK3	T469E	T	469	E	-	loss	MUTAGEN T->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	UniProt
Q9Y2K2	SIK3	S551A	S	551	A	-	loss	MUTAGEN S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	UniProt
Q9Y2K2	SIK3	S551E	S	551	E	-	loss	MUTAGEN S->E: Loss of interaction with 14-3-3 proteins in response to cAMP signaling; inhibits cAMP signaling.	UniProt
Q9H2G2	SLK	K63R	K	63	R	128	loss	MUTAGEN K->R: Loss of activity.	UniProt
Q96Q15	SMG1	D2335A	D	2335	A	-	loss	MUTAGEN D->A: Loss of function.	UniProt
P12931	SRC	K298M	K	298	M	128	loss	MUTAGEN K->M: Kinase inactive. Abolishes ubiquitination promoted by CBLC.	UniProt
P12931	SRC	Y419F	Y	419	F	511	loss	MUTAGEN Y->F: Loss of kinase activity. Loss of interaction with PDLIM4.	UniProt
Q9H3Y6	SRMS	W223A	W	223	A	22	loss	MUTAGEN W->A: Loss of kinase activity.	UniProt
Q96SB4	SRPK1	S51A	S	51	A	2	decrease	MUTAGEN S->A: Protein phosphorylation impaired at this position.	UniProt
Q96SB4	SRPK1	S555A	S	555	A	623	decrease	MUTAGEN S->A: Protein phosphorylation impaired at this position.	UniProt
Q9UEE5	STK17A	K90A	K	90	A	128	loss	MUTAGEN K->A: Loss of activity and of apoptotic function.	UniProt
O94768	STK17B	K62A	K	62	A	128	loss	MUTAGEN K->A: Loss of activity and of apoptotic function.	UniProt
Q9Y2H1	STK38L	T75A	T	75	A	16	decrease	MUTAGEN T->A: Decreased kinase activity. Reduced binding of S100B.	UniProt
Q9Y2H1	STK38L	K119A	K	119	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation and kinase activity.	UniProt
Q9Y2H1	STK38L	S282A	S	282	A	513	loss	MUTAGEN S->A: Loss of autophosphorylation and kinase activity.	UniProt
Q9Y2H1	STK38L	T442A	T	442	A	-	decrease	MUTAGEN T->A: Decreased kinase activity.	UniProt
O94804	STK10	K65I	K	65	I	128	loss	MUTAGEN K->I: Loss of kinase activity.	UniProt
Q15831	STK11	L67P	L	67	P	73	loss	VARIANT L -> P (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs137853077)	UniProt
Q15831	STK11	D176N	D	176	N	390	loss	VARIANT D -> N (in PJS; loss of kinase activity, leading to greatly reduced autophosphorylation; fails to phosphorylate 	UniProt
Q15831	STK11	D176Y	D	176	Y	390	loss	VARIANT D -> Y (in sporadic cancer; somatic mutation; Loss of kinase activity)	UniProt
Q15831	STK11	E199K	E	199	K	449	loss	VARIANT E -> K (in colorectal cancer; somatic mutation; impaired kinase activity; dbSNP:rs121913317)	UniProt
Q15831	STK11	W308C	W	308	C	793	loss	VARIANT W -> C (in PJS; abolishes kinase activity, leading to loss of autophosphorylation; dbSNP:rs1057520042)	UniProt
Q15831	STK11	K78I	K	78	I	128	loss	MUTAGEN K->I: Loss of kinase activity, leading to greatly reduced autophosphorylation.	UniProt
Q15831	STK11	K78M	K	78	M	128	loss	MUTAGEN K->M: Loss of kinase activity, leading to reduced autophosphorylation and acting as a dominant-negative mutant.	UniProt
Q15831	STK11	T189A	T	189	A	429	decrease	MUTAGEN T->A: Reduced phosphorylation.	UniProt
Q15831	STK11	D194A	D	194	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
O75716	STK16	T192A	T	192	A	517	loss	Loss of autophosphorylation.	UniProt
P49842	STK19	K300P	K	300	P	-	decrease	MUTAGEN K->P: Partial loss of activity.	UniProt
P49842	STK19	K315P	K	315	P	-	decrease	MUTAGEN K->P: Partial loss of activity.	UniProt
P49842	STK19	K317P	K	317	P	-	loss	MUTAGEN K->P: Complete loss of activity.	UniProt
Q9Y6E0	STK24	T18A	T	18	A	13	loss	MUTAGEN T->A: Loss of phosphorylation by PKA.	UniProt
Q9Y6E0	STK24	K65A	K	65	A	128	loss	MUTAGEN K->A: Loss of activity and autophosphorylation.	UniProt
Q9Y6E0	STK24	T190A	T	190	A	513	loss	MUTAGEN T->A: Loss of activity and autophosphorylation.	UniProt
O00506	STK25	K49R	K	49	R	128	loss	MUTAGEN K->R: Loss of kinase activity and autophosphorylation.	UniProt
O00506	STK25	D158A	D	158	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q9P289	STK26	K53E	K	53	E	128	loss	MUTAGEN K->E: Abolished serine/threonine-protein kinase activity.	UniProt
Q15208	STK38	T74A	T	74	A	16	decrease	MUTAGEN T->A: Decreases autophosphorylation and kinase activity. Reduced binding of S100B.	UniProt
Q15208	STK38	K118A	K	118	A	128	loss	MUTAGEN K->A: Loss of autophosphorylation and kinase activity.	UniProt
Q15208	STK38	S281A	S	281	A	513	loss	MUTAGEN S->A: Loss of autophosphorylation and kinase activity.	UniProt
Q15208	STK38	T444A	T	444	A	-	decrease	MUTAGEN T->A: Decreases autophosphorylation and kinase activity.	UniProt
Q13188	STK3	K56R	K	56	R	128	loss	MUTAGEN K->R: Loss of activity.	UniProt
Q13043	STK4	K59R	K	59	R	128	loss	MUTAGEN K->R: Loss of activity.	UniProt
Q13043	STK4	T183A	T	183	A	513	loss	MUTAGEN T->A: Loss of activity.	UniProt
Q13043	STK4	L444P	L	444	P	-	loss	MUTAGEN L->P: Loss of homodimerization, activation, and autophosphorylation.	UniProt
Q7RTN6	STRADA	T329A	T	329	A	-	loss	MUTAGEN T->A: Loss of STK11/LKB1-mediated phosphorylation.	UniProt
Q7RTN6	STRADA	T419A	T	419	A	-	loss	MUTAGEN T->A: Loss of STK11/LKB1-mediated phosphorylation.	UniProt
Q7L7X3	TAOK1	K57A	K	57	A	128	loss	MUTAGEN K->A: Abolishes kinase activity, ability to activate the MAPK8/JNK cascade and cleavage by caspase-3 (CASP3).	UniProt
Q7L7X3	TAOK1	D169A	D	169	A	443	loss	MUTAGEN D->A: Loss of serine/threonine-protein kinase activity.	UniProt
Q9H2K8	TAOK3	D165A	D	165	A	443	loss	MUTAGEN D->A: Loss of serine/threonine-protein kinase activity.	UniProt
Q9UHD2	TBK1	R47H	R	47	H	142	loss	VARIANT R -> H (in FTDALS4; loss of kinase activity)	UniProt
Q9UHD2	TBK1	G159A	G	159	A	445	loss	VARIANT G -> A (in IIAE8; loss of kinase activity; loss of autophosphorylation at S-172; loss of IFNB induction; dbSNP:rs1555202947)	UniProt
Q9UHD2	TBK1	R308Q	R	308	Q	-	decrease	VARIANT R -> Q (in FTDALS4; reduced kinase activity)	UniProt
Q9UHD2	TBK1	R357Q	R	357	Q	-	decrease	VARIANT R -> Q (in FTDALS4; reduced kinase activity; dbSNP:rs758357594)	UniProt
Q9UHD2	TBK1	M559R	M	559	R	-	loss	VARIANT M -> R (in FTDALS4; loss of kinase activity)	UniProt
Q9UHD2	TBK1	E696K	E	696	K	-	loss	VARIANT E -> K (in FTDALS4; loss of kinase activity; impairs binding to OPTN; dbSNP:rs748112833)	UniProt
Q9UHD2	TBK1	D33A	D	33	A	110	decrease	MUTAGEN D->A: Decreases phosphorylation and kinase activity.	UniProt
Q9UHD2	TBK1	K38A	K	38	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q9UHD2	TBK1	D135N	D	135	N	390	loss	MUTAGEN D->N: Loss of kinase activity.	UniProt
Q9UHD2	TBK1	S172E	S	172	E	513	decrease	MUTAGEN S->E: Decreased kinase activity.	UniProt
Q9UHD2	TBK1	Y325E	Y	325	E	-	loss	MUTAGEN Y->E: Abolishes phosphorylation and kinase activity.	UniProt
Q9UHD2	TBK1	R547D	R	547	D	-	decrease	MUTAGEN R->D: Decreases phosphorylation and kinase activity. Abolishes dimerization.	UniProt
Q9UHD2	TBK1	Y577A	Y	577	A	-	decrease	MUTAGEN Y->A: Decreases kinase activity. Reduced phosphorylation of STING1.	UniProt
Q9UHD2	TBK1	N578A	N	578	A	-	decrease	MUTAGEN N->A: Reduced phosphorylation of STING1.	UniProt
Q9UHD2	TBK1	E580A	E	580	A	-	decrease	MUTAGEN E->A: Decreases kinase activity.	UniProt
Q9UHD2	TBK1	Q581A	Q	581	A	-	decrease	MUTAGEN Q->A: Reduced phosphorylation of STING1.	UniProt
Q9UHD2	TBK1	I582A	I	582	A	-	decrease	MUTAGEN I->A: Decreases kinase activity.	UniProt
Q9UHD2	TBK1	K589D	K	589	D	-	decrease	MUTAGEN K->D: Decreases phosphorylation and kinase activity.	UniProt
P36897	TGFBR1	T200V	T	200	V	23	loss	MUTAGEN T->V: Loss of phosphorylation. Loss of response to TGF-beta.	UniProt
P36897	TGFBR1	T204V	T	204	V	27	decrease	MUTAGEN T->V: Reduced phosphorylation. Reduced response to TGF-beta.	UniProt
P37173	TGFBR2	K277R	K	277	R	128	loss	MUTAGEN K->R: Abolishes kinase activity, TGF-beta signaling and interaction with DAXX.	UniProt
Q02763	TEK	C224S	C	224	S	-	decrease	MUTAGEN C->S: Reduces protein abundance.	UniProt
Q02763	TEK	K855R	K	855	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q9UKI8	TLK1	D607A	D	607	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q9UKI8	TLK1	S743A	S	743	A	803	loss	MUTAGEN S->A: Loss of kinase inhibition in response to DNA damage.	UniProt
Q9UKI8	TLK1	S743D	S	743	D	803	loss	MUTAGEN S->D: Loss of kinase inhibition in response to DNA damage.	UniProt
Q9UKI8	TLK1	S743E	S	743	E	803	loss	MUTAGEN S->E: Loss of kinase inhibition in response to DNA damage.	UniProt
Q86UE8	TLK2	H493R	H	493	R	130	decrease	VARIANT H -> R (in MRD57; reduced kinase activity; dbSNP:rs1567974030)	UniProt
Q86UE8	TLK2	H518R	H	518	R	180	decrease	VARIANT H -> R (in MRD57; severely reduced kinase activity; dbSNP:rs1567995650)	UniProt
Q86UE8	TLK2	S617L	S	617	L	448	decrease	VARIANT S -> L (in MRD57; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082914686)	UniProt
Q86UE8	TLK2	D629N	D	629	N	466	decrease	VARIANT D -> N (in MRD57; reduced phosphorylation of ASF1A; dbSNP:rs1568006217)	UniProt
Q86UE8	TLK2	H518N	H	518	N	180	decrease	MUTAGEN H->N: Reduced kinase activity.	UniProt
Q86UE8	TLK2	D592V	D	592	V	390	loss	MUTAGEN D->V: Loss of kinase activity. No impact on interaction with ASF1A.	UniProt
Q86UE8	TLK2	D613A	D	613	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
Q86UE8	TLK2	S617D	S	617	D	448	loss	MUTAGEN S->D: Loss of kinase activity.	UniProt
Q86UE8	TLK2	S659A	S	659	A	578	decrease	MUTAGEN S->A: Reduced kinase activity.	UniProt
Q86UE8	TLK2	S686A	S	686	A	624	decrease	MUTAGEN S->A: Reduced kinase activity.	UniProt
Q86UE8	TLK2	S686D	S	686	D	624	decrease	MUTAGEN S->D: Reduced kinase activity.	UniProt
Q86UE8	TLK2	T695A	T	695	A	652	decrease	MUTAGEN T->A: Reduced kinase activity.	UniProt
Q86UE8	TLK2	R720A	R	720	A	763	decrease	MUTAGEN R->A: Reduced phosphorylation of ASF1A.	UniProt
Q59H18	TNNI3K	G526D	G	526	D	208	decrease	VARIANT G -> D (in CCDD; the mutation results in decreased protein solubility; causes abnormal aggregation; markedly reduced protein expression is observed in the sarcoplasm and nuclei of patient cardiomyocytes; dbSNP:rs606231469)	UniProt
Q59H18	TNNI3K	K490R	K	490	R	128	loss	MUTAGEN K->R: Loss of autophosphorylation activity.	UniProt
Q9UKE5	TNIK	K54A	K	54	A	128	loss	MUTAGEN K->A: Kinase dead. Loss of autophosphorylation and loss of function in cytoskeleton regulation.	UniProt
O75962	TRIO	E1299K	E	1299	K	-	decrease	VARIANT E -> K (in MRD44; severely decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth)	UniProt
O75962	TRIO	R1428Q	R	1428	Q	-	decrease	VARIANT R -> Q (in MRD44; severely decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth; dbSNP:rs879255626)	UniProt
O75962	TRIO	H1469R	H	1469	R	-	decrease	VARIANT H -> R (in MRD44; decreased activation of RAC1-mediated signaling; severely decreased neurite outgrowth; dbSNP:rs1554070777)	UniProt
O75962	TRIO	E1299A	E	1299	A	-	decrease	MUTAGEN E->A: 50% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	T1303A	T	1303	A	-	decrease	MUTAGEN T->A: 40% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	V1426A	V	1426	A	-	decrease	MUTAGEN V->A: 90% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	Q1427A	Q	1427	A	-	decrease	MUTAGEN Q->A: 80% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	R1428A	R	1428	A	-	decrease	MUTAGEN R->A: 80% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	T1430A	T	1430	A	-	decrease	MUTAGEN T->A: 80% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	K1431A	K	1431	A	-	loss	MUTAGEN K->A: Loss of nucleotide exchange activity.	UniProt
O75962	TRIO	L1434A	L	1434	A	-	decrease	MUTAGEN L->A: 40% decrease in nucleotide exchange activity.	UniProt
O75962	TRIO	E1438A	E	1438	A	-	decrease	MUTAGEN E->A: 30% decrease in nucleotide exchange activity.	UniProt
Q9BX84	TRPM6	K1804R	K	1804	R	-	loss	MUTAGEN K->R: Abolishes kinase activity but does not affect expression levels or binding to RACK1.	UniProt
Q9BX84	TRPM6	T1851A	T	1851	A	-	decrease	MUTAGEN T->A: Significantly decreases autophosphorylation. Does not alter binding to RACK1 but prevents inhibition by RACK1.	UniProt
Q96QT4	TRPM7	K1648R	K	1648	R	-	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q96QT4	TRPM7	G1799D	G	1799	D	-	loss	MUTAGEN G->D: Loss of kinase activity.	UniProt
Q9BXA7	TSSK1B	T174A	T	174	A	513	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
Q6SA08	TSSK4	K54M	K	54	M	128	loss	MUTAGEN K->M: Loss of kinase activity.	UniProt
Q9BXA6	TSSK6	K41M	K	41	M	128	loss	MUTAGEN K->M: Loss of kinase activity. Loss of binding to TSACC.	UniProt
Q6IQ55	TTBK2	D163A	D	163	A	443	loss	MUTAGEN D->A: Abolishes serine/threonine-protein kinase activity.	UniProt
Q6IQ55	TTBK2	R181E	R	181	E	509	loss	MUTAGEN R->E,A: Impaired serine/threonine-protein kinase activity.	UniProt
Q6IQ55	TTBK2	A184E	A	184	E	512	loss	MUTAGEN A->E,G: Impaired serine/threonine-protein kinase activity.	UniProt
P33981	TTK	D664A	D	664	A	443	loss	MUTAGEN D->A: Loss of kinase activity.	UniProt
P33981	TTK	T686A	T	686	A	522	loss	MUTAGEN T->A: Loss of kinase activity.	UniProt
P42681	TXK	K299A	K	299	A	128	loss	MUTAGEN K->A: Impairs kinase activity.	UniProt
P29597	TYK2	K930R	K	930	R	128	loss	MUTAGEN K->R: Complete loss of catalytic activity.	UniProt
P29597	TYK2	D1023N	D	1023	N	390	loss	MUTAGEN D->N: Complete loss of catalytic activity.	UniProt
O75385	ULK1	K46I	K	46	I	128	loss	MUTAGEN K->I: Abolished serine/threonine-protein kinase activity.	UniProt
Q8IYT8	ULK2	K39R	K	39	R	128	decrease	MUTAGEN K->R: Decreased kinase activity and decreased autophosphorylation.	UniProt
Q6PHR2	ULK3	K44R	K	44	R	128	decrease	MUTAGEN K->R: Decreased kinase activity.	UniProt
Q6PHR2	ULK3	K139R	K	139	R	392	loss	MUTAGEN K->R: Loss of kinase activity. Does not promote GLI1 nuclear localization.	UniProt
P17948	FLT1	Y914F	Y	914	F	273	decrease	MUTAGEN Y->F: Reduces phosphorylation at other tyrosine residues.	UniProt
P17948	FLT1	Y1242F	Y	1242	F	-	loss	MUTAGEN Y->F: Loss of phosphorylation site.	UniProt
P17948	FLT1	Y1327F	Y	1327	F	-	loss	MUTAGEN Y->F: Loss of phosphorylation site.	UniProt
P35968	KDR	V848E	V	848	E	46	decrease	VARIANT V -> E (strongly reduced autophosphorylation and kinase activity; dbSNP:rs1139776)	UniProt
P35968	KDR	R726A	R	726	A	-	decrease	MUTAGEN R->A: Strongly reduced autophosphorylation and activation of MAP kinases.	UniProt
P35968	KDR	D731A	D	731	A	-	decrease	MUTAGEN D->A: Strongly reduced autophosphorylation and activation of MAP kinases.	UniProt
P35968	KDR	K868M	K	868	M	128	loss	MUTAGEN K->M: Loss of enzyme activity.	UniProt
P35968	KDR	Y996F	Y	996	F	26	decrease	MUTAGEN Y->F: Strongly reduced autophosphorylation. Reduces phosphorylation of PLCG1.	UniProt
P35968	KDR	Y1175F	Y	1175	F	810	loss	MUTAGEN Y->F: Abolishes phosphorylation of PLCG1 and MAP kinases in response to VEGFA.	UniProt
P35968	KDR	Y1214F	Y	1214	F	-	loss	MUTAGEN Y->F: Loss of phosphorylation site. Abolishes reorganization of the actin cytoskeleton in response to VEGFA.	UniProt
P35916	FLT4	A855T	A	855	T	41	decrease	VARIANT A -> T (in LMPHM1; recessive form; results in reduced autophosphorylation; results in impaired ligand-induced receptor internalization and downstream signaling; dbSNP:rs121909657)	UniProt
P35916	FLT4	G857R	G	857	R	43	loss	VARIANT G -> R (in LMPHM1; loss of kinase activity; dbSNP:rs267606818)	UniProt
P35916	FLT4	H1035R	H	1035	R	388	loss	VARIANT H -> R (in LMPHM1; loss of kinase activity; dbSNP:rs121909653)	UniProt
P35916	FLT4	R1041P	R	1041	P	394	loss	VARIANT R -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909650)	UniProt
P35916	FLT4	L1044P	L	1044	P	397	loss	VARIANT L -> P (in LMPHM1; loss of kinase activity; dbSNP:rs121909651)	UniProt
P35916	FLT4	P1114L	P	1114	L	617	loss	VARIANT P -> L (in LMPHM1; loss of kinase activity; dbSNP:rs121909652)	UniProt
P35916	FLT4	K879G	K	879	G	128	loss	MUTAGEN K->G: Abolishes enzyme activity.	UniProt
P35916	FLT4	Y1068F	Y	1068	F	463	loss	MUTAGEN Y->F: Global loss of autophosphorylation. Abolishes stimulation of cell proliferation and cell migration.	UniProt
P35916	FLT4	Y1230F	Y	1230	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	UniProt
Q9UM73	ALK	C1156Y	C	1156	Y	137	resistance	-	COSMIC
P35916	FLT4	Y1231F	Y	1231	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation site. Strongly reduces stimulation of cell proliferation and cell migration.	UniProt
P35916	FLT4	Y1333F	Y	1333	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation site. Reduced autophosphorylation.	UniProt
P35916	FLT4	Y1337F	Y	1337	F	-	decrease	MUTAGEN Y->F: Reduced autophosphorylation. Strongly reduces stimulation of cell proliferation and cell migration.	UniProt
P35916	FLT4	Y1363F	Y	1363	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation site. Slightly reduced autophosphorylation.	UniProt
Q99986	VRK1	S342A	S	342	A	-	decrease	MUTAGEN S->A: Abolishes phosphorylation by PLK3 and induction of Golgi fragmentation during mitosis. Strongly reduced autophosphorylation.	UniProt
Q99986	VRK1	T353A	T	353	A	-	decrease	MUTAGEN T->A: Strongly reduced autophosphorylation.	UniProt
Q86Y07	VRK2	K179E	K	179	E	427	loss	Abolished protein serine/threonine kinase;activity.	UniProt
P30291	WEE1	K328R	K	328	R	128	loss	MUTAGEN K->R: Abolishes activity.	UniProt
P30291	WEE1	S642A	S	642	A	-	loss	MUTAGEN S->A: Abolishes phosphorylation by BRSK1 and BRSK2.	UniProt
P0C1S8	WEE2	D234H	D	234	H	100	decrease	VARIANT D -> H (in OOMD5; decreased WEE2 phosphorylation at serine residues; decreased CDK1/CDC2 phosphorylation at 'Y-15'; dbSNP:rs1554415096)	UniProt
P43403	ZAP70	D461N	D	461	N	390	loss	MUTAGEN D->N: Abolishes kinase activity.	UniProt
P43403	ZAP70	D479N	D	479	N	443	loss	MUTAGEN D->N: Abolishes kinase activity.	UniProt
P43403	ZAP70	Y493F	Y	493	F	464	loss	MUTAGEN Y->F: Impairs kinase activity.	UniProt
O00141	SGK1	T256A	T	256	A	513	decrease	MUTAGEN T->A: Low activity.	UniProt
O00141	SGK1	T256D	T	256	D	513	decrease	MUTAGEN T->D: Low activity.	UniProt
O00141	SGK1	T256E	T	256	E	513	decrease	MUTAGEN T->E: Low activity.	UniProt
O00141	SGK1	Y298A	Y	298	A	619	decrease	MUTAGEN Y->A: Abolishes interaction with NEDD4 and NEDD4L.	UniProt
O00141	SGK1	S422A	S	422	A	-	decrease	MUTAGEN S->A: Low activity.	UniProt
O00238	BMPR1B	R31C	R	31	C	-	decrease	VARIANT R -> C (in AMD3; unknown pathological significance; mouse BMPR1B construct containing this mutation shows reduced GDF5-dependent receptor activation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs745854387)	UniProt
O00238	BMPR1B	C53R	C	53	R	-	loss	VARIANT C -> R (in AMD3; mouse BMPR1B construct containing this mutation shows loss of GDF5-dependent receptor activation, chicken BMPR1B construct containing this mutation does not show reduced chondrocyte differentiation, mouse BMPR1B construct containing this mutation shows no loss of cell membrane localization; dbSNP:rs863225041)	UniProt
O00238	BMPR1B	I200K	I	200	K	25	loss	VARIANT I -> K (in BDA2; in animal models loss of kinase activity and loss of positive regulation of chondrocyte differentiation; dbSNP:rs121434417)	UniProt
O00444	PLK4	D154A	D	154	A	443	loss	MUTAGEN D->A: Catalytically inactive mutant that causes some centrosome amplification above background levels when overexpressed.	UniProt
O14730	RIOK3	K290A	K	290	A	-	loss	MUTAGEN K->A: Decreases autophosphorylation (in vitro); abolishes inhibition of TNF-alpha-induced NF-kappaB activation; no effect on interaction with IRF3; fails to activate IFN-beta promoter and IRF3 phosphorylation.	UniProt
O14757	CHEK1	K132R	K	132	R	392	decrease	MUTAGEN K->R: Strong reduction of chromatin-associated CHK1 ubiquitination.	UniProt
O14757	CHEK1	S317A	S	317	A	-	decrease	MUTAGEN S->A: Abrogates interaction with RAD51; when associated with A-345. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Abrogates nuclear retention upon checkpoint activation. Impairs interaction with FBXO6.	UniProt
O14757	CHEK1	S317E	S	317	E	-	increase	MUTAGEN S->E: Enhances interaction with RAD51; when associated with E-345.	UniProt
O14757	CHEK1	F344A	F	344	A	-	increase	MUTAGEN F->A: Impairs nuclear export.	UniProt
O14757	CHEK1	S345A	S	345	A	-	decrease	MUTAGEN S->A: Abrogates interaction with RAD51; when associated with A-317. Reduces phosphorylation and impairs activation by hydroxyurea and ionizing radiation. Impairs interaction with YWHAZ which is required for nuclear retention after checkpoint activation.	UniProt
O14757	CHEK1	S345E	S	345	E	-	increase	MUTAGEN S->E: Enhances interaction with RAD51; when associated with E-317.	UniProt
O14757	CHEK1	M353A	M	353	A	-	increase	MUTAGEN M->A: Impairs nuclear export.	UniProt
O14920	IKBKB	K44A	K	44	A	128	loss	MUTAGEN K->A: Loss of kinase activity and no effect on binding to NIK.	UniProt
O14920	IKBKB	S177E	S	177	E	461	activating	MUTAGEN S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-181. Monoubiquitinated; when associated with R-163 and E-181. Strongly promoted NF-kappa-B gene expression; when associated with E-181.	UniProt
O14920	IKBKB	S181E	S	181	E	513	activating	MUTAGEN S->E: Full activation. Interaction with TRIM21 is enhanced; when associated with E-177. Monoubiquitinated; when associated with R-163 and E-177. Strongly promoted NF-kappa-B gene expression; when associated with E-177.	UniProt
O14965	AURKA	S155R	S	155	R	100	decrease	VARIANT S -> R (in a colorectal adenocarcinoma sample; somatic mutation; reduces interaction with TPX2)	UniProt
O14965	AURKA	G198N	G	198	N	208	decrease	MUTAGEN G->N: Reduces interaction with TPX2. Reduces kinase activity tenfold. Promotes interaction with the AURKB binding partners INCENP and BIRC5 that are normally not bound by AURKA.	UniProt
O14965	AURKA	T287E	T	287	E	512	activating	MUTAGEN T->E: Enhances interaction with TPX2.	UniProt
O14965	AURKA	Y334A	Y	334	A	624	decrease	MUTAGEN Y->A: Reduces binding to MYCN.	UniProt
O14965	AURKA	Q335A	Q	335	A	625	decrease	MUTAGEN Q->A: Reduces binding to MYCN.	UniProt
O15146	MUSK	G584D	G	584	D	40	decrease	MUTAGEN G->C,D: Mild decrease in kinase activity.	UniProt
O15146	MUSK	D743N	D	743	N	443	loss	MUTAGEN D->N: Severe loss of kinase activity.	UniProt
O15530	PDPK1	S241A	S	241	A	513	loss	MUTAGEN S->A: No activation.	UniProt
O15530	PDPK1	Y373F	Y	373	F	-	decrease	MUTAGEN Y->F: Reduction in basal activity.	UniProt
O15530	PDPK1	Y376F	Y	376	F	-	decrease	MUTAGEN Y->F: Reduction in basal activity.	UniProt
O43283	MAP3K13	K195A	K	195	A	128	loss	MUTAGEN K->A: Kinase inactive. Fails to activate NF-kappa-B.	UniProt
O43353	RIPK2	K209R	K	209	R	580	decrease	MUTAGEN K->R: Complete loss of polyubiquitination.	UniProt
O43353	RIPK2	K503R	K	503	R	-	increase	MUTAGEN K->R: Abolished ubiquitination by ZNRF4.	UniProt
O43781	DYRK3	K238M	K	238	M	128	loss	MUTAGEN K->M: Kinase dead; Induces formation of stress granules-like in absence of stress. Impaired dissolution of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material.	UniProt
O43781	DYRK3	S350A	S	350	A	438	decrease	MUTAGEN S->A: Decreased stability of the protein.	UniProt
O43781	DYRK3	S350D	S	350	D	438	increase	MUTAGEN S->E,D: Phosphomimetic mutant; increased stability of the protein.	UniProt
O60285	NUAK1	S600A	S	600	A	-	loss	MUTAGEN S->A: Abrogates phosphorylation by PKB/AKT1. Does not affect ability to induce senescence.	UniProt
O60566	BUB1B	D579E	D	579	E	-	increase	MUTAGEN D->E: Abolishes the cleavage by caspase-3.	UniProt
O60566	BUB1B	D610E	D	610	E	-	increase	MUTAGEN D->E: Abolishes the cleavage by caspase-3.	UniProt
O60566	BUB1B	K795A	K	795	A	4	loss	MUTAGEN K->A: Does not abolish the capacity to inhibit APC/CDC20.	UniProt
O60566	BUB1B	K795R	K	795	R	4	loss	MUTAGEN K->R: Inhibits kinase activity.	UniProt
O60674	JAK2	V617F	V	617	F	-	activating	VARIANT V -> F (in PV, THCYT3 and AML; associated with susceptibility to Budd-Chiari syndrome; somatic mutation in a high percentage of patients with essential thrombocythemia or myelofibrosis; leads to constitutive tyrosine phosphorylation activity that promotes cytokine hypersensitivity; dbSNP:rs77375493)	UniProt
O75116	ROCK2	D1131A	D	1131	A	-	decrease	MUTAGEN D->A: Abolishes cleavage by granzyme B.	UniProt
O75460	ERN1	Q105E	Q	105	E	-	decrease	MUTAGEN Q->E: Impaired ability to homodimerize.	UniProt
O75460	ERN1	D123P	D	123	P	-	loss	MUTAGEN D->P: Abolishes ability to homodimerize.	UniProt
O75460	ERN1	W125A	W	125	A	-	loss	MUTAGEN W->A: Abolishes ability to homodimerize.	UniProt
O75582	RPS6KA5	S212A	S	212	A	513	loss	MUTAGEN S->A: Inactivates the N-terminal kinase domain.	UniProt
O75582	RPS6KA5	T700D	T	700	D	808	decrease	MUTAGEN T->A,D: Strongly reduces phosphorylation of T-581 in response to PMA and UV-C.	UniProt
O75962	TRIO	T1075I	T	1075	I	-	increase	VARIANT T -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased lamellipodia formation)	UniProt
O75962	TRIO	N1080I	N	1080	I	-	increase	VARIANT N -> I (in MRD63; slightly increased occipitofrontal circumference; increased activation of RAC1-mediated signaling; increased neurite outgrowth; dbSNP:rs879255628)	UniProt
O75962	TRIO	K2917A	K	2917	A	392	decrease	MUTAGEN K->A: Expected to disrupt kinase activity. Causes reorganization of the actin cytoskeleton in the absence of NGF.	UniProt
O76039	CDKL5	A40V	A	40	V	126	decrease	VARIANT A -> V (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460159)	UniProt
O76039	CDKL5	C152F	C	152	F	442	decrease	VARIANT C -> F (in DEE2; affect activity; causes mislocalization of the protein in the cytoplasm; dbSNP:rs122460157)	UniProt
O76039	CDKL5	L220P	L	220	P	647	decrease	VARIANT L -> P (in DEE2; causes mislocalization of the protein in the cytoplasm; dbSNP:rs267608511)	UniProt
O95835	LATS1	Y559F	Y	559	F	-	decrease	MUTAGEN Y->F: Loss of interaction with YAP1.	UniProt
O96017	CHEK2	R145W	R	145	W	-	decrease	VARIANT R -> W (in colon cancer and LFS2; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs137853007)	UniProt
O96017	CHEK2	I157T	I	157	T	-	decrease	VARIANT I -> T (might influence susceptibility to different types of cancer; does not cause protein abrogation in familial colorectal cancer; loss of the ability to interact with and phosphorylate CDC25A and to promote CDC25A degradation in response to ionizing radiation; dbSNP:rs17879961)	UniProt
O96017	CHEK2	Y390C	Y	390	C	531	loss	VARIANT Y -> C (in BC; does not phosphorylate p53/TP53; dbSNP:rs200928781)	UniProt
O96017	CHEK2	S379A	S	379	A	461	decrease	MUTAGEN S->A: Abrogates autophosphorylation at Ser-379 and prevents ubiquitination.	UniProt
P00533	EGFR	K745M	K	745	M	128	loss	MUTAGEN K->A,M: Abolishes kinase activity.	UniProt
P00533	EGFR	R1068G	R	1068	G	-	increase	MUTAGEN R->G: Strongly decreases interaction with CBLC.	UniProt
P00533	EGFR	Y1069F	Y	1069	F	-	activating	MUTAGEN Y->F: Abolishes interaction with CBLC.	UniProt
P04049	RAF1	K375W	K	375	W	128	loss	MUTAGEN K->W: Catalytically inactive.	UniProt
P04049	RAF1	T491D	T	491	D	449	activating	MUTAGEN T->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-494.	UniProt
P04049	RAF1	S494D	S	494	D	452	activating	MUTAGEN S->D: Increased kinase activity but can still be inhibited by PPP5C; when associated with D-491.	UniProt
P04629	NTRK1	L93P	L	93	P	-	decrease	VARIANT L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells)	UniProt
P04629	NTRK1	L213P	L	213	P	-	decrease	VARIANT L -> P (in CIPA; aberrantly processed; shows diminished autophosphorylation in neuronal cells; dbSNP:rs747711259)	UniProt
P04629	NTRK1	G522E	G	522	E	43	decrease	VARIANT G -> E (in CIPA; no effect on N-glycosylation, nor on subcellular location; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	UniProt
P36896	ACVR1B	P77A	P	77	A	-	decrease	MUTAGEN P->A: Decreases binding to activin.	UniProt
P04629	NTRK1	G522R	G	522	R	43	decrease	VARIANT G -> R (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs1571699266)	UniProt
P04629	NTRK1	R649W	R	649	W	389	decrease	VARIANT R -> W (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs369353892)	UniProt
P04629	NTRK1	R654C	R	654	C	394	decrease	VARIANT R -> C (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs764992664)	UniProt
P04629	NTRK1	L657P	L	657	P	397	decrease	VARIANT L -> P (in CIPA; following transfection in neuroblastoma cells and NGF treatment, loss of differentiation into neuronal phenotype; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	UniProt
P04629	NTRK1	I699T	I	699	T	537	decrease	VARIANT I -> T (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux)	UniProt
P04629	NTRK1	G714S	G	714	S	588	decrease	VARIANT G -> S (in CIPA; processed as wild-type but shows significantly diminished autophosphorylation in both neuronal and non-neuronal cells; dbSNP:rs770727871)	UniProt
P04629	NTRK1	C763S	C	763	S	764	decrease	VARIANT C -> S (in CIPA; following transfection in neuroblastoma cells and NGF treatment, decreased percentage of cells differentiated into neuronal phenotype and reduced neurite length compared with wild-type; slightly decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal and NGF-induced autophosphorylation; small reduction in NGF-stimulated calcium flux)	UniProt
P04629	NTRK1	R771C	R	771	C	774	decrease	VARIANT R -> C (in CIPA; partially decreased N-glycosylation; reduced expression at the plasma membrane; reduced basal autophosphorylation and complete loss of NGF-induced autophosphorylation; loss of NGF-stimulated calcium flux; dbSNP:rs1324983370)	UniProt
P06213	INSR	I56T	I	56	T	-	decrease	VARIANT I -> T (in LEPRCH; abolishes post-translational processing; dbSNP:rs1555689937)	UniProt
P06213	INSR	G58R	G	58	R	-	decrease	VARIANT G -> R (in LEPRCH; Helmond; inhibits processing and transport; dbSNP:rs52836744)	UniProt
P06213	INSR	R113P	R	113	P	-	loss	VARIANT R -> P (in LEPRCH; Atlanta-1; abolishes insulin binding; dbSNP:rs121913153)	UniProt
P06213	INSR	A119V	A	119	V	-	decrease	VARIANT A -> V (in LEPRCH; markedly impairs insulin binding; dbSNP:rs1347473020)	UniProt
P06213	INSR	L120Q	L	120	Q	-	decrease	VARIANT L -> Q (in LEPRCH; inhibits receptor processing)	UniProt
P06213	INSR	N458D	N	458	D	-	decrease	VARIANT N -> D (in LEPRCH; partially inhibits receptor processing and autophosphorylation; strongly impairs ERK phosphorylation; induces wild-type levels of IRS-1 phosphorylation; dbSNP:rs121913160)	UniProt
P06213	INSR	V657F	V	657	F	-	decrease	VARIANT V -> F (in LEPRCH; impairs post-translational processing; dbSNP:rs1135401737)	UniProt
P06213	INSR	W659R	W	659	R	-	decrease	VARIANT W -> R (in LEPRCH; impairs post-translational processing)	UniProt
P06213	INSR	Y818C	Y	818	C	-	decrease	VARIANT Y -> C (in LEPRCH; abolishes post-translational processing)	UniProt
P06213	INSR	I925T	I	925	T	-	loss	VARIANT I -> T (in LEPRCH; abolishes post-translational processing; abolishes insulin binding; dbSNP:rs1599881881)	UniProt
P06213	INSR	R926W	R	926	W	-	decrease	VARIANT R -> W (in LEPRCH; markedly impairs insulin binding;impairs post-translational processing; dbSNP:rs911929963)	UniProt
P06213	INSR	T937M	T	937	M	-	decrease	VARIANT T -> M (in LEPRCH; impaired receptor processing; impairs post-translational processing)	UniProt
P06213	INSR	I1143T	I	1143	T	356	decrease	VARIANT I -> T (in RMS; reduces insulin binding)	UniProt
P06213	INSR	R1158W	R	1158	W	389	loss	VARIANT R -> W (in RMS; abolishes insulin binding; dbSNP:rs111993466)	UniProt
P06213	INSR	Y999F	Y	999	F	5	loss	MUTAGEN Y->F: Has no effect on insulin-stimulated autophosphorylation, but inhibits the biological activity of the receptor. Abolishes interaction with IRS1 and almost completely prevents interaction with SHC1. Has no effect on interaction with PIK3R1. Abolishes interaction with STAT5B.	UniProt
P06213	INSR	K1057A	K	1057	A	128	loss	MUTAGEN K->A: Abolishes the kinase activity and abolishes interaction with IRS1, SHC1, GRB7 and PIK3R1.	UniProt
P06213	INSR	K1057R	K	1057	R	128	loss	MUTAGEN K->M,R: Abolishes the kinase activity.	UniProt
P06493	CDK1	Y4D	Y	4	D	31	decrease	MUTAGEN Y->D,E: Constitutive polyubiquitination.	UniProt
P06493	CDK1	Y4E	Y	4	E	31	decrease	MUTAGEN Y->D,E: Constitutive polyubiquitination.	UniProt
P07332	FES	R483M	R	483	M	-	decrease	MUTAGEN R->M: Abolishes pTyr binding. Abolishes association with microtubules. Abolishes autophosphorylation. Reduced kinase activity.	UniProt
P07333	CSF1R	Y708F	Y	708	F	-	increase	MUTAGEN Y->F: Impairs degradation of activated CSF1R.	UniProt
P07333	CSF1R	D802V	D	802	V	453	activating	MUTAGEN D->V: Constitutive kinase activity. Loss of inhibition by imatinib.	UniProt
P07947	YES1	Y426F	Y	426	F	511	increase	MUTAGEN Y->F: About 50% loss of CSK-mediated inhibition.	UniProt
P07948	LYN	K275A	K	275	A	128	loss	MUTAGEN K->A: Loss of activity and no effect on localization to the cell membrane. Abundant localization in the nucleus; when associated with A-2 and A-3.	UniProt
P07948	LYN	K275R	K	275	R	128	loss	MUTAGEN K->L,R: Loss of kinase activity.	UniProt
P07949	RET	K758R	K	758	R	128	loss	MUTAGEN K->R: Loss of kinase activity. No effect on interaction with and dissociation from CBLC and CD2AP.	UniProt
P08069	IGF1R	Y980F	Y	980	F	9	decrease	MUTAGEN Y->F: Reduces tyrosine phosphorylation. Abolishes interaction with IRS1 and SHC1. Does not abolish interaction with PIK3R1, nor with GRB10.	UniProt
P08069	IGF1R	K1033A	K	1033	A	128	loss	MUTAGEN K->A: Kinase inactive. Abolishes tyrosine phosphorylation and abolishes interaction with IRS1, SHC1 and PIK3R1.	UniProt
P08581	MET	N375K	N	375	K	-	decrease	VARIANT N -> K (found in lung cancer also including cases carrying EGFR mutations; unknown pathological significance; decreased hepatocyte growth factor-activated receptor activity; decreased interaction with HGF; dbSNP:rs776693512)	UniProt
P08581	MET	P991S	P	991	S	-	increase	VARIANT P -> S (in gastric cancer; prolonged tyrosine phosphorylation in response to HGF/SF; transforming activity in athymic nude mice; dbSNP:rs768678989)	UniProt
P08581	MET	Y1234C	Y	1234	C	462	decrease	VARIANT Y -> C (in DA11; not phosphorylated in reponse to HGF; severely decreased tyrosin kinase activity; dbSNP:rs1554400286)	UniProt
P08922	ROS1	Y2274F	Y	2274	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation at Y-2274 and loss of interaction with PTPN11.	UniProt
P08922	ROS1	Y2334F	Y	2334	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation at Y-2334 and loss of interaction with PTPN11.	UniProt
P09619	PDGFRB	L658P	L	658	P	185	loss	VARIANT L -> P (in IBGC4; no effect on protein abundance; loss of PDGF beta receptor activity; dbSNP:rs397509381)	UniProt
P09619	PDGFRB	Y579F	Y	579	F	7	decrease	MUTAGEN Y->F: Loss of kinase activity; when associated with F-581. Strongly reduces interaction with SRC family kinases. No effect on interaction with GRB10.	UniProt
P09619	PDGFRB	Y581F	Y	581	F	9	decrease	MUTAGEN Y->F: Loss of kinase activity; when associated with F-579. No effect on interaction with GRB10.	UniProt
P09619	PDGFRB	K634A	K	634	A	128	loss	MUTAGEN K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	UniProt
P09619	PDGFRB	K634R	K	634	R	128	loss	MUTAGEN K->A,R: Loss of kinase activity. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	UniProt
P09619	PDGFRB	Y857F	Y	857	F	463	decrease	MUTAGEN Y->F: Reduces kinase activity. No effect on interaction with GRB10. Abolishes interaction with RASA1. No effect on phosphatidylinositol 3-kinase activity.	UniProt
P10721	KIT	D816V	D	816	V	453	activating	VARIANT D -> V (in MASTSYS, MASTC and mast cell leukemia; somatic mutation; constitutively activated; loss of interaction with MPDZ; dbSNP:rs121913507)	UniProt
P10721	KIT	Y823F	Y	823	F	463	activating	MUTAGEN Y->F: No decrease in activity. Leads to autophosphorylation at Tyr-900.	UniProt
P11362	FGFR1	Y374C	Y	374	C	-	increase	VARIANT Y -> C (in OGD; elevated basal activity and increased FGF2-mediated activity; dbSNP:rs121909631)	UniProt
P11362	FGFR1	N546K	N	546	K	204	activating	VARIANT N -> K (in ECCL; somatic mutation; activating mutation; strongly increased speed of the first autophosphorylation and loss of the normal sequential order of autophosphorylation; dbSNP:rs779707422)	UniProt
P11362	FGFR1	R577E	R	577	E	291	decrease	MUTAGEN R->E: Strongly reduced autophosphorylation in response to FGF signaling. No effect on in vitro kinase activity.	UniProt
P11362	FGFR1	Y654F	Y	654	F	463	decrease	MUTAGEN Y->F: Reduced kinase activity. Loss of autophosphorylation and kinase activity; when associated with F-653.	UniProt
P11362	FGFR1	Y766F	Y	766	F	808	decrease	MUTAGEN Y->F: Abolishes interaction with PLCG1 and SHB. Decreases phosphorylation of FRS2, activation of RAS and	UniProt
P11801	PSKH1	D218A	D	218	A	390	decrease	MUTAGEN D->A: Loss of autophosphorylation.	UniProt
P11802	CDK4	T172A	T	172	A	512	decrease	MUTAGEN T->A: Weak enzyme activity towards RB1, but no effect on binding of CCDN1 nor CCDN3.	UniProt
P11802	CDK4	P173S	P	173	S	513	decrease	MUTAGEN P->S: No effect on in vitro phosphorylation by CDK7. Greatly reduced T-172 phosphorylation and enzyme activity.	UniProt
P15056	BRAF	V600E	V	600	E	450	activating	VARIANT V -> E (in CRC; also found in sarcoma, metastatic melanoma, ovarian serous carcinoma, pilocytic astrocytoma; somatic mutation; most common mutation; constitutive and elevated kinase activity; efficiently induces cell transformation; suppression of mutation in melanoma causes growth arrest and promotes apoptosis; loss of regulation by PMRT5; dbSNP:rs113488022)	UniProt
P15056	BRAF	M53D	M	53	D	-	decrease	MUTAGEN M->D: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	UniProt
P15056	BRAF	K88E	K	88	E	-	decrease	MUTAGEN K->E: Reduces interaction with KSR1 and MAP2K1 and thus phosphorylation of MAP2K1.	UniProt
P15056	BRAF	R509H	R	509	H	186	loss	MUTAGEN R->H: Loss of MAP2K1-mediated-BRAF-KSR1 dimerization.	UniProt
P15056	BRAF	K578R	K	578	R	392	loss	MUTAGEN K->R: Blocks EGF-induced ubiquitination and ERK activation.	UniProt
P15056	BRAF	I666R	I	666	R	633	decrease	MUTAGEN I->R: No effect on MAP2K1-mediated-BRAF-KSR1 dimerization, however loss of BRAF-mediated phosphorylation of MAP2K1.	UniProt
P16234	PDGFRA	Y731F	Y	731	F	-	decrease	MUTAGEN Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	UniProt
P16234	PDGFRA	Y742F	Y	742	F	-	decrease	MUTAGEN Y->F: No effect on autophosphorylation and phosphorylation of PLCG1. Abolishes activation of phosphatidylinositol 3-kinase.	UniProt
P17612	PRKACA	R195A	R	195	A	460	decrease	MUTAGEN R->A: No phosphorylation.	UniProt
P17612	PRKACA	G201A	G	201	A	519	loss	MUTAGEN G->A: No phosphorylation.	UniProt
P17612	PRKACA	T202A	T	202	A	522	loss	MUTAGEN T->A: No phosphorylation.	UniProt
P17612	PRKACA	Y205A	Y	205	A	531	decrease	MUTAGEN Y->A: Loss of allosteric regulation.	UniProt
P17948	FLT1	K861M	K	861	M	128	loss	MUTAGEN K->M: Abolishes enzyme activity. Abolishes interaction with PLCG.	UniProt
P19525	EIF2AK2	M11L	M	11	L	-	decrease	VARIANT M -> L (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	UniProt
P19525	EIF2AK2	Y133F	Y	133	F	-	decrease	VARIANT Y -> F (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	UniProt
P19525	EIF2AK2	S461C	S	461	C	566	decrease	VARIANT S -> C (in LEUDEN; unknown pathological significance; reduced phosphorylation of eukaryotic translation initiation factor 2-alpha in patient cells)	UniProt
P54762	EPHB1	Y594F	Y	594	F	4	decrease	MUTAGEN Y->F: Loss of interaction with NCK1.	UniProt
P20594	NPR2	S76P	S	76	P	-	loss	VARIANT S -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs796065355)	UniProt
P20594	NPR2	R110C	R	110	C	-	loss	VARIANT R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; retained in the endoplasmic reticulum; dbSNP:rs758478717)	UniProt
P20594	NPR2	R263P	R	263	P	-	loss	VARIANT R -> P (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; loss of localization to the plasma membrane; dbSNP:rs139036657)	UniProt
P20594	NPR2	Q417E	Q	417	E	-	loss	VARIANT Q -> E (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs796065356)	UniProt
P20594	NPR2	L658F	L	658	F	439	decrease	VARIANT L -> F (in AMD1; no effect on subcellular location; changed glycosylation; no effect on C-type natriuretic peptide binding; decreased guanylate cyclase activity; loss of natriuretic peptide receptor activity; dominant negative effect; dbSNP:rs1314542724)	UniProt
P20594	NPR2	R819C	R	819	C	-	decrease	VARIANT R -> C (in SNSK; loss of C-type natriuretic peptide-induced signaling; dominant negative effect; no effect on cell surface expression; dbSNP:rs766256429)	UniProt
P20794	MAK	Y159F	Y	159	F	517	loss	MUTAGEN Y->F: Abolishes autophosphorylation and impairs kinase activity.	UniProt
P21675	TAF1	E721Q	E	721	Q	-	decrease	MUTAGEN E->Q: 25% decrease in histone acetylation.	UniProt
P21860	ERBB3	T873S	T	873	S	519	decrease	VARIANT T -> S (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	UniProt
P21860	ERBB3	Q932R	Q	932	R	675	decrease	VARIANT Q -> R (in VSCN1; unknown pathological significance; some decrease in ERBB2 phosphorylation upon NG1 treatment, compared to wild-type; does not affect the subcellular localization at the cell membrane)	UniProt
P22455	FGFR4	G388R	G	388	R	-	increase	VARIANT G -> R (in cancer cells, may be associated with accelerated disease progression and increased tumor cell motility, possibly due to increased stability of the protease MMP14; leads to phosphorylation at residue Y-390, resulting in prolonged FGFR4 activity; increases interaction with STAT3, resulting in STAT3 phosphorylation and signaling activation.; dbSNP:rs351855)	UniProt
P22455	FGFR4	Y754F	Y	754	F	807	decrease	MUTAGEN Y->F: Loss of interaction with PLCG1.	UniProt
P22607	FGFR3	K650M	K	650	M	510	activating	VARIANT K -> M (in KERSEB, ACH, TD1 and SADDAN; constitutively activated kinase with impaired internalization and degradation, resulting in prolonged FGFR3 signaling; dbSNP:rs121913105)	UniProt
P22607	FGFR3	K650Q	K	650	Q	510	activating	VARIANT K -> Q (in hypochondroplasia and BLC; in hypochondroplasia the form is milder than that seen in individuals with the K-540 or M-650 mutations; constitutively activated kinase; dbSNP:rs78311289)	UniProt
P22607	FGFR3	Y577F	Y	577	F	305	increase	MUTAGEN Y->F: Minor effect on kinase activity.	UniProt
P22607	FGFR3	Y760F	Y	760	F	808	increase	MUTAGEN Y->F: Minor effect on kinase activity.	UniProt
P22607	FGFR3	Y770F	Y	770	F	818	increase	MUTAGEN Y->F: Minor effect on kinase activity. Increased mitogen activity.	UniProt
P22694	PRKACB	H88R	H	88	R	171	increase	VARIANT H -> R (in CAFD2; increased sensitivity to cAMP activation; dbSNP:rs768056300)	UniProt
P22694	PRKACB	G235R	G	235	R	603	increase	VARIANT G -> R (in CAFD2; increased sensitivity to cAMP activation; decreased interaction with regulatory subunits PRKAR1A and PRKAR2B)	UniProt
P23443	RPS6KB1	T412E	T	412	E	-	increase	MUTAGEN T->E: Mimics phosphorylation. Facilitates phosphorylation of T-252 by PDPK1; when associated with E-434; E-441; E-444 and E-447. Mimics phosphorylation. No effect on interaction with PDPK1 and phosphorylation of T-252. Impairs association with the eIF3 complex.	UniProt
P23458	JAK1	S703I	S	703	I	-	increase	VARIANT S -> I (in AIIDE; increased activation of protein kinase activity; constitutive gain of function through the transactivation of associated JAK kinases; increased receptor signaling pathway via JAK-STAT)	UniProt
P24723	PRKCH	V374I	V	374	I	81	increase	VARIANT V -> I (associated with susceptibility to ischemic stroke; increases autophosphorylation and kinase activity; dbSNP:rs2230500)	UniProt
P25092	GUCY2C	D387G	D	387	G	-	decrease	VARIANT D -> G (in MECIL; activation of guanylate cyclase activity is 60% lower than in wild-type; dbSNP:rs587776905)	UniProt
P25098	GRK2	D3K	D	3	K	-	decrease	MUTAGEN D->K: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 60% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	UniProt
P25098	GRK2	L4A	L	4	A	-	decrease	MUTAGEN L->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin. 90% reduction in phosphorylation of beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	UniProt
P25098	GRK2	D10A	D	10	A	-	decrease	MUTAGEN D->A: 95% reduction in phosphorylation of G-protein coupled receptor rhodopsin and beta-2 adrenergic receptor ADRB2. Does not affect binding to ADRB2. Not activated by receptor binding. No effect on phosphorylation of the non-receptor substrate tubulin.	UniProt
P25440	BRD2	Q78A	Q	78	A	-	loss	MUTAGEN Q->A: Loss of homodimerization.	UniProt
P25440	BRD2	Y153K	Y	153	K	-	loss	MUTAGEN Y->K: Loss of homodimerization.	UniProt
P25440	BRD2	E170A	E	170	A	-	loss	MUTAGEN E->A: Loss of homodimerization.	UniProt
P25440	BRD2	L174E	L	174	E	-	loss	MUTAGEN L->E: Loss of homodimerization.	UniProt
P25440	BRD2	V177E	V	177	E	-	loss	MUTAGEN V->E: Loss of homodimerization.	UniProt
P27448	MARK3	T211A	T	211	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
P28482	MAPK1	I74N	I	74	N	178	increase	VARIANT I -> N (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	UniProt
P36897	TGFBR1	L193G	L	193	G	16	decrease	MUTAGEN L->G: Loss of interaction with FKBP1A.	UniProt
P28482	MAPK1	H80Y	H	80	Y	195	increase	VARIANT H -> Y (in NS13; results in increased MAPK signaling; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	UniProt
P28482	MAPK1	A174V	A	174	V	456	increase	VARIANT A -> V (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	UniProt
P28482	MAPK1	D318G	D	318	G	799	increase	VARIANT D -> G (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	UniProt
P28482	MAPK1	P323R	P	323	R	804	increase	VARIANT P -> R (in NS13; results in increased MAPK signaling; increased translocation to the nucleus; reduced interaction wth DUSP6; no effect on interaction with MAP2K1)	UniProt
P28482	MAPK1	D318A	D	318	A	799	increase	MUTAGEN D->A: Loss of dephosphorylation by PTPRJ.	UniProt
P29317	EPHA2	R103E	R	103	E	-	decrease	MUTAGEN R->E: Significantly reduced response to EFNA1.	UniProt
P29317	EPHA2	D739N	D	739	N	390	increase	MUTAGEN D->N: Increases serum-induced chemotaxis. Loss of EFNA1-dependent regulation of cell migration.	UniProt
P29317	EPHA2	S897D	S	897	D	823	loss	MUTAGEN S->A,D: Loss of serum-induced phosphorylation by PKB. Loss of serum-induced chemotaxis.	UniProt
P29376	LTK	R241A	R	241	A	-	loss	MUTAGEN R->A: Abolished homodimerization following interaction with ALKAL1.	UniProt
P29376	LTK	Y753F	Y	753	F	757	loss	MUTAGEN Y->F: Abolishes interaction with PI3-kinase subunit p85, impairs PI3 kinase activity and leads to apoptosis (demonstrated with chimeric EGFR-LTK).	UniProt
P29597	TYK2	Y1054F	Y	1054	F	463	decrease	MUTAGEN Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	UniProt
P29597	TYK2	Y1055F	Y	1055	F	464	decrease	MUTAGEN Y->F: Reduces basal catalytic activity and abolishes IFN-dependent activation.	UniProt
P30530	AXL	E63R	E	63	R	-	decrease	MUTAGEN E->R: Slightly reduced affinity for GAS6.	UniProt
P30530	AXL	E66R	E	66	R	-	decrease	MUTAGEN E->R: Reduced affinity for GAS6.	UniProt
P30530	AXL	T84R	T	84	R	-	decrease	MUTAGEN T->R: Reduced affinity for GAS6.	UniProt
P30530	AXL	K567M	K	567	M	128	loss	MUTAGEN K->M: Catalytically inactive mutant.	UniProt
P31749	AKT1	R25C	R	25	C	-	decrease	VARIANT R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	UniProt
P31749	AKT1	K14A	K	14	A	-	decrease	MUTAGEN K->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	UniProt
P31749	AKT1	K14R	K	14	R	-	decrease	MUTAGEN K->R: Substantial reduction of ubiquitination, phosphorylation at T-308 and S-473, AKT activation, loss of binding to PIP3 as well as IGF1-induced membrane recruitment.	UniProt
P31749	AKT1	K20R	K	20	R	-	increase	MUTAGEN K->R: Slight increase of phosphorylation at T-308 and S-473.	UniProt
P31749	AKT1	R25A	R	25	A	-	decrease	MUTAGEN R->A,C: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	UniProt
P31749	AKT1	R86A	R	86	A	-	decrease	MUTAGEN R->A: Impairs interaction with PtdIns(3,4,5)P3 and PtdIns(3,4)P2.	UniProt
P31749	AKT1	Y176F	Y	176	F	123	decrease	MUTAGEN Y->F: Significant loss of interaction with TNK2. Loss of membrane localization. Significant reduction in phosphorylation on Ser-473.	UniProt
P31749	AKT1	T305A	T	305	A	510	increase	MUTAGEN T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-312.	UniProt
P31749	AKT1	T312A	T	312	A	522	increase	MUTAGEN T->A: Reduces O-GlcNAc levels; Reduces O-GlcNAc levels even more; when associated with A-305.	UniProt
P31749	AKT1	Y474F	Y	474	F	-	decrease	MUTAGEN Y->F: 55% inhibition of activation.	UniProt
P31751	AKT2	E17K	E	17	K	-	activating	VARIANT E -> K (in HIHGHH; exhibits plasma membrane localization in serum-starved cells and produced inappropriate tonic nuclear exclusion of FOXO1 in preadipocytes; dbSNP:rs387906659)	UniProt
P31751	AKT2	R274H	R	274	H	389	increase	VARIANT R -> H (in T2D; associated with typical metabolic dyslipidemia with elevated fastin triglyceride, high VLDL triglyceride/cholesterol ratios, low HDL cholesterol levels and high small dense LDL levels; de novo lipogenesis and liver fat are also significantly elevated in this subject; dbSNP:rs121434593)	UniProt
P34925	RYK	N484F	N	484	F	444	increase	MUTAGEN N->F: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with A-359. Gain of an autophosphorylation activity; when associated with G-334 and G-482.	UniProt
P34925	RYK	A485G	A	485	G	445	increase	MUTAGEN A->G: Gain of an autophosphorylation activity. Gain of an autophosphorylation activity; when associated with G-334 and F-481.	UniProt
P34947	GRK5	K215R	K	215	R	128	decrease	MUTAGEN K->R: Failed to phosphorylate p53/TP53.	UniProt
P35968	KDR	C482R	C	482	R	-	decrease	VARIANT C -> R (in HCI; associated with disease susceptibility; expression of FLT1 in hemangioma endothelial cells is markedly reduced and KDR activity is increased compared to controls; low FLT1 expression in hemangioma cells is caused by reduced activity of a pathway involving ITGB1, ANTXR1, KDR and NFATC2IP; the mutation predicts to result in loss-of-function and disruption of the normal association of these molecules; dbSNP:rs34231037)	UniProt
P35968	KDR	Y801F	Y	801	F	-	loss	MUTAGEN Y->F: Abolishes stimulation of nitric oxide synthesis.	UniProt
P35968	KDR	Y951F	Y	951	F	-	loss	MUTAGEN Y->F: Abolishes reorganization of the actin cytoskeleton and cell migration in response to VEGFA.	UniProt
P36888	FLT3	Y589F	Y	589	F	8	decrease	MUTAGEN Y->F: Reduced phosphorylation of the wild-type kinase in response to ligand binding. No effect on the phosphorylation of the constitutively activated mutant kinase variants. Abolishes activation of STAT5A.	UniProt
P36888	FLT3	Y591F	Y	591	F	10	decrease	MUTAGEN Y->F: No significant effect on tyrosine phosphorylation. Abolishes activation of STAT5A.	UniProt
P36888	FLT3	Y599F	Y	599	F	18	decrease	MUTAGEN Y->F: Abolishes interaction with PTPN11/SHP2 and phosphorylation of PTPN11/SHP2.	UniProt
P36896	ACVR1B	I70A	I	70	A	-	decrease	MUTAGEN I->A: Decreases binding to activin.	UniProt
P36896	ACVR1B	L75A	L	75	A	-	decrease	MUTAGEN L->A: Decreases binding to activin.	UniProt
P36897	TGFBR1	P194K	P	194	K	17	decrease	MUTAGEN P->K: Loss of interaction with FKBP1A.	UniProt
P36897	TGFBR1	T200D	T	200	D	23	decrease	MUTAGEN T->D: Loss of response to TGF-beta.	UniProt
P37173	TGFBR2	L308P	L	308	P	207	decrease	VARIANT L -> P (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs28934568)	UniProt
P37173	TGFBR2	N435S	N	435	S	564	decrease	VARIANT N -> S (in a breast tumor; signaling of TGF-beta significantly inhibited)	UniProt
P37173	TGFBR2	D446N	D	446	N	583	decrease	VARIANT D -> N (in LDS2; dbSNP:rs886039551)	UniProt
P37173	TGFBR2	V447A	V	447	A	584	decrease	VARIANT V -> A (in a breast tumor; signaling of TGF-beta significantly inhibited)	UniProt
P37173	TGFBR2	S449F	S	449	F	586	decrease	VARIANT S -> F (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893807)	UniProt
P37173	TGFBR2	L452M	L	452	M	589	decrease	VARIANT L -> M (in a breast tumor; signaling of TGF-beta significantly inhibited)	UniProt
P37173	TGFBR2	R537C	R	537	C	797	decrease	VARIANT R -> C (in LDS2; has a negative effect on TGF-beta signaling; dbSNP:rs104893809)	UniProt
P41279	MAP3K8	T290A	T	290	A	522	loss	MUTAGEN T->A: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. Loss of IL1-stimulated MEK phosphorylation activity but not of IL1-stimulated autophosphorylation activity. No effect on KSR2 binding.	UniProt
P41279	MAP3K8	T290D	T	290	D	522	decrease	MUTAGEN T->D: Impaired MEK phosphorylation and autophosphorylation activities. No effect on KSR2 binding.	UniProt
P41279	MAP3K8	T290E	T	290	E	522	decrease	MUTAGEN T->E: Loss of MEK phosphorylation activity and almost abolished autophosphorylation activity. No effect on KSR2 binding.	UniProt
P41743	PRKCI	D72A	D	72	A	-	decrease	MUTAGEN D->A: Loss of interaction with ECT2, PARD6A and with SQSTM1.	UniProt
P43250	GRK6	N9A	N	9	A	-	loss	MUTAGEN N->A: 140-fold defects in kinase activity.	UniProt
P43250	GRK6	L12A	L	12	A	-	loss	MUTAGEN L->A: 1100-fold defects in kinase activity.	UniProt
P43403	ZAP70	R192W	R	192	W	-	decrease	VARIANT R -> W (in ADMIO2; decreases interaction with phosphorylated CD247; decreases ZAP70 phosphorylation; no effect on subcellular localization of CD69 at the cell surface; dbSNP:rs199840952)	UniProt
P43403	ZAP70	R360P	R	360	P	92	increase	VARIANT R -> P (in ADMIO2; no effect on interaction with phosphorylated CD247; increases TCR-induced Y-319 and Y-493 phosphorylation of ZAP70 and phosphorylation of LAT and LCP2; increases subcellular localization of CD69 at the cell surface; weakly decreases autoinhibition conformation; dbSNP:rs869025224)	UniProt
P43405	SYK	S297A	S	297	A	-	decrease	MUTAGEN S->A: Abolishes YWHAG binding.	UniProt
P43405	SYK	Y630F	Y	630	F	803	decrease	MUTAGEN Y->F: Loss of interaction with BLNK.	UniProt
P45983	MAPK8	T183A	T	183	A	512	decrease	MUTAGEN T->A: Phosphorylation blocked.	UniProt
P45983	MAPK8	Y185F	Y	185	F	517	decrease	MUTAGEN Y->F: Phosphorylation blocked.	UniProt
P46734	MAP2K3	S218A	S	218	A	460	loss	MUTAGEN S->A: Inactivation.	UniProt
P46734	MAP2K3	T222A	T	222	A	512	loss	MUTAGEN T->A: Inactivation.	UniProt
P49336	CDK8	D173A	D	173	A	443	loss	MUTAGEN D->A: Abrogates kinase activity and TFIIH-dependent transcriptional repression.	UniProt
P49841	GSK3B	R96A	R	96	A	174	loss	MUTAGEN R->A: Prevents the phosphorylation of phosphate-primed glycogen synthase.	UniProt
P49842	STK19	V134Y	V	134	Y	-	decrease	MUTAGEN V->Y: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	UniProt
P49842	STK19	L139V	L	139	V	-	decrease	MUTAGEN L->V: Prevents inhibition by ZT-12-037-01 (1a) without affecting much the serine/threonine-protein kinase activity.	UniProt
P50750	CDK9	D167N	D	167	N	443	loss	MUTAGEN D->N: Abrogates kinase activity.	UniProt
P50750	CDK9	T186A	T	186	A	512	decrease	MUTAGEN T->A: Abrogates autophosphorylation; no effect on kinase activity, but impaired CTD phosphorylation.	UniProt
P51451	BLK	A71T	A	71	T	-	decrease	VARIANT A -> T (associated with MODY11; reduces the enhancing effect of BLK on insulin secretion; reduces the inducing effect of BLK on the expression of PDX1 and NKX6-1; found as somatic mutation in a colorectal adenocarcinoma sample; dbSNP:rs55758736)	UniProt
P51817	PRKX	R283L	R	283	L	769	increase	MUTAGEN R->L: Increases the affinity for PRKAR2A and PRKAR2B.	UniProt
P52564	MAP2K6	S207A	S	207	A	460	loss	MUTAGEN S->A: Inactivation.	UniProt
P52564	MAP2K6	T211A	T	211	A	512	loss	MUTAGEN T->A: Inactivation.	UniProt
P53350	PLK1	K82M	K	82	M	128	loss	MUTAGEN K->M: Loss of kinase activity. No effect on S-phase progression.	UniProt
P53350	PLK1	K82R	K	82	R	128	loss	MUTAGEN K->R: Loss of kinase activity. No effect on RIOK2-binding.	UniProt
P53350	PLK1	T210V	T	210	V	513	decrease	MUTAGEN T->V: Reduced catalytic activity, but no effect on affinity for ATP.	UniProt
P53355	DAPK1	S289E	S	289	E	808	decrease	MUTAGEN S->E: Reduction in proapoptotic activity.	UniProt
P53355	DAPK1	S308A	S	308	A	-	increase	MUTAGEN S->A: Elevated Ca(2+)-calmodulin binding and Ca(2+)-calmodulin-independent kinase activity. Increases apoptotic activity.	UniProt
P53667	LIMK1	C84S	C	84	S	-	increase	MUTAGEN C->S: Enhances actin aggregation.	UniProt
P53667	LIMK1	D460N	D	460	N	390	loss	MUTAGEN D->N,A: Abrogates kinase activity.	UniProt
P53667	LIMK1	D460A	D	460	A	390	loss	MUTAGEN D->N,A: Abrogates kinase activity.	UniProt
P53671	LIMK2	D451A	D	451	A	390	loss	MUTAGEN D->A: Abrogates kinase activity.	UniProt
P53779	MAPK10	C462S	C	462	S	-	loss	MUTAGEN C->S: Loss of palmitoylation.	UniProt
P53779	MAPK10	C463S	C	463	S	-	loss	MUTAGEN C->S: Loss of palmitoylation.	UniProt
P54760	EPHB4	F867L	F	867	L	784	decrease	VARIANT F -> L (in CMAVM2; loss of tyrosine phosphorylation; loss of interaction with RASA1; dbSNP:rs1584652949)	UniProt
P54760	EPHB4	L95R	L	95	R	-	decrease	MUTAGEN L->R: Reduces binding affinity for EFNB2.	UniProt
P54762	EPHB1	Y600F	Y	600	F	10	decrease	MUTAGEN Y->F: Loss of interaction with SHC1 and SRC.	UniProt
P54762	EPHB1	Y778F	Y	778	F	511	decrease	MUTAGEN Y->F: Loss of interaction with SHC1.	UniProt
P54762	EPHB1	Y928F	Y	928	F	-	decrease	MUTAGEN Y->F: Disrupts binding with the GRB10 SH2 domain, providing evidence for phosphorylation. Disrupts interaction with GRB7 and ACP1.	UniProt
P57059	SIK1	S186T	S	186	T	522	decrease	MUTAGEN S->T: Does not autophosphorylation and kinase activity.	UniProt
P57059	SIK1	T473E	T	473	E	-	decrease	MUTAGEN T->E: Reduced but still present interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit TORC activity.	UniProt
P57059	SIK1	S575A	S	575	A	-	decrease	MUTAGEN S->A: Loss of interaction with 14-3-3 proteins in response to cAMP signaling and, thus, still able to inhibit	UniProt
P78527	PRKDC	L1510P	L	1510	P	-	decrease	MUTAGEN L->P: Loss of interaction with C1D.	UniProt
P80192	MAP3K9	T305A	T	305	A	461	decrease	MUTAGEN T->A: Little effect on threonine phosphorylation. Mildly impairs JNK activation.	UniProt
Q00535	CDK5	S159T	S	159	T	512	decrease	MUTAGEN S->T: Impaired p35/p25 (CDK5R1) binding.	UniProt
Q00536	CDK16	S119A	S	119	A	-	decrease	MUTAGEN S->A: Strongly reduces interaction with CCNY.	UniProt
Q00536	CDK16	S153A	S	153	A	19	activating	MUTAGEN S->A: Constitutively activated, due to loss of an inhibitory phosphorylation site. Increases interaction with CCNY.	UniProt
Q00536	CDK16	S153D	S	153	D	19	decrease	MUTAGEN S->D: Abolishes interaction with CCNY.	UniProt
Q02156	PRKCE	S729A	S	729	A	-	decrease	MUTAGEN S->A: Enhances T-566 dephosphorylation.	UniProt
Q02750	MAP2K1	K97R	K	97	R	128	loss	MUTAGEN K->R: Loss of catalytic activity. No effect on BRAF-KSR1 or BRAF-KSR2 dimerization.	UniProt
Q02750	MAP2K1	F311S	F	311	S	700	decrease	MUTAGEN F->S: Loss of interaction with BRAF and KSR1. Loss of BRAF-KSR1 dimerization.	UniProt
Q02763	TEK	Y611C	Y	611	C	-	loss	VARIANT Y -> C (in GLC3E; reduced response to ligand; loss of ligand-induced phosphorylation; no effect on basal membrane location; dbSNP:rs1306527531)	UniProt
Q02763	TEK	Y1102F	Y	1102	F	807	decrease	MUTAGEN Y->F: Abolishes interaction with SHC1.	UniProt
Q02846	GUCY2D	A710V	A	710	V	533	loss	VARIANT A -> V (in LCA1; loss of basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs781725943)	UniProt
Q02846	GUCY2D	P873R	P	873	R	-	loss	VARIANT P -> R (in CORD6; loss basal and GUCA1A-induced guanylate cyclase activity; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1567961680)	UniProt
Q02846	GUCY2D	V902L	V	902	L	-	increase	VARIANT V -> L (in LCA1; increases basal and GUCA1A-induced guanylate cyclase activity; inhibition by RD3 is less effective; does not affect endoplasmic reticulum membrane localization; dbSNP:rs1598150793)	UniProt
Q02846	GUCY2D	R822P	R	822	P	815	decrease	MUTAGEN R->P: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	UniProt
Q02846	GUCY2D	M823R	M	823	R	816	decrease	MUTAGEN M->R: Fails to become activated by GUCA1A and by GUCA1B. Does not affect the binding to RP3.	UniProt
Q04759	PRKCQ	K409E	K	409	E	128	loss	MUTAGEN K->A,E: Loss of kinase activity.	UniProt
Q04771	ACVR1	Q207D	Q	207	D	27	increase	MUTAGEN Q->D: Strong induction of SMAD1 phosphorylation.	UniProt
Q05397	PTK2	Y397F	Y	397	F	3	decrease	MUTAGEN Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC and activation of BMX. Reduces phosphorylation of NEDD9.	UniProt
Q05397	PTK2	V928G	V	928	G	-	decrease	MUTAGEN V->G: Loss of interaction with TGFB1I1.	UniProt
Q05397	PTK2	L1034S	L	1034	S	-	decrease	MUTAGEN L->S: Loss of interaction with TGFB1I1.	UniProt
Q05513	PRKCZ	D62A	D	62	A	-	decrease	MUTAGEN D->A: Loss of interaction with SQSTM1 and PARD6B.	UniProt
Q05513	PRKCZ	D66A	D	66	A	-	decrease	MUTAGEN D->A: Loss of interaction with SQSTM1 and PARD6B.	UniProt
Q06187	BTK	R520Q	R	520	Q	389	loss	VARIANT R -> Q (in XLA; severe; prevents activation due to absence of contact between the catalytic loop and the regulatory phosphorylated residue; dbSNP:rs128621202)	UniProt
Q06187	BTK	R525Q	R	525	Q	394	decrease	VARIANT R -> Q (in XLA; severe; disturbs ATP-binding; dbSNP:rs128620183)	UniProt
Q06187	BTK	E589G	E	589	G	593	decrease	VARIANT E -> G (in XLA; moderate; interferes with substrate binding; dbSNP:rs128621206)	UniProt
Q06187	BTK	G594E	G	594	E	603	decrease	VARIANT G -> E (in XLA; mild; interferes with substrate binding)	UniProt
Q06187	BTK	G613D	G	613	D	640	decrease	VARIANT G -> D (in XLA; mild; interferes with substrate binding and/or domain interactions; dbSNP:rs128621209)	UniProt
Q06187	BTK	Y617E	Y	617	E	673	decrease	MUTAGEN Y->E: Defective in mediating calcium response.	UniProt
Q06418	TYRO3	I99R	I	99	R	-	loss	MUTAGEN I->R: Abolishes dimerization.	UniProt
Q07912	TNK2	R34L	R	34	L	-	increase	VARIANT R -> L (in a lung adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates; no effect on subcellular localization to perinuclear region)	UniProt
Q07912	TNK2	R99Q	R	99	Q	2	increase	VARIANT R -> Q (in an ovarian mucinous carcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region; dbSNP:rs113498671)	UniProt
Q07912	TNK2	E346K	E	346	K	667	increase	VARIANT E -> K (in an ovarian endometrioid cancer sample; somatic mutation; undergoes autoactivation and causes phosphorylation on Y-284 leading to activation of AKT1; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on catalytic activity itself as the purified kinase domain has activity in vitro comparable to wild-type protein; no effect on subcellular localization to perinuclear region; dbSNP:rs970946035)	UniProt
Q14289	PTK2B	Y402F	Y	402	F	5	loss	MUTAGEN Y->F: Abolishes autophosphorylation. Abolishes interaction with SRC.	UniProt
Q07912	TNK2	M409I	M	409	I	823	increase	VARIANT M -> I (in a gastric adenocarcinoma sample; somatic mutation; increased autophosphorylation at Y-284; increased function in phosphorylation of peptide substrates and WASP; no effect on subcellular localization to perinuclear region)	UniProt
Q07912	TNK2	V638M	V	638	M	-	increase	VARIANT V -> M (found in patients with childhood-onset epilepsy; unknown pathological significance; loss of interaction with NEDD4 and NEDD4L; increased protein abundance; dbSNP:rs201407161)	UniProt
Q08345	DDR1	R105A	R	105	A	-	decrease	MUTAGEN R->A: Inhibits collagen-induced phosphorylation.	UniProt
Q08345	DDR1	N260Q	N	260	Q	-	decrease	MUTAGEN N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	UniProt
Q08345	DDR1	N371Q	N	371	Q	-	decrease	MUTAGEN N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	UniProt
Q08345	DDR1	N394Q	N	394	Q	-	decrease	MUTAGEN N->Q: Phosphorylates in response to collagen, but at lower levels compared to wild-type. No activation in the absence of collagen.	UniProt
Q08345	DDR1	G707A	G	707	A	274	increase	MUTAGEN G->A: Confers over 20-fold resistance to the ability of an inhibitor to inhibit autophosphorylation.	UniProt
Q08345	DDR1	Y740F	Y	740	F	343	decrease	MUTAGEN Y->F: Abolishes interaction with PTPN11.	UniProt
Q08881	ITK	P288G	P	288	G	-	decrease	MUTAGEN P->G: Complete loss of interaction with PPIA/CYPA.	UniProt
Q12979	ABR	V859A	V	859	A	-	decrease	MUTAGEN V->A: Abolishes interaction with DLG4. No effect on synaptic localization.	UniProt
Q13131	PRKAA1	V307Q	V	307	Q	822	increase	MUTAGEN V->G,Q: Activates the kinase activity.	UniProt
Q13153	PAK1	Y131C	Y	131	C	-	increase	VARIANT Y -> C (in IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565638316)	UniProt
Q13153	PAK1	Y429C	Y	429	C	530	increase	VARIANT Y -> C (in IDDMSSD; gain-of-function; enhanced PAK1 kinase activity and significantly reduced homodimerization; dbSNP:rs1565583382)	UniProt
Q13163	MAP2K5	K195M	K	195	M	128	loss	MUTAGEN K->M: Inactivation.	UniProt
Q13163	MAP2K5	S311A	S	311	A	460	loss	MUTAGEN S->A: Inactivation.	UniProt
Q13163	MAP2K5	T315A	T	315	A	513	loss	MUTAGEN T->A: Inactivation.	UniProt
Q13177	PAK2	E435K	E	435	K	593	loss	VARIANT E -> K (in KNO2; loss of protein serine/threonine kinase activity)	UniProt
Q13315	ATM	H2554D	H	2554	D	-	loss	VARIANT H -> D (in AT; lack of phosphorylation of target proteins)	UniProt
Q13315	ATM	G2765S	G	2765	S	-	loss	VARIANT G -> S (may contribute to breast cancer; lack of phosphorylation of target proteins; dbSNP:rs748634900)	UniProt
Q13315	ATM	R3008C	R	3008	C	-	loss	VARIANT R -> C (in AT; also found in T-prolymphocytic leukemia and mantle cell lymphoma; lack of phosphorylation of target proteins; dbSNP:rs587782292)	UniProt
Q13315	ATM	S367A	S	367	A	-	loss	MUTAGEN S->A: Loss of IR-induced S-367 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-1893 nor S-1981 autophosphorylation.	UniProt
Q13315	ATM	S1893A	S	1893	A	-	loss	MUTAGEN S->A: Loss of IR-induced S-1893 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1981 autophosphorylation.	UniProt
Q13315	ATM	S1981A	S	1981	A	-	loss	MUTAGEN S->A: Loss of IR-induced S-1981 autophosphorylation. Reduced correction of cell cycle checkpoint defects and DNA-repair activity. No effect on S-367 nor S-1893 autophosphorylation. No dimer disruption.	UniProt
Q13315	ATM	S1981D	S	1981	D	-	activating	MUTAGEN S->D,E: Disrupts the dimer.	UniProt
Q13315	ATM	S1981E	S	1981	E	-	activating	MUTAGEN S->D,E: Disrupts the dimer.	UniProt
Q13315	ATM	K3016Q	K	3016	Q	-	activating	MUTAGEN K->Q: Mimics acetylation, preventing dephosphorylation and subsequent ATM deactivation during the late stage of DNA damage response.	UniProt
Q13418	ILK	E359K	E	359	K	535	loss	MUTAGEN E->K: Inactivation of ILK.	UniProt
Q13554	CAMK2B	E110K	E	110	K	324	increase	VARIANT E -> K (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554402092)	UniProt
Q13554	CAMK2B	P139L	P	139	L	393	increase	VARIANT P -> L (in MRD54; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554389088)	UniProt
Q13554	CAMK2B	E237K	E	237	K	675	increase	VARIANT E -> K (in MRD54; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554386687)	UniProt
Q13554	CAMK2B	K301E	K	301	E	823	loss	VARIANT K -> E (in MRD54; no effect on protein abundance; loss of autophosphorylation; changed function in neuronal migration; dbSNP:rs1554385111)	UniProt
Q13882	PTK6	Y342A	Y	342	A	462	decrease	MUTAGEN Y->A: 3-fold lower specific kinase activity. Decreased, but still significant, autophosphorylation. Decreased, but still significant, autophosphorylation; when associated with A-447.	UniProt
Q13882	PTK6	Y447F	Y	447	F	804	increase	MUTAGEN Y->F: Decrease in transforming potential and increase in the kinase activity level. Decreased, but still significant, autophosphorylation; when associated with A-342.	UniProt
Q14012	CAMK1	K49A	K	49	A	128	loss	MUTAGEN K->A: Catalytically inactive form; prevents CDK4 activation.	UniProt
Q14012	CAMK1	T177D	T	177	D	513	increase	MUTAGEN T->D: Partial activation in absence of CaMKK1.	UniProt
Q14164	IKBKE	K30A	K	30	A	93	decrease	MUTAGEN K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	UniProt
Q14164	IKBKE	K30R	K	30	R	93	decrease	MUTAGEN K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	UniProt
Q14164	IKBKE	K401A	K	401	A	-	decrease	MUTAGEN K->A: Loss of ubiquitination and decreased kinase activity. No effect on homodimerization.	UniProt
Q14164	IKBKE	K401R	K	401	R	-	decrease	MUTAGEN K->R: Loss of ubiquitination and decreased kinase activity. Decreases interaction with IKBKB, IKBKG and MYD88. No effect on homodimerization.	UniProt
Q14680	MELK	Y163F	Y	163	F	463	decrease	MUTAGEN Y->F: Abolishes autophosphorylation on tyrosine but still active on exogenous substrates.	UniProt
Q14680	MELK	T167E	T	167	E	513	activating	MUTAGEN T->D,E: Phosphomimetic mutant that has similar kinase activity as wild-type.	UniProt
Q14680	MELK	S171D	S	171	D	522	loss	MUTAGEN S->D: Inactive.	UniProt
Q15120	PDK3	R158H	R	158	H	-	activating	VARIANT R -> H (in CMTX6; gain of function; results in a 5-fold increase in kinase activity, decreased sensitivity to pyruvate inhibition, reduced affinity for nucleotides and increased affinity for pyruvate dehydrogenase complex component E2 (PDC-E2), leading to PDC hyperphosphorylation and increased inactivation; dbSNP:rs397515323)	UniProt
Q15139	PRKD1	Y463F	Y	463	F	-	decrease	MUTAGEN Y->F: Decreased phosphorylation level when coexpressed with either SRC or ABL in HeLa cells. Decreased kinase activity.	UniProt
Q15303	ERBB4	Y1056A	Y	1056	A	-	loss	MUTAGEN Y->A: Abolishes interaction with NEDD4 and impairs ubiquitination. Promotes nuclear translocation of ERBB4 intracellular domain E4ICD1.	UniProt
Q15759	MAPK11	T180A	T	180	A	512	loss	MUTAGEN T->A: Inactivation.	UniProt
Q15759	MAPK11	Y182F	Y	182	F	517	loss	MUTAGEN Y->F: Inactivation.	UniProt
Q15831	STK11	G163D	G	163	D	359	decrease	VARIANT G -> D (in TGCT; a tumor with seminoma and teratoma components; associated with severely impaired but detectable kinase activity; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; predominantly nuclear localization; dbSNP:rs137853078)	UniProt
Q15831	STK11	Q170P	Q	170	P	372	loss	VARIANT Q -> P (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	UniProt
Q15831	STK11	G171S	G	171	S	373	loss	VARIANT G -> S (in colorectal cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1599926499)	UniProt
Q15831	STK11	H174R	H	174	R	388	loss	VARIANT H -> R (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	UniProt
Q15831	STK11	I177N	I	177	N	391	loss	VARIANT I -> N (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520041)	UniProt
Q15831	STK11	N181E	N	181	E	395	loss	VARIANT N -> E (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; requires 2 nucleotide substitutions; dbSNP:rs1568707668)	UniProt
Q15831	STK11	S216F	S	216	F	522	loss	VARIANT S -> F (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39; dbSNP:rs1057520017)	UniProt
Q15831	STK11	E223V	E	223	V	535	loss	VARIANT E -> V (in sporadic cancer; somatic mutation; impairs heterotrimeric complex assembly with STRADA and CAB39)	UniProt
Q16288	NTRK3	T93M	T	93	M	-	decrease	VARIANT T -> M (probable disease-associated variant found in patients with CHD; associated with CHD susceptibility; significantly reduced autophosphorylation; decreased NTRK3 signaling associated with decreased apoptosis in absence of NTF3; dbSNP:rs147992979)	UniProt
Q16512	PKN1	D451A	D	451	A	-	loss	MUTAGEN D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	UniProt
Q16512	PKN1	D454A	D	454	A	-	loss	MUTAGEN D->A: Abolishes cleavage by caspase-3 and formation of 70 kDa fragment.	UniProt
Q16512	PKN1	D558A	D	558	A	-	loss	MUTAGEN D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	UniProt
Q16512	PKN1	D560A	D	560	A	-	loss	MUTAGEN D->A: Abolishes cleavage by caspase-3 and formation of AF3 fragment.	UniProt
Q16513	PKN2	F977A	F	977	A	-	decrease	MUTAGEN F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%.	UniProt
Q16513	PKN2	F977L	F	977	L	-	decrease	MUTAGEN F->A,L: Abolishes interaction with PDPK1 and prevents the phosphorylation of AKT1 at 'Ser-473'. Reduces catalytic activity by 90%.	UniProt
Q16513	PKN2	F977Y	F	977	Y	-	decrease	MUTAGEN F->W,Y: Reduces catalytic activity by 50%.	UniProt
Q16513	PKN2	Y979L	Y	979	L	-	decrease	MUTAGEN Y->F,L,W: Reduces catalytic activity by 25%.	UniProt
Q16513	PKN2	Y979W	Y	979	W	-	decrease	MUTAGEN Y->F,L,W: Reduces catalytic activity by 25%.	UniProt
Q16539	MAPK14	D176A	D	176	A	457	increase	MUTAGEN D->A: Emulation of the active state. Increase in activity; when associated with S-327 or L-327.	UniProt
Q16539	MAPK14	F327L	F	327	L	813	increase	MUTAGEN F->L: Emulation of the active state. Increase in activity; when associated with A-176.	UniProt
Q16539	MAPK14	F327S	F	327	S	813	increase	MUTAGEN F->S: Emulation of the active state. Increase in activity; when associated with A-176.	UniProt
Q16566	CAMK4	S189A	S	189	A	448	increase	MUTAGEN S->A: Increases phosphorylation of CREB1 2-fold. Decreases total O-linked glycosylation 2-fold. Increases ATP-binding affinity.	UniProt
Q16832	DDR2	Y736F	Y	736	F	457	decrease	MUTAGEN Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-740 and F-741.	UniProt
Q16832	DDR2	Y740F	Y	740	F	462	increase	MUTAGEN Y->F: Promotes autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-741.	UniProt
Q16832	DDR2	Y741F	Y	741	F	463	decrease	MUTAGEN Y->F: Reduces autophosphorylation. Abolishes phosphorylation by SRC; when associated with F-736 and F-740.	UniProt
Q2M2I8	AAK1	K74A	K	74	A	128	loss	MUTAGEN K->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization. Does not interact with monoubiquitinated NOTCH1.	UniProt
Q2M2I8	AAK1	D176A	D	176	A	390	loss	MUTAGEN D->A: Inhibits autophosphorylation and phosphorylation of AP2M1. Does not affect NUMB localization.	UniProt
Q38SD2	LRRK1	K746G	K	746	G	-	decrease	MUTAGEN K->G: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	UniProt
Q38SD2	LRRK1	F1022C	F	1022	C	-	loss	MUTAGEN F->C: No effect on GTP-binding but loss of subsequent stimulation of kinase activity.	UniProt
Q38SD2	LRRK1	I1412T	I	1412	T	446	decrease	MUTAGEN I->T: No effect on GTP-binding but reduction in subsequent stimulation of kinase activity.	UniProt
Q8TDX7	NEK7	R131A	R	131	A	315	loss	MUTAGEN R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	UniProt
Q5S007	LRRK2	R1441C	R	1441	C	-	increase	VARIANT R -> C (in PARK8; shows an increase in activity in both autophosphorylation and phosphorylation of a generic substrate; loss of interaction with SEC16A; shows an increase in activity in phosphorylation of RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs33939927)	UniProt
Q5S007	LRRK2	R1441H	R	1441	H	-	increase	VARIANT R -> H (in PARK8; shows an increase in activity in phosphorylation of RAB8A and RAB10; decreases phosphorylation-dependent binding to YWHAG; dbSNP:rs34995376)	UniProt
Q5S007	LRRK2	C727D	C	727	D	-	decrease	MUTAGEN C->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	UniProt
Q5S007	LRRK2	L728D	L	728	D	-	decrease	MUTAGEN L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	UniProt
Q5S007	LRRK2	L729D	L	729	D	-	decrease	MUTAGEN L->D: Decreased kinase activity. Loss of RAB29-mediated activation and autophosphorylation of S-910, S-935, S-955, S-973 and S-1292. Decreased membrane association; when associated with G-1441, C-1699 and S-2019.	UniProt
Q5S007	LRRK2	K1347A	K	1347	A	-	loss	MUTAGEN K->A: GTPase-dead mutant. Loss of interaction with SEC16A and impaired ability to recruit SEC16A to endoplasmic reticulum exit sites.	UniProt
Q5S007	LRRK2	K1906A	K	1906	A	128	loss	MUTAGEN K->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with N-1994 and A-2017.	UniProt
Q5S007	LRRK2	D1994N	D	1994	N	390	loss	MUTAGEN D->N: Loss of kinase activity. No loss of interaction with SEC16A and no loss of ability to recruit SEC16A to endoplasmic reticulum exit sites. Decreases proteosomal degradation of MAPT; when associated with A-1906 and A-2017.	UniProt
Q5S007	LRRK2	D2017A	D	2017	A	443	loss	MUTAGEN D->A: Loss of kinase activity. Decreases proteosomal degradation of MAPT; when associated with A-1906 and N-1994. Loss of phosphorylation of RAB10; when associated with G-1441, C-1699, or S-2019.	UniProt
Q6IQ55	TTBK2	K50E	K	50	E	128	loss	MUTAGEN K->E,A: Leads to inactivation/destabilization of the protein.	UniProt
Q6IQ55	TTBK2	K50A	K	50	A	128	loss	MUTAGEN K->E,A: Leads to inactivation/destabilization of the protein.	UniProt
Q6IQ55	TTBK2	K143E	K	143	E	392	loss	MUTAGEN K->E,A: Leads to inactivation/destabilization of the protein.	UniProt
Q6IQ55	TTBK2	K143A	K	143	A	392	loss	MUTAGEN K->E,A: Leads to inactivation/destabilization of the protein.	UniProt
Q6IQ55	TTBK2	R181A	R	181	A	509	loss	MUTAGEN R->E,A: Impaired serine/threonine-protein kinase activity.	UniProt
Q6IQ55	TTBK2	A184G	A	184	G	512	loss	MUTAGEN A->E,G: Impaired serine/threonine-protein kinase activity.	UniProt
Q7KZI7	MARK2	T208A	T	208	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q86UE8	TLK2	D551G	D	551	G	275	decrease	VARIANT D -> G (in MRD57; unknown pathological significance; exhibits abnormal perinuclear localization instead of diffuse nuclear localization; mildly impairs kinase activity; reduced phosphorylation of ASF1A; dbSNP:rs2082811958)	UniProt
Q8IU85	CAMK1D	K52A	K	52	A	128	loss	MUTAGEN K->A: Catalytically inactive form.	UniProt
Q8IVH8	MAP4K3	K45E	K	45	E	128	loss	MUTAGEN K->E: Loss of kinase activity and ability to activate JNK family.	UniProt
Q8IWQ3	BRSK2	T174A	T	174	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q8IY84	NIM1K	T229E	T	229	E	513	activating	MUTAGEN T->E: Constitutively active.	UniProt
Q8NB16	MLKL	K230M	K	230	M	-	loss	MUTAGEN K->M: Abolishes ATP-binding.	UniProt
Q8NB16	MLKL	K331N	K	331	N	-	loss	MUTAGEN K->N: Impairs ATP-binding.	UniProt
Q8NB16	MLKL	E351K	E	351	K	-	increase	MUTAGEN E->K: Binds ATP with an enhanced affinity.	UniProt
Q8NG66	NEK11	K61R	K	61	R	128	loss	MUTAGEN K->R: Loss of kinase activity.	UniProt
Q8TAS1	UHMK1	K54A	K	54	A	128	loss	MUTAGEN K->A: Loss of kinase activity.	UniProt
Q8TD08	MAPK15	D155A	D	155	A	443	loss	MUTAGEN D->A: Unable to induce the formation of autophagosomal structures. Is able to bind to MAP1LC3B and to colocalize with this protein to autophagosomal structures. Does not induce phosphorylation by methyl methanesulfonate. Loas of phosphorylation. Dominant negative mutant. Not phosphorylated at Thr-175 and Tyr-177.	UniProt
Q8TD08	MAPK15	T175A	T	175	A	512	loss	MUTAGEN T->A: Loss of autophosphorylation and activity. Still heavily phosphorylated at Tyr-177. Does not rescues inhibition of O-glycosylation in MAPK15-depleted cells; when associated with F-177.	UniProt
Q8TDC3	BRSK1	T189A	T	189	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q8TDR2	STK35	K231M	K	231	M	128	loss	MUTAGEN K->M: No autophosphorylation.	UniProt
Q8TDX7	NEK7	Y28A	Y	28	A	24	decrease	MUTAGEN Y->A: Significant decrease in catalytic activity; when associated with A-31.	UniProt
Q8TDX7	NEK7	L31A	L	31	A	27	decrease	MUTAGEN L->A: Significant decrease in catalytic activity; when associated with A-28.	UniProt
Q8TDX7	NEK7	N90A	N	90	A	186	decrease	MUTAGEN N->A: Reduced protein kinase activity.	UniProt
Q8TDX7	NEK7	N90R	N	90	R	186	decrease	MUTAGEN N->R,K: Strongly reduced protein kinase activity.	UniProt
Q8TDX7	NEK7	N90K	N	90	K	186	decrease	MUTAGEN N->R,K: Strongly reduced protein kinase activity.	UniProt
Q8TDX7	NEK7	K96E	K	96	E	204	increase	MUTAGEN K->E: Strongly increased protein kinase activity.	UniProt
Q8TDX7	NEK7	Y97L	Y	97	L	206	increase	MUTAGEN Y->F,L: Moderate increase in catalytic activity.	UniProt
Q8TDX7	NEK7	M122A	M	122	A	286	decrease	MUTAGEN M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity.	UniProt
Q8TDX7	NEK7	M122R	M	122	R	286	decrease	MUTAGEN M->A,R: Decreased interaction with NEK9 and subsequent activation of NEK7 kinase activity.	UniProt
Q9P0L2	MARK1	T215A	T	215	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q8TDX7	NEK7	R131D	R	131	D	315	loss	MUTAGEN R->A,D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	UniProt
Q8TDX7	NEK7	L132D	L	132	D	316	loss	MUTAGEN L->D: Abolished interaction with NEK9 and subsequent activation of NEK7 kinase activity.	UniProt
Q8TDX7	NEK7	R155E	R	155	E	372	decrease	MUTAGEN R->E: Strongly reduced protein kinase activity.	UniProt
Q8TDX7	NEK7	S195A	S	195	A	513	loss	MUTAGEN S->A: Abolished phosphorylation with NEK9 and protein kinase activity.	UniProt
Q8WZ42	TTN	K32207A	K	32207	A	128	loss	MUTAGEN K->A: Disrupts catalytic activity.	UniProt
Q96GD4	AURKB	K215Q	K	215	Q	440	activating	MUTAGEN K->Q: Mimics acetylation, promoting accurate chromosome segregation.	UniProt
Q96GD4	AURKB	K215R	K	215	R	440	loss	MUTAGEN K->R: Abolished acetylation by KAT5, leading to impaired chromosome segregation.	UniProt
Q96L34	MARK4	T214A	T	214	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q99683	MAP3K5	S966A	S	966	A	823	increase	MUTAGEN S->A: Enhanced induction of apoptosis, increased kinase activity, and loss of YWHAG binding.	UniProt
Q9BQI3	EIF2AK1	I448V	I	448	V	396	decrease	VARIANT I -> V (in LEMSPAD; unknown pathological significance; mildly reduced phosphorylation of eukaryotic translation initiation factor 2-alpha; dbSNP:rs1583476115)	UniProt
Q9BRS2	RIOK1	D324A	D	324	A	-	loss	MUTAGEN D->A: Abolishes autophosphorylation activity; enhances association with pre-40S ribosomal subunits; inhibits processing of 18S-E pre-rRNA to the mature 18S rRNA.	UniProt
Q9BVS4	RIOK2	K123A	K	123	A	-	loss	MUTAGEN K->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-246.	UniProt
Q9BVS4	RIOK2	D246A	D	246	A	-	loss	MUTAGEN D->A: Abolishes autophosphorylation; impairs release of pre-40S trans-acting factors and rRNA processing; when associated with A-123.	UniProt
Q9BX84	TRPM6	S141L	S	141	L	-	decrease	VARIANT S -> L (in HOMG1; impairs heterodimer formation resulting in intracellular retention; dbSNP:rs121912625)	UniProt
Q9BX84	TRPM6	L708P	L	708	P	-	loss	VARIANT L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	UniProt
Q9BX84	TRPM6	E872G	E	872	G	-	loss	VARIANT E -> G (in HOMG1; loss of function; no effect on cell membrane localization)	UniProt
Q9BX84	TRPM6	Y1053C	Y	1053	C	-	loss	VARIANT Y -> C (in HOMG1; loss of function; no effect on cell membrane localization)	UniProt
Q9BX84	TRPM6	L1143P	L	1143	P	-	loss	VARIANT L -> P (in HOMG1; loss of function; no effect on cell membrane localization)	UniProt
Q9BX84	TRPM6	S1754N	S	1754	N	-	loss	VARIANT S -> N (in HOMG1; loss of function; no effect on cell membrane localization)	UniProt
Q9BX84	TRPM6	T1851D	T	1851	D	-	loss	MUTAGEN T->D: Significantly decreases autophosphorylation. Does not alter binding to RACK1 or inhibition by RACK1.	UniProt
Q9BXA6	TSSK6	D135N	D	135	N	390	loss	MUTAGEN D->N: Loss of kinase activity. No effect of binding to TSACC.	UniProt
Q9BXM7	PINK1	G309D	G	309	D	254	decrease	VARIANT G -> D (in PARK6; fails to maintain mitochondrial membrane potential; full-length mutant has no effect on autophosphorylation; strongly reduces interaction with PRKN; decreases PRKN and SNCAIP ubiquitination and degradation; decreases Drp1 phosphorylation; dbSNP:rs74315355)	UniProt
Q9BXM7	PINK1	L347P	L	347	P	357	decrease	VARIANT L -> P (in PARK6; strongly reduces interaction with PRKN; reduced ubiquitination of MIRO1; dbSNP:rs28940285)	UniProt
Q9BXM7	PINK1	P399L	P	399	L	465	decrease	VARIANT P -> L (probable disease-associated variant found in early-onset Parkinson disease with digenic inheritance; found in a patient also carrying mutation S-39 in PARK7; decreases PRKN and SNCAIP ubiquitination and degradation; dbSNP:rs119451946)	UniProt
Q9BXM7	PINK1	D384N	D	384	N	443	loss	MUTAGEN D->N: Loss of activity. Abolishes Drp1 phosphorylation. No effect on localization to mitochondria.	UniProt
Q9BYP7	WNK3	D294A	D	294	A	443	loss	MUTAGEN D->A: Catalytically inactive form. Inhibits sodium-coupled chloride cotransporters and activates potassium-coupled chloride cotransporters.	UniProt
Q9BZL6	PRKD2	Y438D	Y	438	D	-	increase	MUTAGEN Y->D: Slight increase in Tyr-717 phosphorylation. No effect on Ser-706 or/and Ser-710 phosphorylation. Increase in Tyr-717 phosphorylation; when associated with E-706 and E-710.	UniProt
Q9BZL6	PRKD2	Y438F	Y	438	F	-	decrease	MUTAGEN Y->F: Loss of phosphorylation. No effect on phosphorylation of Tyr-717 and on Ser-706 or/and Ser-710 phosphorylation.	UniProt
Q9H093	NUAK2	T208A	T	208	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q9H0K1	SIK2	T175A	T	175	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q9H2X6	HIPK2	K228A	K	228	A	128	loss	MUTAGEN K->A: Locates in the nucleoplasm, no effect on interaction with RANBP9, but loss of kinase activity toward PML, RUNX1, EP300 and DAZAP2.	UniProt
Q9H2X6	HIPK2	K228R	K	228	R	128	loss	MUTAGEN K->R: Abolishes enzymatic activity, no effect on interaction with TP53 and TP73 or on BMP-induced transcriptional activation. Enhances BMP-induced transcriptional activation; when associated with 359-AAF-361.	UniProt
Q9H3Y6	SRMS	K258M	K	258	M	128	loss	MUTAGEN K->M: Loss of kinase activity. Exhibits a diffused cytoplasmic localization. No effect on interaction with KHDRBS1 or VIM but abolishes tyrosine phosphorylation of both substrates.	UniProt
Q9H3Y6	SRMS	Y380F	Y	380	F	462	decrease	MUTAGEN Y->F: Significant reduction in phosphorylation.	UniProt
Q9H4B4	PLK3	T219E	T	219	E	513	loss	MUTAGEN T->E: Kinase-defective mutant.	UniProt
Q9NRH2	SNRK	T173A	T	173	A	513	loss	MUTAGEN T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q9NRH2	SNRK	T173E	T	173	E	513	loss	MUTAGEN T->A,E: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q9NWZ3	IRAK4	G298D	G	298	D	359	decrease	VARIANT G -> D (in IMD67; decreases inhibition of NF-kappa-B complex activation; impairs neutrophil migration and phagocytosis; dbSNP:rs568782766)	UniProt
Q9UBE8	NLK	K167N	K	167	N	128	loss	MUTAGEN K->N: Abrogates kinase activity.	UniProt
Q9UHD2	TBK1	S172A	S	172	A	513	loss	MUTAGEN S->A: Loss of kinase activity. No effect on dimerization. Loss of localization to cytoplasmic spherical structures.	UniProt
Q9UHD2	TBK1	L316E	L	316	E	-	decrease	MUTAGEN L->E: Decreases kinase activity. No effect on phosphorylation.	UniProt
Q9UL54	TAOK2	K57A	K	57	A	128	loss	MUTAGEN K->A: Loss of kinase activity. In isoform 1, excluded from the nucleus. No effect on microtubule-binding.	UniProt
Q9UL54	TAOK2	D169A	D	169	A	443	loss	MUTAGEN D->A: Loss of kinase activity; No effect on MAP3K7-mediated activation of NF-kappa-B.	UniProt
Q9UPZ9	CILK1	T157A	T	157	A	512	decrease	MUTAGEN T->A: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with F-159.	UniProt
Q9UPZ9	CILK1	Y159F	Y	159	F	517	decrease	MUTAGEN Y->F: Reduction of activity and loss of autophosphorylation. Loss of activity and autophosphorylation; when associated with A-157.	UniProt
Q9UQM7	CAMK2A	F98S	F	98	S	284	decrease	VARIANT F -> S (in MRD53; no effect on protein abundance; decreased autophosphorylation; decreased neuronal migration; dbSNP:rs1554122526)	UniProt
Q9UQM7	CAMK2A	E109D	E	109	D	324	increase	VARIANT E -> D (in MRD53; no effect on protein abundance; increased autophosphorylation; decreased neuronal migration)	UniProt
Q9UQM7	CAMK2A	E183V	E	183	V	535	decrease	VARIANT E -> V (in MRD53; increased ubiquitin-mediated proteasomal degradation with a dominant negative effect on wild-type protein; decreased localization to dendritic spines; no effect on holoenzyme assembly; loss of interaction with SHANK3; loss of interaction with GRIN2B; loss of interaction with CACNB2; loss of interaction with LRRC7; loss of interaction with GRM5; decreased protein serine/threonine kinase activity with a dominant negative effect on wild-type protein; decreased autophosphorylation; changed dendritic spine development; decreased neuronal migration; dbSNP:rs1554122129)	UniProt
Q9UQM7	CAMK2A	H282R	H	282	R	805	increase	VARIANT H -> R (in MRD53; decreased protein abundance; increased autophosphorylation; decreased neuronal migration; dbSNP:rs1554121875)	UniProt
Q9Y243	AKT3	T305D	T	305	D	513	increase	MUTAGEN T->D: 2-fold increase of phosphorylation steady state level, no activation after pervanadate treatment.	UniProt
Q9Y243	AKT3	S472D	S	472	D	-	increase	MUTAGEN S->D: 1.4-fold increase of phosphorylation steady state level, 50% decrease of activity after pervanadate treatment.	UniProt
Q9Y2K2	SIK3	R187C	R	187	C	389	decrease	VARIANT R -> C (in SEMDK; decreased protein expression; decreased kinase activity; no effect on the interaction with DEPTOR, MLST8/GbetaL, RICTOR and RPTOR; dbSNP:rs1565460853)	UniProt
Q9Y2K2	SIK3	T221A	T	221	A	513	loss	MUTAGEN T->A: Prevents phosphorylation and activation by STK11/LKB1 complex.	UniProt
Q9Y463	DYRK1B	R102C	R	102	C	22	decrease	VARIANT R -> C (in AOMS3; accumulation of intracellular lipid is significantly greater than with wild-type protein; cells expressing the variant are able to transform into mature adipocytes without requiring adipogenic medium; expression levels of CEBPA, PPARG forms 1 and 2 and PPARGC1A are higher and those of GLI1 and CDKN1B are lower in cells transfected with the mutant protein compared to wild-type; WNT1 signaling activity is lower in mutant cells compared to wild-type; dbSNP:rs367643250)	UniProt
Q9Y572	RIPK3	K50A	K	50	A	128	loss	MUTAGEN K->A: Abolishes kinase activity. Loss of PGAM5- and MLKL-binding. No effect on RIPK1-binding. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of STUB1-mediated ubiquitination.	UniProt
Q9Y572	RIPK3	T182A	T	182	A	522	loss	MUTAGEN T->A: Abolishes kinase activity. Loss of interaction with PELI1 and PELI1-mediated ubiquitination. No loss of interaction with STUB1 and STUB1-mediated ubiquitination. No loss of interaction with RIPK1. Loss of ability to mediate TNF-induced necroptosis. Loss of autophosphorylation at Ser-227.	UniProt
Q9Y572	RIPK3	S227A	S	227	A	628	decrease	MUTAGEN S->A: Abolishes ability to mediate necroptosis. Partial loss of kinase activity. No loss of PELI1-mediated degradation.	UniProt
Q04771	ACVR1	R206H	R	206	H	26	activating	VARIANT constitutively-active	UniProt
Q06187	BTK	E41K	E	41	K	-	activating	VARIANT constitutively-active	UniProt
P31749	AKT1	S473D	S	473	D	-	activating	VARIANT constitutively-active	UniProt
P06239	LCK	Y505F	Y	505	F	811	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	R683G	R	683	G	-	activating	VARIANT constitutively-active	UniProt
P29597	TYK2	V678F	V	678	F	-	activating	VARIANT constitutively-active	UniProt
P11362	FGFR1	K656E	K	656	E	510	activating	VARIANT constitutively-active	UniProt
Q13418	ILK	S343D	S	343	D	448	activating	VARIANT constitutively-active	UniProt
Q02750	MAP2K1	K57E	K	57	E	20	activating	VARIANT constitutively-active	UniProt
Q02750	MAP2K1	Q56P	Q	56	P	19	activating	VARIANT constitutively-active	UniProt
P22607	FGFR3	G382D	G	382	D	-	activating	VARIANT constitutively-active	UniProt
P22607	FGFR3	G375C	G	375	C	-	activating	VARIANT constitutively-active	UniProt
P06241	FYN	Y531F	Y	531	F	809	activating	VARIANT constitutively-active	UniProt
P04626	ERBB2	V659E	V	659	E	-	activating	VARIANT constitutively-active	UniProt
O00141	SGK1	S429D	S	429	D	-	activating	VARIANT constitutively-active	UniProt
P31749	AKT1	T308D	T	308	D	513	activating	VARIANT constitutively-active	UniProt
Q8TDC3	BRSK1	T189E	T	189	E	513	activating	VARIANT constitutively-active	UniProt
Q04771	ACVR1	Q207E	Q	207	E	27	activating	VARIANT constitutively-active	UniProt
P23458	JAK1	S646F	S	646	F	-	activating	VARIANT constitutively-active	UniProt
P16234	PDGFRA	V536E	V	536	E	-	activating	VARIANT constitutively-active	UniProt
P16234	PDGFRA	I537D	I	537	D	-	activating	VARIANT constitutively-active	UniProt
P15056	BRAF	V600F	V	600	F	450	activating	VARIANT constitutively-active	UniProt
P12931	SRC	Y530F	Y	530	F	809	activating	VARIANT constitutively-active	UniProt
P06493	CDK1	Y15F	Y	15	F	42	activating	VARIANT constitutively-active	UniProt
P04626	ERBB2	Q646C	Q	646	C	-	activating	VARIANT constitutively-active	UniProt
P00533	EGFR	G652R	G	652	R	-	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	K539A	K	539	A	-	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	H574R	H	574	R	-	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	H345L	H	345	L	-	activating	VARIANT constitutively-active	UniProt
Q5S007	LRRK2	G2019S	G	2019	S	445	activating	VARIANT constitutively-active	UniProt
P52333	JAK3	A572V	A	572	V	-	activating	VARIANT constitutively-active	UniProt
P10721	KIT	N822K	N	822	K	462	activating	VARIANT constitutively-active	UniProt
P10721	KIT	L576P	L	576	P	15	activating	VARIANT constitutively-active	UniProt
P22607	FGFR3	A391E	A	391	E	-	activating	VARIANT constitutively-active	UniProt
P21802	FGFR2	C342Y	C	342	Y	-	activating	VARIANT constitutively-active	UniProt
P09619	PDGFRB	N666H	N	666	H	204	activating	VARIANT constitutively-active	UniProt
P07949	RET	Y606C	Y	606	C	-	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	S523L	S	523	L	-	activating	VARIANT constitutively-active	UniProt
P15056	BRAF	V600K	V	600	K	450	activating	VARIANT constitutively-active	UniProt
P11802	CDK4	R24C	R	24	C	73	activating	VARIANT constitutively-active	UniProt
O60674	JAK2	R867Q	R	867	Q	73	activating	VARIANT constitutively-active	UniProt
P08581	MET	N1100Y	N	1100	Y	100	activating	VARIANT constitutively-acttive	UniProt
Q15139	PRKD1	R603H	R	603	H	87	activating	VARIANT constitutively-active	UniProt
P10721	KIT	T670I	T	670	I	267	resistance	-	COSMIC
P00533	EGFR	T790M	T	790	M	267	resistance	-	COSMIC
P10721	KIT	V654A	V	654	A	203	resistance	-	COSMIC
P00519	ABL1	T315I	T	315	I	267	resistance	-	COSMIC
P00519	ABL1	G250E	G	250	E	39	resistance	-	COSMIC
P00519	ABL1	Y253H	Y	253	H	42	resistance	-	COSMIC
P00519	ABL1	E255K	E	255	K	44	resistance	-	COSMIC
Q9UM73	ALK	L1196M	L	1196	M	267	resistance	-	COSMIC
P16234	PDGFRA	D842V	D	842	V	453	resistance	-	COSMIC
P10721	KIT	N822K	N	822	K	462	resistance	-	COSMIC
P10721	KIT	Y823D	Y	823	D	463	resistance	-	COSMIC
Q06187	BTK	C481S	C	481	S	275	resistance	-	COSMIC
P00533	EGFR	L718Q	L	718	Q	37	resistance	-	COSMIC
P00533	EGFR	C797S	C	797	S	275	resistance	-	COSMIC
P21802	FGFR2	N549K	N	549	K	204	resistance	-	COSMIC
P21802	FGFR2	V395D	V	395	D	-	resistance	-	COSMIC
P21802	FGFR2	L617M	L	617	M	366	resistance	-	COSMIC
Q9UM73	ALK	G1202R	G	1202	R	274	resistance	-	COSMIC
P10721	KIT	D816H	D	816	H	453	resistance	-	COSMIC
P10721	KIT	D820Y	D	820	Y	460	resistance	-	COSMIC
P00519	ABL1	F317L	F	317	L	269	resistance	-	COSMIC
P21802	FGFR2	V564F	V	564	F	267	resistance	-	COSMIC
Q06187	BTK	C481Y	C	481	Y	275	resistance	-	COSMIC
P11362	FGFR1	N546K	N	546	K	204	resistance	-	COSMIC
P10721	KIT	N822Y	N	822	Y	462	resistance	-	COSMIC
Q9UM73	ALK	I1171N	I	1171	N	180	resistance	-	COSMIC
P36507	MAP2K2	C125S	C	125	S	185	resistance	-	COSMIC
P10721	KIT	D820G	D	820	G	460	resistance	-	COSMIC
P15056	BRAF	V600E	V	600	E	450	resistance	-	COSMIC
P00533	EGFR	G796D	G	796	D	274	resistance	-	COSMIC
P00533	EGFR	L718V	L	718	V	37	resistance	-	COSMIC
P21802	FGFR2	E565A	E	565	A	268	resistance	-	COSMIC
P21802	FGFR2	N549H	N	549	H	204	resistance	-	COSMIC
P36888	FLT3	F691L	F	691	L	267	resistance	-	COSMIC
P36888	FLT3	D835H	D	835	H	453	resistance	-	COSMIC
P08581	MET	Y1230H	Y	1230	H	457	resistance	-	COSMIC
P00533	EGFR	G719A	G	719	A	38	resistance	-	COSMIC
P10721	KIT	D820E	D	820	E	460	resistance	-	COSMIC
P00533	EGFR	C797G	C	797	G	275	resistance	-	COSMIC
P00533	EGFR	L792F	L	792	F	269	resistance	-	COSMIC
Q06187	BTK	C481R	C	481	R	275	resistance	-	COSMIC
P00533	EGFR	L792H	L	792	H	269	resistance	-	COSMIC
P36888	FLT3	D835V	D	835	V	453	resistance	-	COSMIC
P35968	KDR	L840F	L	840	F	37	resistance	-	COSMIC
P04626	ERBB2	L869R	L	869	R	453	resistance	-	COSMIC
P10721	KIT	D816E	D	816	E	453	resistance	-	COSMIC
P10721	KIT	A829P	A	829	P	517	resistance	-	COSMIC
P00533	EGFR	G796R	G	796	R	274	resistance	-	COSMIC
P00533	EGFR	L792R	L	792	R	269	resistance	-	COSMIC
P36507	MAP2K2	N126D	N	126	D	186	resistance	-	COSMIC
P00519	ABL1	D276G	D	276	G	136	resistance	-	COSMIC
Q9UM73	ALK	F1174L	F	1174	L	185	resistance	-	COSMIC
P10721	KIT	K642E	K	642	E	177	resistance	-	COSMIC
P36507	MAP2K2	F57C	F	57	C	16	resistance	-	COSMIC
P00533	EGFR	L747P	L	747	P	130	resistance	-	COSMIC
P10721	KIT	C809G	C	809	G	442	resistance	-	COSMIC
P22455	FGFR4	V550L	V	550	L	267	resistance	-	COSMIC
P08581	MET	D1228N	D	1228	N	453	resistance	-	COSMIC
Q02750	MAP2K1	P124L	P	124	L	196	resistance	-	COSMIC
P36507	MAP2K2	V35M	V	35	M	-	resistance	-	COSMIC
Q02750	MAP2K1	V60E	V	60	E	23	resistance	-	COSMIC
P36888	FLT3	D835Y	D	835	Y	453	resistance	-	COSMIC
Q9UM73	ALK	F1174V	F	1174	V	185	resistance	-	COSMIC
P15056	BRAF	L505H	L	505	H	180	resistance	-	COSMIC
P08581	MET	Y1230C	Y	1230	C	457	resistance	-	COSMIC
P00519	ABL1	F311I	F	311	I	260	resistance	-	COSMIC
Q9UM73	ALK	S1206F	S	1206	F	285	resistance	-	COSMIC
Q02750	MAP2K1	G128V	G	128	V	204	resistance	-	COSMIC
Q02750	MAP2K1	C121S	C	121	S	185	resistance	-	COSMIC
P08581	MET	D1228V	D	1228	V	453	resistance	-	COSMIC
P08581	MET	Y1230S	Y	1230	S	457	resistance	-	COSMIC
P04626	ERBB2	S310Y	S	310	Y	-	resistance	-	COSMIC
P00533	EGFR	L792V	L	792	V	269	resistance	-	COSMIC
P21802	FGFR2	N549T	N	549	T	204	resistance	-	COSMIC
P00533	EGFR	G796S	G	796	S	274	resistance	-	COSMIC
P00533	EGFR	L792P	L	792	P	269	resistance	-	COSMIC
P10721	KIT	N655T	N	655	T	204	resistance	-	COSMIC
P21802	FGFR2	K641R	K	641	R	440	resistance	-	COSMIC
P00533	EGFR	D761Y	D	761	Y	174	resistance	-	COSMIC
P21802	FGFR2	L617V	L	617	V	366	resistance	-	COSMIC
Q02750	MAP2K1	G128D	G	128	D	204	resistance	-	COSMIC
Q02750	MAP2K1	P124S	P	124	S	196	resistance	-	COSMIC
Q02750	MAP2K1	E203K	E	203	K	429	resistance	-	COSMIC
P36507	MAP2K2	E207K	E	207	K	429	resistance	-	COSMIC
P36507	MAP2K2	L46F	L	46	F	5	resistance	-	COSMIC
P10721	KIT	D716N	D	716	N	-	resistance	-	COSMIC
Q02750	MAP2K1	K57E	K	57	E	20	resistance	-	COSMIC
P08581	MET	D1228H	D	1228	H	453	resistance	-	COSMIC
P21802	FGFR2	M537I	M	537	I	178	resistance	-	COSMIC
P10721	KIT	D816G	D	816	G	453	resistance	-	COSMIC
Q02750	MAP2K1	K57N	K	57	N	20	resistance	-	COSMIC
P36507	MAP2K2	Q60P	Q	60	P	19	resistance	-	COSMIC
P36888	FLT3	D835I	D	835	I	453	resistance	-	COSMIC
Q02750	MAP2K1	K57T	K	57	T	20	resistance	-	COSMIC
P29322	EPHA8	S457P	S	457	P	-	neutral	AC/AN:0.88932 ; Hom/AC:0.20792	gnomAD
P29322	EPHA8	L492F	L	492	F	-	neutral	AC/AN:0.18058 ; Hom/AC:0.05123	gnomAD
P29322	EPHA8	E612Q	E	612	Q	7	neutral	AC/AN:0.21325 ; Hom/AC:0.05150	gnomAD
Q15418	RPS6KA1	K243T	K	243	T	581	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K324T	K	324	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K335T	K	335	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K243T	K	243	T	581	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K319T	K	319	T	792	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	K344T	K	344	T	-	neutral	AC/AN:0.50458 ; Hom/AC:0.12063	gnomAD
Q15418	RPS6KA1	N112Y	N	112	Y	175	neutral	AC/AN:0.21583 ; Hom/AC:0.06027	gnomAD
O95382	MAP3K6	G1233A	G	1233	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G1225A	G	1225	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G49A	G	49	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	G1233A	G	1233	A	-	neutral	AC/AN:0.10044 ; Hom/AC:0.05152	gnomAD
O95382	MAP3K6	N622K	N	622	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N614K	N	614	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N346K	N	346	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	N622K	N	622	K	-	neutral	AC/AN:0.51193 ; Hom/AC:0.13321	gnomAD
O95382	MAP3K6	T455I	T	455	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T447I	T	447	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T179I	T	179	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	T455I	T	455	I	-	neutral	AC/AN:0.74595 ; Hom/AC:0.17898	gnomAD
O95382	MAP3K6	V207G	V	207	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
O95382	MAP3K6	V199G	V	199	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
O95382	MAP3K6	V207G	V	207	G	-	neutral	AC/AN:0.03254 ; Hom/AC:0.05581	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R89Q	R	89	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R89Q	R	89	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q32MK0	MYLK3	R45Q	R	45	Q	-	neutral	AC/AN:0.03575 ; Hom/AC:0.06229	gnomAD
Q8N2I9	STK40	A395T	A	395	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q8N2I9	STK40	A400T	A	400	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q8N2I9	STK40	A395T	A	395	T	-	neutral	AC/AN:0.47319 ; Hom/AC:0.11256	gnomAD
Q5JZY3	EPHA10	G244E	G	244	E	-	neutral	AC/AN:0.32070 ; Hom/AC:0.08330	gnomAD
Q5JZY3	EPHA10	G749E	G	749	E	-	neutral	AC/AN:0.32070 ; Hom/AC:0.08330	gnomAD
Q5JZY3	EPHA10	F281I	F	281	I	-	neutral	AC/AN:0.72042 ; Hom/AC:0.16031	gnomAD
Q5JZY3	EPHA10	T220K	T	220	K	-	neutral	AC/AN:0.09279 ; Hom/AC:0.08134	gnomAD
Q6P0Q8	MAST2	G1468A	G	1468	A	-	neutral	AC/AN:0.11771 ; Hom/AC:0.05223	gnomAD
Q6P0Q8	MAST2	G1278A	G	1278	A	-	neutral	AC/AN:0.11771 ; Hom/AC:0.05223	gnomAD
Q6P0Q8	MAST2	D1551G	D	1551	G	-	neutral	AC/AN:0.17180 ; Hom/AC:0.05170	gnomAD
Q6P0Q8	MAST2	D1361G	D	1361	G	-	neutral	AC/AN:0.17180 ; Hom/AC:0.05170	gnomAD
Q01973	ROR1	T518M	T	518	M	-	neutral	AC/AN:0.71010 ; Hom/AC:0.16383	gnomAD
O96013	PAK4	C22S	C	22	S	-	neutral	AC/AN:0.18396 ; Hom/AC:0.11271	gnomAD
Q58F21	BRDT	K238N	K	238	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K165N	K	165	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K192N	K	192	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	K238N	K	238	N	-	neutral	AC/AN:0.24883 ; Hom/AC:0.09343	gnomAD
Q58F21	BRDT	N410K	N	410	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N337K	N	337	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N364K	N	364	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
Q58F21	BRDT	N410K	N	410	K	-	neutral	AC/AN:0.48628 ; Hom/AC:0.12083	gnomAD
P16066	NPR1	R939Q	R	939	Q	-	neutral	AC/AN:0.18491 ; Hom/AC:0.05437	gnomAD
P14616	INSRR	P928L	P	928	L	-	neutral	AC/AN:0.37614 ; Hom/AC:0.08625	gnomAD
Q07002	CDK18	G67R	G	67	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q07002	CDK18	G46R	G	46	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q07002	CDK18	G67R	G	67	R	-	neutral	AC/AN:0.17997 ; Hom/AC:0.05679	gnomAD
Q14164	IKBKE	A602V	A	602	V	-	neutral	AC/AN:0.23145 ; Hom/AC:0.14858	gnomAD
Q14164	IKBKE	A517V	A	517	V	-	neutral	AC/AN:0.23145 ; Hom/AC:0.14858	gnomAD
Q14164	IKBKE	P713L	P	713	L	-	neutral	AC/AN:0.45776 ; Hom/AC:0.11190	gnomAD
Q14164	IKBKE	P628L	P	628	L	-	neutral	AC/AN:0.45776 ; Hom/AC:0.11190	gnomAD
P49137	MAPKAPK2	G51V	G	51	V	15	neutral	AC/AN:0.02575 ; Hom/AC:0.06265	gnomAD
Q96NX5	CAMK1G	V329I	V	329	I	-	neutral	AC/AN:0.42860 ; Hom/AC:0.10153	gnomAD
P51955	NEK2	N354S	N	354	S	-	neutral	AC/AN:0.35664 ; Hom/AC:0.08258	gnomAD
P51955	NEK2	N311S	N	311	S	-	neutral	AC/AN:0.35664 ; Hom/AC:0.08258	gnomAD
Q5VT25	CDC42BPA	V1304I	V	1304	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1276I	V	1276	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1317I	V	1317	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1339I	V	1339	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1223I	V	1223	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1304I	V	1304	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V202I	V	202	I	391	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V529I	V	529	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V633I	V	633	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V507I	V	507	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VT25	CDC42BPA	V1284I	V	1284	I	-	neutral	AC/AN:0.74395 ; Hom/AC:0.16889	gnomAD
Q5VST9	OBSCN	A908T	A	908	T	-	neutral	AC/AN:0.80204 ; Hom/AC:0.18220	gnomAD
Q5VST9	OBSCN	A1000T	A	1000	T	-	neutral	AC/AN:0.80204 ; Hom/AC:0.18220	gnomAD
Q5VST9	OBSCN	C170G	C	170	G	-	neutral	AC/AN:0.02710 ; Hom/AC:0.07446	gnomAD
Q5VST9	OBSCN	C1698G	C	1698	G	-	neutral	AC/AN:0.02710 ; Hom/AC:0.07446	gnomAD
Q5VST9	OBSCN	A1532V	A	1532	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A188V	A	188	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1532V	A	1532	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1716V	A	1716	V	-	neutral	AC/AN:0.67259 ; Hom/AC:0.15117	gnomAD
Q5VST9	OBSCN	A1601T	A	1601	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A257T	A	257	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A1601T	A	1601	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	A1785T	A	1785	T	-	neutral	AC/AN:0.05925 ; Hom/AC:0.07780	gnomAD
Q5VST9	OBSCN	N93D	N	93	D	-	neutral	AC/AN:0.84674 ; Hom/AC:0.18630	gnomAD
Q5VST9	OBSCN	N2674D	N	2674	D	-	neutral	AC/AN:0.84674 ; Hom/AC:0.18630	gnomAD
Q5VST9	OBSCN	R2529Q	R	2529	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R1376Q	R	1376	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R377Q	R	377	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R2529Q	R	2529	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	R2958Q	R	2958	Q	-	neutral	AC/AN:0.10895 ; Hom/AC:0.09175	gnomAD
Q5VST9	OBSCN	V2720M	V	2720	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V1567M	V	1567	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V568M	V	568	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V2720M	V	2720	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	V3149M	V	3149	M	-	neutral	AC/AN:0.66269 ; Hom/AC:0.15329	gnomAD
Q5VST9	OBSCN	R2812W	R	2812	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R1659W	R	1659	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R660W	R	660	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R2812W	R	2812	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R88W	R	88	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	R3241W	R	3241	W	-	neutral	AC/AN:0.10741 ; Hom/AC:0.07645	gnomAD
Q5VST9	OBSCN	A3300T	A	3300	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A2147T	A	2147	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A419T	A	419	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A3300T	A	3300	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A576T	A	576	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	A3729T	A	3729	T	-	neutral	AC/AN:0.66563 ; Hom/AC:0.15151	gnomAD
Q5VST9	OBSCN	E3372D	E	3372	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E2219D	E	2219	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E491D	E	491	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E3372D	E	3372	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E648D	E	648	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	E3801D	E	3801	D	-	neutral	AC/AN:0.11689 ; Hom/AC:0.09493	gnomAD
Q5VST9	OBSCN	S3373C	S	3373	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S2220C	S	2220	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S492C	S	492	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S3373C	S	3373	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S649C	S	649	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	S3802C	S	3802	C	-	neutral	AC/AN:0.11774 ; Hom/AC:0.09494	gnomAD
Q5VST9	OBSCN	T3726P	T	3726	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T2573P	T	2573	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T845P	T	845	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T3726P	T	3726	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T1002P	T	1002	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T4155P	T	4155	P	-	neutral	AC/AN:0.03822 ; Hom/AC:0.05159	gnomAD
Q5VST9	OBSCN	T1089M	T	1089	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	T1246M	T	1246	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	T4399M	T	4399	M	-	neutral	AC/AN:0.42870 ; Hom/AC:0.10311	gnomAD
Q5VST9	OBSCN	G4039R	G	4039	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G1673R	G	1673	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G1158R	G	1158	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G4039R	G	4039	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	G4996R	G	4996	R	-	neutral	AC/AN:0.94104 ; Hom/AC:0.22601	gnomAD
Q5VST9	OBSCN	H4489Q	H	4489	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H2123Q	H	2123	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H1608Q	H	1608	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H4489Q	H	4489	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	H5446Q	H	5446	Q	-	neutral	AC/AN:0.44226 ; Hom/AC:0.10041	gnomAD
Q5VST9	OBSCN	R4534H	R	4534	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R2168H	R	2168	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R1653H	R	1653	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R4534H	R	4534	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R5491H	R	5491	H	-	neutral	AC/AN:0.60081 ; Hom/AC:0.15512	gnomAD
Q5VST9	OBSCN	R4662C	R	4662	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R2296C	R	2296	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R1781C	R	1781	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R4662C	R	4662	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	R5619C	R	5619	C	-	neutral	AC/AN:0.11184 ; Hom/AC:0.09937	gnomAD
Q5VST9	OBSCN	G4666S	G	4666	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G2300S	G	2300	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G1785S	G	1785	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G4666S	G	4666	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	G5623S	G	5623	S	-	neutral	AC/AN:0.43487 ; Hom/AC:0.10504	gnomAD
Q5VST9	OBSCN	L5269V	L	5269	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L2903V	L	2903	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L2388V	L	2388	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L5269V	L	5269	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	L6226V	L	6226	V	-	neutral	AC/AN:0.85074 ; Hom/AC:0.19160	gnomAD
Q5VST9	OBSCN	R5575H	R	5575	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R3209H	R	3209	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R2694H	R	2694	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R5575H	R	5575	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R191H	R	191	H	-	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R6532H	R	6532	H	212	neutral	AC/AN:0.30265 ; Hom/AC:0.07811	gnomAD
Q5VST9	OBSCN	R6535H	R	6535	H	257	neutral	AC/AN:0.28423 ; Hom/AC:0.08382	gnomAD
Q5VST9	OBSCN	R3654H	R	3654	H	-	neutral	AC/AN:0.28423 ; Hom/AC:0.08382	gnomAD
Q5VST9	OBSCN	P3905S	P	3905	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P6271S	P	6271	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P888S	P	888	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	P7228S	P	7228	S	-	neutral	AC/AN:0.28400 ; Hom/AC:0.08446	gnomAD
Q5VST9	OBSCN	R5358H	R	5358	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R7724H	R	7724	H	186	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R2341H	R	2341	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5VST9	OBSCN	R8681H	R	8681	H	-	neutral	AC/AN:0.28187 ; Hom/AC:0.08216	gnomAD
Q5TCX8	MAP3K21	R4P	R	4	P	-	neutral	AC/AN:0.33969 ; Hom/AC:0.07865	gnomAD
Q5TCX8	MAP3K21	V174I	V	174	I	178	neutral	AC/AN:0.52460 ; Hom/AC:0.13173	gnomAD
Q5TCX8	MAP3K21	V728I	V	728	I	-	neutral	AC/AN:0.52460 ; Hom/AC:0.13173	gnomAD
Q5TCX8	MAP3K21	E187D	E	187	D	207	neutral	AC/AN:0.53157 ; Hom/AC:0.13261	gnomAD
Q5TCX8	MAP3K21	E741D	E	741	D	-	neutral	AC/AN:0.53157 ; Hom/AC:0.13261	gnomAD
Q5TCX8	MAP3K21	C230G	C	230	G	315	neutral	AC/AN:0.53060 ; Hom/AC:0.13246	gnomAD
Q5TCX8	MAP3K21	C784G	C	784	G	-	neutral	AC/AN:0.53060 ; Hom/AC:0.13246	gnomAD
Q92519	TRIB2	P192L	P	192	L	-	neutral	AC/AN:0.58348 ; Hom/AC:0.16331	gnomAD
Q86Y07	VRK2	I167V	I	167	V	391	neutral	AC/AN:0.82320 ; Hom/AC:0.19039	gnomAD
Q86Y07	VRK2	I144V	I	144	V	347	neutral	AC/AN:0.82320 ; Hom/AC:0.19039	gnomAD
O96017	CHEK2	Q142H	Q	142	H	-	neutral	AC/AN:0.41254 ; Hom/AC:0.09122	gnomAD
O96017	CHEK2	Q114H	Q	114	H	-	neutral	AC/AN:0.41254 ; Hom/AC:0.09122	gnomAD
O96017	CHEK2	R844K	R	844	K	-	neutral	AC/AN:0.13897 ; Hom/AC:0.17763	gnomAD
O96017	CHEK2	R816K	R	816	K	-	neutral	AC/AN:0.13897 ; Hom/AC:0.17763	gnomAD
Q9NZJ5	EIF2AK3	S136C	S	136	C	-	neutral	AC/AN:0.69543 ; Hom/AC:0.16740	gnomAD
Q04912	MST1R	P6S	P	6	S	-	neutral	AC/AN:0.53927 ; Hom/AC:0.12401	gnomAD
Q12866	MERTK	S118N	S	118	N	-	neutral	AC/AN:0.53107 ; Hom/AC:0.12978	gnomAD
Q56UN5	MAP3K19	Q1104H	Q	1104	H	168	neutral	AC/AN:0.09665 ; Hom/AC:0.12886	gnomAD
Q56UN5	MAP3K19	I1100T	I	1100	T	144	neutral	AC/AN:0.53365 ; Hom/AC:0.13918	gnomAD
Q56UN5	MAP3K19	E699G	E	699	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E812G	E	812	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E829G	E	829	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E202G	E	202	G	-	neutral	AC/AN:0.09872 ; Hom/AC:0.12888	gnomAD
Q56UN5	MAP3K19	E563Q	E	563	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E676Q	E	676	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E693Q	E	693	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	E66Q	E	66	Q	-	neutral	AC/AN:0.12096 ; Hom/AC:0.11969	gnomAD
Q56UN5	MAP3K19	T325I	T	325	I	-	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	T438I	T	438	I	177	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	T455I	T	455	I	-	neutral	AC/AN:0.36705 ; Hom/AC:0.09217	gnomAD
Q56UN5	MAP3K19	R22Q	R	22	Q	-	neutral	AC/AN:0.31725 ; Hom/AC:0.10032	gnomAD
Q8NER5	ACVR1C	I482V	I	482	V	798	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I402V	I	402	V	598	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I325V	I	325	V	392	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8NER5	ACVR1C	I432V	I	432	V	651	neutral	AC/AN:0.18845 ; Hom/AC:0.08766	gnomAD
Q8WXR4	MYO3B	K318E	K	318	E	819	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	K309E	K	309	E	810	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	K318E	K	318	E	819	neutral	AC/AN:0.86863 ; Hom/AC:0.19954	gnomAD
Q8WXR4	MYO3B	E782G	E	782	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q8WXR4	MYO3B	E773G	E	773	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q8WXR4	MYO3B	E782G	E	782	G	-	neutral	AC/AN:0.78665 ; Hom/AC:0.18424	gnomAD
Q9NYL2	MAP3K20	S531L	S	531	L	-	neutral	AC/AN:0.88270 ; Hom/AC:0.21935	gnomAD
Q9NYL2	MAP3K20	Y773H	Y	773	H	-	neutral	AC/AN:0.27452 ; Hom/AC:0.08167	gnomAD
Q9NRP7	STK36	K295R	K	295	R	-	neutral	AC/AN:0.17886 ; Hom/AC:0.07738	gnomAD
Q9NRP7	STK36	D415E	D	415	E	-	neutral	AC/AN:0.02774 ; Hom/AC:0.05272	gnomAD
Q9NRP7	STK36	R583Q	R	583	Q	-	neutral	AC/AN:0.94937 ; Hom/AC:0.22110	gnomAD
Q9NRP7	STK36	G1003D	G	1003	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	G982D	G	982	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	G1003D	G	1003	D	-	neutral	AC/AN:0.73373 ; Hom/AC:0.17971	gnomAD
Q9NRP7	STK36	V1004I	V	1004	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	V983I	V	983	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	V1004I	V	1004	I	-	neutral	AC/AN:0.03684 ; Hom/AC:0.10022	gnomAD
Q9NRP7	STK36	C1231G	C	1231	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q9NRP7	STK36	C1210G	C	1210	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q9NRP7	STK36	C1231G	C	1231	G	-	neutral	AC/AN:0.03571 ; Hom/AC:0.09701	gnomAD
Q96RG2	PASK	F1266C	F	1266	C	809	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1273C	F	1273	C	816	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1266C	F	1266	C	809	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1050C	F	1050	C	173	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	F1080C	F	1080	C	266	neutral	AC/AN:0.43830 ; Hom/AC:0.14673	gnomAD
Q96RG2	PASK	V1210M	V	1210	M	667	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1217M	V	1217	M	677	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1210M	V	1210	M	667	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V994M	V	994	M	26	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	V1024M	V	1024	M	118	neutral	AC/AN:0.02414 ; Hom/AC:0.05497	gnomAD
Q96RG2	PASK	R1130W	R	1130	W	392	neutral	AC/AN:0.38520 ; Hom/AC:0.12259	gnomAD
Q96RG2	PASK	P844Q	P	844	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	P628Q	P	628	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	P658Q	P	658	Q	-	neutral	AC/AN:0.02089 ; Hom/AC:0.05821	gnomAD
Q96RG2	PASK	G725D	G	725	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	G509D	G	509	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	G539D	G	539	D	-	neutral	AC/AN:0.12743 ; Hom/AC:0.10935	gnomAD
Q96RG2	PASK	L514S	L	514	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	L298S	L	298	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	L328S	L	328	S	-	neutral	AC/AN:0.12782 ; Hom/AC:0.11020	gnomAD
Q96RG2	PASK	V250I	V	250	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V34I	V	34	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V65I	V	65	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V34I	V	34	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	V64I	V	64	I	-	neutral	AC/AN:0.72801 ; Hom/AC:0.16954	gnomAD
Q96RG2	PASK	M2T	M	2	T	-	neutral	AC/AN:0.67814 ; Hom/AC:0.16549	gnomAD
O43187	IRAK2	L392V	L	392	V	-	neutral	AC/AN:0.84552 ; Hom/AC:0.19761	gnomAD
Q6ZWH5	NEK10	R190K	R	190	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R275K	R	275	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R190K	R	190	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	R878K	R	878	K	-	neutral	AC/AN:0.05080 ; Hom/AC:0.13407	gnomAD
Q6ZWH5	NEK10	L513S	L	513	S	25	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
Q6ZWH5	NEK10	L46S	L	46	S	-	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
Q6ZWH5	NEK10	L513S	L	513	S	25	neutral	AC/AN:0.61446 ; Hom/AC:0.14507	gnomAD
O95747	OXSR1	T304I	T	304	I	807	neutral	AC/AN:0.28958 ; Hom/AC:0.08938	gnomAD
Q96C45	ULK4	V851I	V	851	I	-	neutral	AC/AN:0.44023 ; Hom/AC:0.11698	gnomAD
Q96C45	ULK4	L844M	L	844	M	-	neutral	AC/AN:0.44025 ; Hom/AC:0.11695	gnomAD
Q96C45	ULK4	A715T	A	715	T	-	neutral	AC/AN:0.28332 ; Hom/AC:0.07451	gnomAD
Q96C45	ULK4	L603S	L	603	S	-	neutral	AC/AN:0.04579 ; Hom/AC:0.08910	gnomAD
Q96C45	ULK4	K569R	K	569	R	-	neutral	AC/AN:0.38652 ; Hom/AC:0.09233	gnomAD
Q96C45	ULK4	S417P	S	417	P	-	neutral	AC/AN:0.03465 ; Hom/AC:0.05185	gnomAD
Q96C45	ULK4	S348G	S	348	G	-	neutral	AC/AN:0.28457 ; Hom/AC:0.07394	gnomAD
P17948	FLT1	E579D	E	579	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E577D	E	577	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E535D	E	535	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	E566D	E	566	D	-	neutral	AC/AN:0.74825 ; Hom/AC:0.17024	gnomAD
P17948	FLT1	A193V	A	193	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	A149V	A	149	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	A180V	A	180	V	-	neutral	AC/AN:0.03080 ; Hom/AC:0.08487	gnomAD
P17948	FLT1	K47R	K	47	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K3R	K	3	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K47R	K	47	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K3R	K	3	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K58R	K	58	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	K34R	K	34	R	-	neutral	AC/AN:0.94348 ; Hom/AC:0.23473	gnomAD
P17948	FLT1	A29T	A	29	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
P17948	FLT1	A40T	A	40	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
P17948	FLT1	A16T	A	16	T	-	neutral	AC/AN:0.77747 ; Hom/AC:0.17612	gnomAD
Q04912	MST1R	R1335G	R	1335	G	785	neutral	AC/AN:0.93778 ; Hom/AC:0.22976	gnomAD
Q04912	MST1R	R1286G	R	1286	G	615	neutral	AC/AN:0.93778 ; Hom/AC:0.22976	gnomAD
Q04912	MST1R	T957M	T	957	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	T908M	T	908	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	T4M	T	4	M	-	neutral	AC/AN:0.03918 ; Hom/AC:0.07053	gnomAD
Q04912	MST1R	Q523R	Q	523	R	-	neutral	AC/AN:0.93542 ; Hom/AC:0.22897	gnomAD
P51957	NEK4	P225A	P	225	A	673	neutral	AC/AN:0.86579 ; Hom/AC:0.20498	gnomAD
P51957	NEK4	P136A	P	136	A	395	neutral	AC/AN:0.86579 ; Hom/AC:0.20498	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K481R	K	481	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K448R	K	448	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K174R	K	174	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K448R	K	448	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K236R	K	236	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K464R	K	464	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K481R	K	481	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K17R	K	17	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K53R	K	53	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	K344R	K	344	R	-	neutral	AC/AN:0.64890 ; Hom/AC:0.16830	gnomAD
Q7Z7A4	PXK	A518V	A	518	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A535V	A	535	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A502V	A	502	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A269V	A	269	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
Q7Z7A4	PXK	A398V	A	398	V	-	neutral	AC/AN:0.66327 ; Hom/AC:0.16779	gnomAD
P29320	EPHA3	W924R	W	924	R	-	neutral	AC/AN:0.85065 ; Hom/AC:0.20128	gnomAD
Q9UF33	EPHA6	A805V	A	805	V	397	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q9UF33	EPHA6	A171V	A	171	V	-	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q9UF33	EPHA6	A197V	A	197	V	-	neutral	AC/AN:0.06660 ; Hom/AC:0.07642	gnomAD
Q32MK0	MYLK3	T1016A	T	1016	A	-	neutral	AC/AN:0.03485 ; Hom/AC:0.09074	gnomAD
Q32MK0	MYLK3	T1085A	T	1085	A	-	neutral	AC/AN:0.03485 ; Hom/AC:0.09074	gnomAD
Q32MK0	MYLK3	D845E	D	845	E	-	neutral	AC/AN:0.23416 ; Hom/AC:0.16471	gnomAD
Q32MK0	MYLK3	D914E	D	914	E	-	neutral	AC/AN:0.23416 ; Hom/AC:0.16471	gnomAD
Q32MK0	MYLK3	L792P	L	792	P	816	neutral	AC/AN:0.26460 ; Hom/AC:0.16671	gnomAD
Q32MK0	MYLK3	L861P	L	861	P	-	neutral	AC/AN:0.26460 ; Hom/AC:0.16671	gnomAD
Q32MK0	MYLK3	V261A	V	261	A	-	neutral	AC/AN:0.27866 ; Hom/AC:0.18212	gnomAD
Q32MK0	MYLK3	A128V	A	128	V	-	neutral	AC/AN:0.03933 ; Hom/AC:0.06602	gnomAD
Q32MK0	MYLK3	P21H	P	21	H	-	neutral	AC/AN:0.27173 ; Hom/AC:0.09004	gnomAD
Q8NG66	NEK11	V562A	V	562	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V378A	V	378	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V562A	V	562	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
Q8NG66	NEK11	V457A	V	457	A	-	neutral	AC/AN:0.24293 ; Hom/AC:0.09014	gnomAD
P34925	RYK	S97N	S	97	N	-	neutral	AC/AN:0.37431 ; Hom/AC:0.10848	gnomAD
P34925	RYK	S79N	S	79	N	-	neutral	AC/AN:0.37431 ; Hom/AC:0.10848	gnomAD
Q8WTQ7	GRK7	P460T	P	460	T	811	neutral	AC/AN:0.21528 ; Hom/AC:0.05844	gnomAD
P32298	GRK4	R33L	R	33	L	-	neutral	AC/AN:0.74135 ; Hom/AC:0.17757	gnomAD
P32298	GRK4	R65L	R	65	L	-	neutral	AC/AN:0.74135 ; Hom/AC:0.17757	gnomAD
P32298	GRK4	A110V	A	110	V	-	neutral	AC/AN:0.83615 ; Hom/AC:0.19953	gnomAD
P32298	GRK4	A142V	A	142	V	-	neutral	AC/AN:0.83615 ; Hom/AC:0.19953	gnomAD
Q9NY57	STK32B	R198G	R	198	G	566	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
Q9NY57	STK32B	R151G	R	151	G	395	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
Q9NY57	STK32B	R121G	R	121	G	325	neutral	AC/AN:0.42116 ; Hom/AC:0.13069	gnomAD
P16234	PDGFRA	S478P	S	478	P	-	neutral	AC/AN:0.35425 ; Hom/AC:0.09483	gnomAD
Q9NSY1	BMP2K	G405S	G	405	S	-	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	G98S	G	98	S	178	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	G405S	G	405	S	-	neutral	AC/AN:0.13986 ; Hom/AC:0.05445	gnomAD
Q9NSY1	BMP2K	T1002S	T	1002	S	-	neutral	AC/AN:0.24667 ; Hom/AC:0.06889	gnomAD
Q9NSY1	BMP2K	T695S	T	695	S	-	neutral	AC/AN:0.24667 ; Hom/AC:0.06889	gnomAD
Q8TEA7	TBCK	M471I	M	471	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M408I	M	408	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M432I	M	432	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
Q8TEA7	TBCK	M471I	M	471	I	-	neutral	AC/AN:0.36736 ; Hom/AC:0.08991	gnomAD
P17948	FLT1	R431K	R	431	K	-	neutral	AC/AN:0.22562 ; Hom/AC:0.06369	gnomAD
P17948	FLT1	R389K	R	389	K	-	neutral	AC/AN:0.22562 ; Hom/AC:0.06369	gnomAD
Q96QP1	ALPK1	N175D	N	175	D	-	neutral	AC/AN:0.17690 ; Hom/AC:0.05013	gnomAD
Q96QP1	ALPK1	N97D	N	97	D	-	neutral	AC/AN:0.17690 ; Hom/AC:0.05013	gnomAD
Q8NG66	NEK11	E724G	E	724	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E752G	E	752	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E680G	E	680	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E708G	E	708	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q8NG66	NEK11	E655G	E	655	G	-	neutral	AC/AN:0.23062 ; Hom/AC:0.05435	gnomAD
Q9BVS4	RIOK2	S96C	S	96	C	-	neutral	AC/AN:0.93360 ; Hom/AC:0.21306	gnomAD
P09619	PDGFRB	I29F	I	29	F	-	neutral	AC/AN:0.08611 ; Hom/AC:0.07243	gnomAD
P22455	FGFR4	V10I	V	10	I	-	neutral	AC/AN:0.56547 ; Hom/AC:0.14421	gnomAD
P22455	FGFR4	G388R	G	388	R	-	neutral	AC/AN:0.74806 ; Hom/AC:0.17306	gnomAD
P22455	FGFR4	G24R	G	24	R	-	neutral	AC/AN:0.74806 ; Hom/AC:0.17306	gnomAD
P35916	FLT4	R1146H	R	1146	H	759	neutral	AC/AN:0.17164 ; Hom/AC:0.05167	gnomAD
P35916	FLT4	T494A	T	494	A	-	neutral	AC/AN:0.20288 ; Hom/AC:0.05594	gnomAD
Q86YV6	MYLK4	T242M	T	242	M	438	neutral	AC/AN:0.48346 ; Hom/AC:0.12862	gnomAD
Q86YV6	MYLK4	T126M	T	126	M	87	neutral	AC/AN:0.21370 ; Hom/AC:0.06049	gnomAD
Q86YV6	MYLK4	G50R	G	50	R	-	neutral	AC/AN:0.37657 ; Hom/AC:0.10323	gnomAD
Q08345	DDR1	P200L	P	200	L	-	neutral	AC/AN:0.37402 ; Hom/AC:0.08951	gnomAD
Q08345	DDR1	P265L	P	265	L	-	neutral	AC/AN:0.37402 ; Hom/AC:0.08951	gnomAD
P49842	STK19	S307G	S	307	G	-	neutral	AC/AN:0.22949 ; Hom/AC:0.09947	gnomAD
P49842	STK19	S311G	S	311	G	-	neutral	AC/AN:0.22949 ; Hom/AC:0.09947	gnomAD
P25440	BRD2	D647N	D	647	N	-	neutral	AC/AN:0.49802 ; Hom/AC:0.11905	gnomAD
Q13308	PTK7	Y455C	Y	455	C	-	neutral	AC/AN:0.09810 ; Hom/AC:0.11354	gnomAD
Q5TCY1	TTBK1	G623A	G	623	A	-	neutral	AC/AN:0.74211 ; Hom/AC:0.16051	gnomAD
Q5TCY1	TTBK1	G572A	G	572	A	-	neutral	AC/AN:0.74211 ; Hom/AC:0.16051	gnomAD
Q5TCY1	TTBK1	K1145R	K	1145	R	-	neutral	AC/AN:0.55516 ; Hom/AC:0.12768	gnomAD
Q5TCY1	TTBK1	L1184S	L	1184	S	-	neutral	AC/AN:0.60008 ; Hom/AC:0.13796	gnomAD
Q96GD4	AURKB	Q293P	Q	293	P	677	neutral	AC/AN:0.54833 ; Hom/AC:0.12910	gnomAD
Q96GD4	AURKB	C491R	C	491	R	-	neutral	AC/AN:0.45967 ; Hom/AC:0.11020	gnomAD
Q96GD4	AURKB	C1395Y	C	1395	Y	-	neutral	AC/AN:0.60798 ; Hom/AC:0.14704	gnomAD
Q96GD4	AURKB	C214Y	C	214	Y	439	neutral	AC/AN:0.60798 ; Hom/AC:0.14704	gnomAD
Q96GD4	AURKB	T1445S	T	1445	S	-	neutral	AC/AN:0.03661 ; Hom/AC:0.07669	gnomAD
Q96GD4	AURKB	T264S	T	264	S	592	neutral	AC/AN:0.03661 ; Hom/AC:0.07669	gnomAD
O95835	LATS1	S8L	S	8	L	-	neutral	AC/AN:0.90877 ; Hom/AC:0.21350	gnomAD
Q9BQI3	EIF2AK1	K558R	K	558	R	759	neutral	AC/AN:0.20765 ; Hom/AC:0.08619	gnomAD
Q9BQI3	EIF2AK1	K434R	K	434	R	368	neutral	AC/AN:0.20765 ; Hom/AC:0.08619	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q71H	Q	71	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q71H	Q	71	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	Q48H	Q	48	H	-	neutral	AC/AN:0.64700 ; Hom/AC:0.15118	gnomAD
Q9BXU1	STK31	E238K	E	238	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E261K	E	261	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E238K	E	238	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	E261K	E	261	K	-	neutral	AC/AN:0.30369 ; Hom/AC:0.08036	gnomAD
Q9BXU1	STK31	K245N	K	245	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K268N	K	268	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K245N	K	245	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	K268N	K	268	N	-	neutral	AC/AN:0.30488 ; Hom/AC:0.07959	gnomAD
Q9BXU1	STK31	G387E	G	387	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G410E	G	410	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G387E	G	387	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	G410E	G	410	E	-	neutral	AC/AN:0.45230 ; Hom/AC:0.12705	gnomAD
Q9BXU1	STK31	N598K	N	598	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N621K	N	621	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N598K	N	598	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	N621K	N	621	K	-	neutral	AC/AN:0.34834 ; Hom/AC:0.08943	gnomAD
Q9BXU1	STK31	S600I	S	600	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S623I	S	623	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S600I	S	600	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q9BXU1	STK31	S623I	S	623	I	-	neutral	AC/AN:0.26899 ; Hom/AC:0.06871	gnomAD
Q14004	CDK13	T500A	T	500	A	-	neutral	AC/AN:0.30609 ; Hom/AC:0.09793	gnomAD
Q13554	CAMK2B	E510K	E	510	K	-	neutral	AC/AN:0.15426 ; Hom/AC:0.05213	gnomAD
P17948	FLT1	R521K	R	521	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	R468K	R	468	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	R476K	R	476	K	-	neutral	AC/AN:0.67141 ; Hom/AC:0.16124	gnomAD
P17948	FLT1	S703F	S	703	F	-	neutral	AC/AN:0.02038 ; Hom/AC:0.05628	gnomAD
Q8IWU2	LMTK2	P30A	P	30	A	-	neutral	AC/AN:0.18442 ; Hom/AC:0.05710	gnomAD
Q8IWU2	LMTK2	I693T	I	693	T	-	neutral	AC/AN:0.21838 ; Hom/AC:0.12574	gnomAD
Q8IWU2	LMTK2	L780M	L	780	M	-	neutral	AC/AN:0.92301 ; Hom/AC:0.24054	gnomAD
Q7Z695	ADCK2	S66G	S	66	G	-	neutral	AC/AN:0.39950 ; Hom/AC:0.14159	gnomAD
Q7Z695	ADCK2	S307P	S	307	P	-	neutral	AC/AN:0.39557 ; Hom/AC:0.14298	gnomAD
Q7Z695	ADCK2	S145P	S	145	P	-	neutral	AC/AN:0.39557 ; Hom/AC:0.14298	gnomAD
Q7Z695	ADCK2	P622L	P	622	L	-	neutral	AC/AN:0.23721 ; Hom/AC:0.06555	gnomAD
Q7Z695	ADCK2	P219L	P	219	L	-	neutral	AC/AN:0.23721 ; Hom/AC:0.06555	gnomAD
Q86YV5	PRAG1	A1111T	A	1111	T	-	neutral	AC/AN:0.74111 ; Hom/AC:0.18421	gnomAD
Q86YV5	PRAG1	S576C	S	576	C	-	neutral	AC/AN:0.88740 ; Hom/AC:0.21616	gnomAD
Q86YV5	PRAG1	P567L	P	567	L	-	neutral	AC/AN:0.88968 ; Hom/AC:0.21494	gnomAD
Q86YV5	PRAG1	R402Q	R	402	Q	-	neutral	AC/AN:0.90168 ; Hom/AC:0.21785	gnomAD
Q96KB5	PBK	N107S	N	107	S	255	neutral	AC/AN:0.32802 ; Hom/AC:0.09946	gnomAD
P78527	PRKDC	I3433T	I	3433	T	-	neutral	AC/AN:0.27397 ; Hom/AC:0.11109	gnomAD
Q96QS6	PSKH2	I336V	I	336	V	810	neutral	AC/AN:0.04316 ; Hom/AC:0.05421	gnomAD
Q96QS6	PSKH2	A176S	A	176	S	371	neutral	AC/AN:0.79559 ; Hom/AC:0.18327	gnomAD
Q96QS6	PSKH2	Q132R	Q	132	R	259	neutral	AC/AN:0.05584 ; Hom/AC:0.12670	gnomAD
Q14289	PTK2B	T84A	T	84	A	-	neutral	AC/AN:0.50714 ; Hom/AC:0.13434	gnomAD
Q8TD08	MAPK15	R247T	R	247	T	687	neutral	AC/AN:0.57367 ; Hom/AC:0.14986	gnomAD
Q9Y6S9	RPS6KL1	L86F	L	86	F	-	neutral	AC/AN:0.23735 ; Hom/AC:0.06319	gnomAD
P22612	PRKACG	H268D	H	268	D	759	neutral	AC/AN:0.61603 ; Hom/AC:0.14507	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1579E	K	1579	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1579E	K	1579	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	K1584E	K	1584	E	-	neutral	AC/AN:0.46122 ; Hom/AC:0.12331	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1388I	V	1388	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1388I	V	1388	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
Q9BX84	TRPM6	V1393I	V	1393	I	-	neutral	AC/AN:0.27206 ; Hom/AC:0.07692	gnomAD
P53355	DAPK1	V416I	V	416	I	-	neutral	AC/AN:0.05390 ; Hom/AC:0.14139	gnomAD
Q9Y3S1	WNK2	P865S	P	865	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P477S	P	477	S	818	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P865S	P	865	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P469S	P	469	S	810	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P477S	P	477	S	818	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	P861S	P	861	S	-	neutral	AC/AN:0.11936 ; Hom/AC:0.09781	gnomAD
Q9Y3S1	WNK2	Q1112H	Q	1112	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q724H	Q	724	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q1112H	Q	1112	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q716H	Q	716	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q724H	Q	724	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
Q9Y3S1	WNK2	Q1108H	Q	1108	H	-	neutral	AC/AN:0.02257 ; Hom/AC:0.05931	gnomAD
O15146	MUSK	S159G	S	159	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	S41G	S	41	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	S159G	S	159	G	-	neutral	AC/AN:0.35365 ; Hom/AC:0.08511	gnomAD
O15146	MUSK	M413I	M	413	I	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	G5R	G	5	R	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	M413I	M	413	I	-	neutral	AC/AN:0.27468 ; Hom/AC:0.07129	gnomAD
O15146	MUSK	V829L	V	829	L	753	neutral	AC/AN:0.09976 ; Hom/AC:0.06078	gnomAD
O15146	MUSK	V821L	V	821	L	671	neutral	AC/AN:0.09976 ; Hom/AC:0.06078	gnomAD
Q8NE28	STKLD1	L212R	L	212	R	-	neutral	AC/AN:0.18577 ; Hom/AC:0.05128	gnomAD
Q8NE28	STKLD1	L679R	L	679	R	-	neutral	AC/AN:0.18577 ; Hom/AC:0.05128	gnomAD
Q04759	PRKCQ	P330L	P	330	L	-	neutral	AC/AN:0.70198 ; Hom/AC:0.16660	gnomAD
Q04759	PRKCQ	P205L	P	205	L	-	neutral	AC/AN:0.70198 ; Hom/AC:0.16660	gnomAD
Q8NEV4	MYO3A	T1284S	T	1284	S	-	neutral	AC/AN:0.94533 ; Hom/AC:0.20955	gnomAD
Q96GX5	MASTL	P620A	P	620	A	-	neutral	AC/AN:0.18856 ; Hom/AC:0.05252	gnomAD
P36894	BMPR1A	P2T	P	2	T	-	neutral	AC/AN:0.82175 ; Hom/AC:0.21004	gnomAD
P34947	GRK5	Q41L	Q	41	L	-	neutral	AC/AN:0.08627 ; Hom/AC:0.07515	gnomAD
P34947	GRK5	R199H	R	199	H	44	neutral	AC/AN:0.24990 ; Hom/AC:0.06885	gnomAD
P34947	GRK5	R304H	R	304	H	371	neutral	AC/AN:0.24990 ; Hom/AC:0.06885	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M71T	M	71	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M97T	M	97	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M71T	M	71	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
P21802	FGFR2	M186T	M	186	T	-	neutral	AC/AN:0.10441 ; Hom/AC:0.09481	gnomAD
Q86UX6	STK32C	S136R	S	136	R	170	neutral	AC/AN:0.77222 ; Hom/AC:0.18168	gnomAD
Q86UX6	STK32C	S136N	S	136	N	170	neutral	AC/AN:0.77195 ; Hom/AC:0.18174	gnomAD
Q86UX6	STK32C	G67R	G	67	R	5	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G72R	G	72	R	10	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G35R	G	35	R	-	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	G69R	G	69	R	7	neutral	AC/AN:0.75404 ; Hom/AC:0.17771	gnomAD
Q86UX6	STK32C	H62Y	H	62	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H67Y	H	67	Y	5	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H30Y	H	30	Y	-	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	H64Y	H	64	Y	2	neutral	AC/AN:0.47884 ; Hom/AC:0.12558	gnomAD
Q86UX6	STK32C	V17F	V	17	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	V22F	V	22	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	V19F	V	19	F	-	neutral	AC/AN:0.34311 ; Hom/AC:0.09835	gnomAD
Q86UX6	STK32C	A15E	A	15	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	A20E	A	20	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	A17E	A	17	E	-	neutral	AC/AN:0.77365 ; Hom/AC:0.17863	gnomAD
Q86UX6	STK32C	R6S	R	6	S	-	neutral	AC/AN:0.77775 ; Hom/AC:0.17652	gnomAD
Q86UX6	STK32C	R3S	R	3	S	-	neutral	AC/AN:0.77775 ; Hom/AC:0.17652	gnomAD
Q9BYT3	STK33	A437T	A	437	T	-	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A250T	A	250	T	405	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A437T	A	437	T	-	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	A396T	A	396	T	809	neutral	AC/AN:0.59503 ; Hom/AC:0.13817	gnomAD
Q9BYT3	STK33	D436E	D	436	E	-	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D249E	D	249	E	404	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D436E	D	436	E	-	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
Q9BYT3	STK33	D395E	D	395	E	808	neutral	AC/AN:0.59502 ; Hom/AC:0.13816	gnomAD
O75676	RPS6KA4	S510A	S	510	A	353	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
O75676	RPS6KA4	S758A	S	758	A	-	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
O75676	RPS6KA4	S751A	S	751	A	-	neutral	AC/AN:0.74826 ; Hom/AC:0.17949	gnomAD
Q9UBS0	RPS6KB2	A420V	A	420	V	-	neutral	AC/AN:0.95100 ; Hom/AC:0.22665	gnomAD
P54764	EPHA4	S192Y	S	192	Y	-	neutral	AC/AN:0.58429 ; Hom/AC:0.16931	gnomAD
P54764	EPHA4	R402Q	R	402	Q	-	neutral	AC/AN:0.40442 ; Hom/AC:0.11958	gnomAD
Q8NFD2	ANKK1	A239T	A	239	T	647	neutral	AC/AN:0.58205 ; Hom/AC:0.15204	gnomAD
Q8NFD2	ANKK1	G318R	G	318	R	-	neutral	AC/AN:0.89394 ; Hom/AC:0.22618	gnomAD
Q8NFD2	ANKK1	H490R	H	490	R	-	neutral	AC/AN:0.90232 ; Hom/AC:0.22154	gnomAD
Q8NFD2	ANKK1	E713K	E	713	K	-	neutral	AC/AN:0.60637 ; Hom/AC:0.15287	gnomAD
Q9Y2K2	SIK3	P1078R	P	1078	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P413R	P	413	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1136R	P	1136	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P917R	P	917	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1178R	P	1178	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1076R	P	1076	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9Y2K2	SIK3	P1018R	P	1018	R	-	neutral	AC/AN:0.43115 ; Hom/AC:0.09983	gnomAD
Q9H4A3	WNK1	A141T	A	141	T	-	neutral	AC/AN:0.27368 ; Hom/AC:0.07445	gnomAD
Q9H4A3	WNK1	L730F	L	730	F	-	neutral	AC/AN:0.29124 ; Hom/AC:0.06622	gnomAD
Q9H4A3	WNK1	M1808I	M	1808	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M1401I	M	1401	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M2306I	M	2306	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M1561I	M	1561	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q9H4A3	WNK1	M2068I	M	2068	I	-	neutral	AC/AN:0.84972 ; Hom/AC:0.19390	gnomAD
Q5S007	LRRK2	N551K	N	551	K	-	neutral	AC/AN:0.19930 ; Hom/AC:0.05437	gnomAD
Q5S007	LRRK2	N299K	N	299	K	-	neutral	AC/AN:0.19930 ; Hom/AC:0.05437	gnomAD
Q5S007	LRRK2	R1398H	R	1398	H	-	neutral	AC/AN:0.19462 ; Hom/AC:0.05171	gnomAD
Q5S007	LRRK2	S1647T	S	1647	T	-	neutral	AC/AN:0.68107 ; Hom/AC:0.15828	gnomAD
Q9NWZ3	IRAK4	A304T	A	304	T	371	neutral	AC/AN:0.26103 ; Hom/AC:0.06736	gnomAD
Q9NWZ3	IRAK4	A428T	A	428	T	754	neutral	AC/AN:0.26103 ; Hom/AC:0.06736	gnomAD
P37023	ACVRL1	Q150R	Q	150	R	-	neutral	AC/AN:0.60526 ; Hom/AC:0.13994	gnomAD
P36896	ACVR1B	R478H	R	478	H	766	neutral	AC/AN:0.02010 ; Hom/AC:0.06593	gnomAD
P21860	ERBB3	S1119C	S	1119	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S1060C	S	1060	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S476C	S	476	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S239C	S	239	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S426C	S	426	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
P21860	ERBB3	S360C	S	360	C	-	neutral	AC/AN:0.20410 ; Hom/AC:0.05165	gnomAD
Q9Y616	IRAK3	Y69C	Y	69	C	-	neutral	AC/AN:0.03741 ; Hom/AC:0.10727	gnomAD
Q92630	DYRK2	G33S	G	33	S	-	neutral	AC/AN:0.82403 ; Hom/AC:0.18641	gnomAD
Q6P3W7	SCYL2	P357L	P	357	L	824	neutral	AC/AN:0.18882 ; Hom/AC:0.05526	gnomAD
O60285	NUAK1	P543R	P	543	R	-	neutral	AC/AN:0.52323 ; Hom/AC:0.12530	gnomAD
Q96RR4	CAMKK2	R363C	R	363	C	571	neutral	AC/AN:0.43407 ; Hom/AC:0.11813	gnomAD
Q96RR4	CAMKK2	R150C	R	150	C	16	neutral	AC/AN:0.43407 ; Hom/AC:0.11813	gnomAD
Q96RR4	CAMKK2	T85S	T	85	S	-	neutral	AC/AN:0.85910 ; Hom/AC:0.19908	gnomAD
O75385	ULK1	P714L	P	714	L	-	neutral	AC/AN:0.58519 ; Hom/AC:0.15904	gnomAD
O75385	ULK1	P62L	P	62	L	174	neutral	AC/AN:0.58519 ; Hom/AC:0.15904	gnomAD
P36888	FLT3	V557I	V	557	I	-	neutral	AC/AN:0.02931 ; Hom/AC:0.06737	gnomAD
Q6P3R8	NEK5	K255Q	K	255	Q	790	neutral	AC/AN:0.24489 ; Hom/AC:0.05968	gnomAD
P51956	NEK3	E305D	E	305	D	-	neutral	AC/AN:0.06119 ; Hom/AC:0.06370	gnomAD
Q6SA08	TSSK4	Q196R	Q	196	R	512	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q206R	Q	206	R	533	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q13R	Q	13	R	19	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q6SA08	TSSK4	Q120R	Q	120	R	320	neutral	AC/AN:0.02466 ; Hom/AC:0.06081	gnomAD
Q9Y572	RIPK3	P492Q	P	492	Q	-	neutral	AC/AN:0.16834 ; Hom/AC:0.05392	gnomAD
Q9Y4K4	MAP4K5	T633M	T	633	M	-	neutral	AC/AN:0.16070 ; Hom/AC:0.05731	gnomAD
Q9Y6S9	RPS6KL1	P121L	P	121	L	-	neutral	AC/AN:0.81677 ; Hom/AC:0.19701	gnomAD
Q9Y6S9	RPS6KL1	R21Q	R	21	Q	-	neutral	AC/AN:0.86426 ; Hom/AC:0.20025	gnomAD
P27448	MARK3	S427G	S	427	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S466G	S	466	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S364G	S	364	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S443G	S	443	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S195G	S	195	G	442	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
P27448	MARK3	S22G	S	22	G	-	neutral	AC/AN:0.02478 ; Hom/AC:0.07618	gnomAD
Q9P2K8	EIF2AK4	I441L	I	441	L	441	neutral	AC/AN:0.34468 ; Hom/AC:0.12393	gnomAD
Q9P2K8	EIF2AK4	I247L	I	247	L	-	neutral	AC/AN:0.34468 ; Hom/AC:0.12393	gnomAD
Q9P2K8	EIF2AK4	G1306C	G	1306	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
Q9P2K8	EIF2AK4	G1278C	G	1278	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
Q9P2K8	EIF2AK4	G1084C	G	1084	C	-	neutral	AC/AN:0.29725 ; Hom/AC:0.08067	gnomAD
O60566	BUB1B	E390D	E	390	D	-	neutral	AC/AN:0.02027 ; Hom/AC:0.05230	gnomAD
O60566	BUB1B	E404D	E	404	D	-	neutral	AC/AN:0.02027 ; Hom/AC:0.05230	gnomAD
O60566	BUB1B	V618A	V	618	A	-	neutral	AC/AN:0.04698 ; Hom/AC:0.11829	gnomAD
O60566	BUB1B	V632A	V	632	A	-	neutral	AC/AN:0.04698 ; Hom/AC:0.11829	gnomAD
Q9NQU5	PAK6	M76V	M	76	V	-	neutral	AC/AN:0.23993 ; Hom/AC:0.07146	gnomAD
Q9NQU5	PAK6	H215R	H	215	R	-	neutral	AC/AN:0.24160 ; Hom/AC:0.07235	gnomAD
Q9NQU5	PAK6	P337L	P	337	L	-	neutral	AC/AN:0.25976 ; Hom/AC:0.06671	gnomAD
Q9NYL2	MAP3K20	R42Q	R	42	Q	123	neutral	AC/AN:0.29857 ; Hom/AC:0.08764	gnomAD
Q06418	TYRO3	I346N	I	346	N	-	neutral	AC/AN:0.51627 ; Hom/AC:0.09405	gnomAD
Q06418	TYRO3	I301N	I	301	N	-	neutral	AC/AN:0.51627 ; Hom/AC:0.09405	gnomAD
Q6IQ55	TTBK2	L8P	L	8	P	17	neutral	AC/AN:0.84471 ; Hom/AC:0.21104	gnomAD
Q96QT4	TRPM7	T1482I	T	1482	I	-	neutral	AC/AN:0.19439 ; Hom/AC:0.05027	gnomAD
Q9UIK4	DAPK2	L483V	L	483	V	-	neutral	AC/AN:0.98972 ; Hom/AC:0.21626	gnomAD
Q9UIK4	DAPK2	L470V	L	470	V	-	neutral	AC/AN:0.33979 ; Hom/AC:0.08438	gnomAD
Q9C098	DCLK3	A113T	A	113	T	-	neutral	AC/AN:0.70345 ; Hom/AC:0.21569	gnomAD
Q9C098	DCLK3	R78H	R	78	H	-	neutral	AC/AN:0.25273 ; Hom/AC:0.13254	gnomAD
Q9H792	PEAK1	S1542T	S	1542	T	-	neutral	AC/AN:0.58122 ; Hom/AC:0.13301	gnomAD
Q9H792	PEAK1	R1071K	R	1071	K	-	neutral	AC/AN:0.67941 ; Hom/AC:0.16475	gnomAD
Q96L96	ALPK3	T414S	T	414	S	-	neutral	AC/AN:0.50062 ; Hom/AC:0.12335	gnomAD
Q96L96	ALPK3	G579E	G	579	E	-	neutral	AC/AN:0.50076 ; Hom/AC:0.12352	gnomAD
Q96L96	ALPK3	L1622P	L	1622	P	-	neutral	AC/AN:0.52730 ; Hom/AC:0.12506	gnomAD
Q38SD2	LRRK1	G1935D	G	1935	D	-	neutral	AC/AN:0.70979 ; Hom/AC:0.15950	gnomAD
Q38SD2	LRRK1	G1938D	G	1938	D	-	neutral	AC/AN:0.70979 ; Hom/AC:0.15950	gnomAD
Q99640	PKMYT1	A566V	A	566	V	-	neutral	AC/AN:0.09027 ; Hom/AC:0.09120	gnomAD
Q76MJ5	ERN2	S535T	S	535	T	46	neutral	AC/AN:0.71508 ; Hom/AC:0.17247	gnomAD
Q76MJ5	ERN2	S435T	S	435	T	-	neutral	AC/AN:0.71508 ; Hom/AC:0.17247	gnomAD
P05771	PRKCB	M82V	M	82	V	-	neutral	AC/AN:0.89462 ; Hom/AC:0.20452	gnomAD
Q96Q40	CDK15	P33A	P	33	A	-	neutral	AC/AN:0.17578 ; Hom/AC:0.07086	gnomAD
Q96Q40	CDK15	K30R	K	30	R	-	neutral	AC/AN:0.45365 ; Hom/AC:0.13638	gnomAD
Q8TF76	HASPIN	G204D	G	204	D	-	neutral	AC/AN:0.69072 ; Hom/AC:0.17293	gnomAD
Q8TF76	HASPIN	I328T	I	328	T	-	neutral	AC/AN:0.68735 ; Hom/AC:0.17268	gnomAD
Q8N4C8	MINK1	V834I	V	834	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q8N4C8	MINK1	V863I	V	863	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q8N4C8	MINK1	V843I	V	843	I	-	neutral	AC/AN:0.34540 ; Hom/AC:0.13589	gnomAD
Q02846	GUCY2D	A52S	A	52	S	-	neutral	AC/AN:0.96906 ; Hom/AC:0.23334	gnomAD
Q02846	GUCY2D	P701S	P	701	S	513	neutral	AC/AN:0.12048 ; Hom/AC:0.05212	gnomAD
Q02846	GUCY2D	L782H	L	782	H	759	neutral	AC/AN:0.28235 ; Hom/AC:0.09072	gnomAD
Q96J92	WNK4	A601S	A	601	S	-	neutral	AC/AN:0.08132 ; Hom/AC:0.07725	gnomAD
Q96J92	WNK4	P961S	P	961	S	-	neutral	AC/AN:0.08241 ; Hom/AC:0.07801	gnomAD
Q8IWB6	TEX14	N786D	N	786	D	-	neutral	AC/AN:0.35321 ; Hom/AC:0.09336	gnomAD
Q8IWB6	TEX14	N780D	N	780	D	-	neutral	AC/AN:0.35321 ; Hom/AC:0.09336	gnomAD
O75460	ERN1	L914M	L	914	M	-	neutral	AC/AN:0.03925 ; Hom/AC:0.07383	gnomAD
Q6ZMQ8	AATK	A1314T	A	1314	T	-	neutral	AC/AN:0.03898 ; Hom/AC:0.06171	gnomAD
Q6ZMQ8	AATK	A1211T	A	1211	T	-	neutral	AC/AN:0.03898 ; Hom/AC:0.06171	gnomAD
Q6ZMQ8	AATK	F1266S	F	1266	S	-	neutral	AC/AN:0.81421 ; Hom/AC:0.20424	gnomAD
Q6ZMQ8	AATK	F1163S	F	1163	S	-	neutral	AC/AN:0.81421 ; Hom/AC:0.20424	gnomAD
Q6ZMQ8	AATK	A541T	A	541	T	-	neutral	AC/AN:0.30812 ; Hom/AC:0.07814	gnomAD
Q6ZMQ8	AATK	A438T	A	438	T	-	neutral	AC/AN:0.30812 ; Hom/AC:0.07814	gnomAD
P31152	MAPK4	V38M	V	38	M	73	neutral	AC/AN:0.84038 ; Hom/AC:0.19592	gnomAD
Q86TB3	ALPK2	H1767Y	H	1767	Y	-	neutral	AC/AN:0.23825 ; Hom/AC:0.06351	gnomAD
Q86TB3	ALPK2	Q1579R	Q	1579	R	-	neutral	AC/AN:0.23212 ; Hom/AC:0.06395	gnomAD
Q86TB3	ALPK2	A1551S	A	1551	S	-	neutral	AC/AN:0.97477 ; Hom/AC:0.22698	gnomAD
Q86TB3	ALPK2	P1449S	P	1449	S	-	neutral	AC/AN:0.97253 ; Hom/AC:0.22663	gnomAD
Q86TB3	ALPK2	S977T	S	977	T	-	neutral	AC/AN:0.12755 ; Hom/AC:0.06292	gnomAD
Q9HBH9	MKNK2	Q10K	Q	10	K	-	neutral	AC/AN:0.22442 ; Hom/AC:0.05934	gnomAD
O43293	DAPK3	A79T	A	79	T	206	neutral	AC/AN:0.40134 ; Hom/AC:0.09191	gnomAD
P29597	TYK2	V362F	V	362	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
P29597	TYK2	V177F	V	177	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
P29597	TYK2	V362F	V	362	F	-	neutral	AC/AN:0.63083 ; Hom/AC:0.15243	gnomAD
Q16512	PKN1	A102T	A	102	T	-	neutral	AC/AN:0.06236 ; Hom/AC:0.09828	gnomAD
Q16512	PKN1	V901I	V	901	I	821	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	V907I	V	907	I	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	R109H	R	109	H	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	R158H	R	158	H	-	neutral	AC/AN:0.39210 ; Hom/AC:0.19421	gnomAD
Q16512	PKN1	H133Y	H	133	Y	-	neutral	AC/AN:0.46321 ; Hom/AC:0.12211	gnomAD
Q16512	PKN1	H182Y	H	182	Y	-	neutral	AC/AN:0.46321 ; Hom/AC:0.12211	gnomAD
Q8NE63	HIPK4	A386T	A	386	T	-	neutral	AC/AN:0.07849 ; Hom/AC:0.10832	gnomAD
Q8NE63	HIPK4	R302Q	R	302	Q	737	neutral	AC/AN:0.20750 ; Hom/AC:0.05811	gnomAD
Q6DT37	CDC42BPG	I154T	I	154	T	274	neutral	AC/AN:0.03085 ; Hom/AC:0.06897	gnomAD
Q6DT37	CDC42BPG	L423V	L	423	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L433V	L	433	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L418V	L	418	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L82V	L	82	V	42	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q6DT37	CDC42BPG	L428V	L	428	V	-	neutral	AC/AN:0.29802 ; Hom/AC:0.07912	gnomAD
Q96Q04	LMTK3	V938A	V	938	A	-	neutral	AC/AN:0.14343 ; Hom/AC:0.05289	gnomAD
Q96Q04	LMTK3	V909A	V	909	A	-	neutral	AC/AN:0.14343 ; Hom/AC:0.05289	gnomAD
Q8IV63	VRK3	S371G	S	371	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S321G	S	321	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S140G	S	140	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S67G	S	67	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S371G	S	371	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	S321G	S	321	G	-	neutral	AC/AN:0.03227 ; Hom/AC:0.08482	gnomAD
Q8IV63	VRK3	C288Y	C	288	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C238Y	C	238	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C57Y	C	57	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C288Y	C	288	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	C238Y	C	238	Y	-	neutral	AC/AN:0.03219 ; Hom/AC:0.08519	gnomAD
Q8IV63	VRK3	S268L	S	268	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S218L	S	218	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S37L	S	37	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S268L	S	268	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	S218L	S	218	L	-	neutral	AC/AN:0.03221 ; Hom/AC:0.08549	gnomAD
Q8IV63	VRK3	H21R	H	21	R	-	neutral	AC/AN:0.03164 ; Hom/AC:0.08464	gnomAD
Q8IV63	VRK3	T188A	T	188	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T138A	T	138	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T188A	T	188	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	T138A	T	138	A	-	neutral	AC/AN:0.03176 ; Hom/AC:0.08398	gnomAD
Q8IV63	VRK3	F171L	F	171	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F171L	F	171	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F139L	F	139	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	F121L	F	121	L	-	neutral	AC/AN:0.03234 ; Hom/AC:0.08649	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P73T	P	73	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P105T	P	105	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	P55T	P	55	T	-	neutral	AC/AN:0.03229 ; Hom/AC:0.08635	gnomAD
Q8IV63	VRK3	S59F	S	59	F	-	neutral	AC/AN:0.03217 ; Hom/AC:0.08610	gnomAD
Q8TDC3	BRSK1	G749S	G	749	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q8TDC3	BRSK1	G444S	G	444	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q8TDC3	BRSK1	G765S	G	765	S	-	neutral	AC/AN:0.17501 ; Hom/AC:0.05098	gnomAD
Q96RU7	TRIB3	Q84R	Q	84	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q96RU7	TRIB3	Q111R	Q	111	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q96RU7	TRIB3	Q84R	Q	84	R	-	neutral	AC/AN:0.40659 ; Hom/AC:0.11093	gnomAD
Q8TDR2	STK35	R69G	R	69	G	-	neutral	AC/AN:0.81385 ; Hom/AC:0.17843	gnomAD
Q9P286	PAK5	S511N	S	511	N	208	neutral	AC/AN:0.85408 ; Hom/AC:0.21473	gnomAD
Q9P286	PAK5	R335P	R	335	P	-	neutral	AC/AN:0.28536 ; Hom/AC:0.08907	gnomAD
Q9P286	PAK5	G118D	G	118	D	-	neutral	AC/AN:0.05270 ; Hom/AC:0.07614	gnomAD
Q8N2I9	STK40	V312M	V	312	M	766	neutral	AC/AN:0.60435 ; Hom/AC:0.15429	gnomAD
Q8N2I9	STK40	V257M	V	257	M	584	neutral	AC/AN:0.60435 ; Hom/AC:0.15429	gnomAD
Q9H3Y6	SRMS	V457L	V	457	L	759	neutral	AC/AN:0.16202 ; Hom/AC:0.09787	gnomAD
Q9H3Y6	SRMS	A453T	A	453	T	753	neutral	AC/AN:0.23072 ; Hom/AC:0.11041	gnomAD
Q9H3Y6	SRMS	P452L	P	452	L	752	neutral	AC/AN:0.06895 ; Hom/AC:0.14812	gnomAD
Q9H3Y6	SRMS	A397V	A	397	V	536	neutral	AC/AN:0.06557 ; Hom/AC:0.13550	gnomAD
Q9H3Y6	SRMS	V301L	V	301	L	266	neutral	AC/AN:0.09508 ; Hom/AC:0.08783	gnomAD
Q9H3Y6	SRMS	P218L	P	218	L	17	neutral	AC/AN:0.15206 ; Hom/AC:0.08715	gnomAD
Q9H3Y6	SRMS	I88V	I	88	V	-	neutral	AC/AN:0.05253 ; Hom/AC:0.12599	gnomAD
P57058	HUNK	R591C	R	591	C	-	neutral	AC/AN:0.52329 ; Hom/AC:0.12303	gnomAD
P57078	RIPK4	A12G	A	12	G	17	neutral	AC/AN:0.29974 ; Hom/AC:0.07703	gnomAD
P57059	SIK1	G15S	G	15	S	19	neutral	AC/AN:0.52904 ; Hom/AC:0.12422	gnomAD
Q07002	CDK18	S278R	S	278	R	429	neutral	AC/AN:0.32490 ; Hom/AC:0.09690	gnomAD
O60566	BUB1B	H310R	H	310	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	H230R	H	230	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	H299R	H	299	R	-	neutral	AC/AN:0.31318 ; Hom/AC:0.07271	gnomAD
O60566	BUB1B	R175Q	R	175	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R176Q	R	176	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R95Q	R	95	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
O60566	BUB1B	R164Q	R	164	Q	-	neutral	AC/AN:0.31225 ; Hom/AC:0.07246	gnomAD
Q96PF2	TSSK2	T280M	T	280	M	802	neutral	AC/AN:0.50665 ; Hom/AC:0.11998	gnomAD
P53671	LIMK2	G35S	G	35	S	-	neutral	AC/AN:0.35065 ; Hom/AC:0.11460	gnomAD
P53671	LIMK2	Q684R	Q	684	R	-	neutral	AC/AN:0.13604 ; Hom/AC:0.11803	gnomAD
P53671	LIMK2	Q627R	Q	627	R	-	neutral	AC/AN:0.13604 ; Hom/AC:0.11803	gnomAD
O15075	DCLK1	S648G	S	648	G	795	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
O15075	DCLK1	S598G	S	598	G	638	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
O15075	DCLK1	S648G	S	648	G	795	neutral	AC/AN:0.86883 ; Hom/AC:0.23017	gnomAD
P53778	MAPK12	T103M	T	103	M	257	neutral	AC/AN:0.14636 ; Hom/AC:0.05496	gnomAD
P53778	MAPK12	T23M	T	23	M	27	neutral	AC/AN:0.14636 ; Hom/AC:0.05496	gnomAD
